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Abstract 
 
Rosacea is a chronic inflammatory dermatological condition that has been reported 
to affect at least 3% of the population in Ireland. Symptoms are concentrated around the 
center of the face and include chronic inflammation, telangiectasias and inflammatory 
lesions (papules, pustules and plaques). Up to 50% of those suffering from rosacea have 
symptoms that manifest in the periocular region, including irritation, inflammation of the 
eyelids (blepharitis), increased vascularisation of the ocular surface and in severe cases 
inflammation of the cornea (keratitis) can develop leading to sterile ulcers and visual 
impairment. Individuals with rosacea often have an elevated presence of Demodex mites in 
their skin follicles and eyelashes. Bacillus oleronius is a gram negative bacterium isolated 
from a Demodex folliculorum mite from the face of a rosacea patient. Antigens associated 
with the bacterium (62 and 83 kDa) were isolated and shown to cause immunoreactivity in 
the serum of papulopustular rosacea patients. A collaboration with Dr. Scheffer Tseng 
(Ocular Surface Research Centre, Miami) lead to the publication of work that proved a 
strong correlation has between serum reactivity to these B. oleronius antigens and eye lid 
margin inflammation (p = 0.04), and ocular rosacea (p = 0.009). Proteomics techniques 
were used to investigate the environmental conditions which lead to antigen production in 
the bacterium. Another area of focus was the effect of Bacillus proteins on Neutrophils and 
Corneal epithelial cells. Neutrophils are known to play a part in the development of 
inflammation in rosacea. Our studies showed that there was an increase in neutrophil 
degranulation, migration and cytokine production following exposure to the bacterial 
antigens. Corneal epithelial (hTCEpi) cells responded to the bacterial antigens by increasing 
motility and migration, decreasing proliferation and altering protein production. This work 
provides strong evidence for the role of Demodex associated Bacillus proteins in the 
development of facial and ocular symptoms of rosacea. 
 
 
 CHAPTER 1 
 
 
 
Introduction 
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1.1 Rosacea 
 
Rosacea is typically described as a chronic inflammatory dermatological 
disorder. The onset of the condition usually occurs between the ages of 30-50 years 
(Dahl et al., 2002) with approximately 57% of cases diagnosed in the under 50’s 
(Elewski et al., 2010). Rare cases have been reported in children as young as four 
(Cetinkaya & Akova 2006). Symptoms can progress from ‘pre-rosacea’ characterised 
by transient flushing to repeated flushing and inflammation that cause vascular damage 
(Gupta and Chaudhry 2005). The course of the disease consists of exacerbations 
followed by periods of remission and can be controlled with treatment and avoidance of 
certain trigger factors rather than cured. Symptoms are concentrated in the t-zone which 
consists of the forehead, nose and chin (Figure 1.1), and can extend towards the cheeks, 
ears and neck. Excess production of sebum (the body’s natural oil) may occur in the 
skin of the t-zone due to the presence of a greater number of sebaceous glands. The role 
of sebum in the pathogenesis of rosacea is unknown however it has recently been shown 
that paptients with papulopustular rosacea (PPR) have an abnormal sebaceous fatty acid 
composition (Ni Raghallaigh et al., 2012) these findings indicate the possibility of 
employing sebum-modifying nonantibiotic treatments. 
Reports have suggested the prevalence of rosacea is as high as 10% of the 
population in Sweden (McAleer et al., 2010) and according to the National Rosacea 
Society over 16 million Americans are estimated to have rosacea. The study carried out 
by McAleer et al., (2010) estimated the prevalence of Papulopustular rosacea in Ireland 
at 2.7%. Table 1.1 is adapted from that study and lists results from six studies carried 
out in five countries with occurrence in the populations ranging from 0.9% – 10%. 
Some reports have suggested that occurrence is more frequent in women (Elewski et al., 
2010) however some reports claim both genders are equally affected but symptoms can 
be more severe among men (Fimmel et al., 2008). It occurs among all racial 
demographics however increased frequency among fair skinned individuals suggests a 
genetic predisposition and has lead to rosacea being referred to as the ‘Curse of the 
Celts’. 
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Figure 1.5 Schematic view of the region of the face where rosacea symptoms 
typically occur. 
Symptoms of rosacea are often concentrated in the t-zone region of the face, which is 
indicated above. 
[Taken from the website: www.getacnehomeremedies.info/search/overview-on-rosacea-
acne-treatment-causes-and-prevention] 
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Population Country Intention of 
Study 
Population 
type 
Rosacea 
definition  
Prevalence 
2341 Denmark 
(Faroe 
Islands) 
Prevalence of 
skin 
Diseases 
Households Not defined 0.09% 
809 Sweden Prevalence of 
rosacea 
 
Office 
workers 
ETT: redness 
and 
telangiectasia 
of face; PPR: 
papules and 
pustules of 
face 
10% (ETT: 
8.2%; 
PPR: 1.8%) 
9293 United 
States  
Health survey  Sample of 
civilian 
US 
population 
Not defined 1.9% 
402 United 
States 
Relationship 
between 
childhood stye 
and rosacea 
Database of 
medical 
records 
Not defined 2.1% 
50,237 Greece Rosacea in 
dermatology 
outpatients 
Database of 
dermatology 
outpatients 
Not defined 1.22% 
(ETT: 
0.88%; 
PPR: 
0.34%) 
1000 Ireland Prevalence of 
papulopustular 
rosacea (PPR) 
and its 
relationship to 
UV 
Radiation 
500 hospital 
staff and 
500 
inhabitants 
of the Aran 
Islands 
PPR 2.7% (PPR) 
 
ETT = Erythematotelangiectatic Rosacea PPR = Papulopustular Rosacea 
Table 1.1 Summary of Rosacea prevalence from six studies. Adapted from 
(McAleer et al., 2010). 
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1.2 Diagnostic Features 
 
Despite the fact that rosacea is a common condition that causes visible 
symptoms that are painful and can lower the self esteem of those affected the 
pathogenesis of the condition remains elusive. Patients present with a range of 
symptoms including: cutaneous abnormalities such as flushing, telangiectasia, 
erythema, papules, pustules, edema ocular lesions and rhinophyma (Crawford et al., 
2004). Unfortunately no serologic or diagnostic assays exist for diagnosis of the 
condition. 
 According to the standard classification of rosacea reported by the National 
Rosacea Society the presence of one or more of the primary features affecting the 
central convexities of the face indicates a diagnosis of rosacea (Dahl et al., 2002). 
Primary diagnostic features include transient flushing, non-transient erythema 
(persistent redness of the facial skin), telangiectasia (dialated small blood vessel) or the 
presence of papules (red dome shaped elevations of the skin) and pustules (skin 
elevation containing fluid consisting of white blood cells). These symptoms may occur 
simultaneously or independently and most individuals have underlying extremely 
sensitive skin. 
 Secondary features usually accompany the primary features but can occur 
independently in some individuals. They include stinging sensation, dry skin, elevated 
red plaques or edema (soft or solid which is exacerbated by inflammation). The most 
common secondary feature are ocular manifestations occurring in up to 50% of 
individuals with rosacea (Elewski et al., 2010). 
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1.3 Rosacea Subtypes 
 
The National Rosacea Society developed a standard classification system that 
describes four subtypes and one variant (Granulomatus rosacea). Those subtypes are 
Erythematotelangiectaic, Papulopustular, Phymatous and Ocular (Dahl et al., 2002). In 
2004 the society published a further report focused on the grading of severity of the 
condition (Wilkin et al., 2004). Primary symptoms are graded from mild, moderate or 
severe (0-3) and secondary symptoms are deemed present or absent. This grading 
system aids the physician in deciding the course of therapy. 
 
1.3.1 Erythematotelangiectatic Rosacea 
Type one rosacea (Erythematotelangiectatic rosacea) is characterised by 
persistent erythema and telangiectases in the central region of the face (Figure 1.2). The 
erythema or flushing associated with this type of rosacea can last over 10 minutes 
therefore it can be distinguished from the blushing seen in response to embarrassment. 
The small dilated blood vessels (telangiectasias) often appear as the condition worsens 
to grade 2 or 3 (Crawford et al., 2004). People with this subtype of rosacea have 
extremely sensitive skin that can be rough or scaly and usually report itching, burning 
and stinging sensations in response to topical application of creams to the skin even 
those prescribed to treat the condition. 
 
1.3.2 Papulopustular Rosacea 
Patients with Papulopustular rosacea often present with symptoms of type one 
rosacea combined with persistent papules (red elevations of the skin that can be up to 10 
mm in diameter) and pustules (smaller elevations containing inflammatory cells that 
appear as a cloudy fluid). In severe cases of this subtype (grade 3), the papules and 
pustules can form and inflammatory legion or plaque (Figure 1.3). This condition was 
originally described as acne rosacea however the presence of telangiectasias, more 
persistent erythema and the absence of comodones can assist physicians in 
distinguishing the two allowing a proper diagnosis of papulopustular rosacea. 
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1.3.3 Phymatous Rosacea 
Phymatous rosacea presents as thickening of the skin accompanied by irregular 
nodules usually concentrated in the nasal region, rhinophyma (Figure 1.4) but can occur 
on the ears forehead, cheeks and chin. This condition can occur in conjunction with the 
first two subtypes but can present spontaneously without any other symptoms. This is 
the rarest subtype of rosacea and has been reported to be up to 20 times more common 
in men and at its most severe stage this condition requires surgical correction (Powell, 
2005). 
 
1.3.4 Ocular Rosacea 
As with the preceding subtypes, ocular rosacea can present in combination with 
symptoms of types one and two rosacea, it can also occur prior to or spontaneously of 
any cutaneous manifestations (Oltz & Check 2011). As seen in Figure 1.5, this 
condition often presents as inflammation of the eyelids (blepharitis or conjunctivitis). 
Patients also experience burning, stinging or dryness of the eyes, telangiectasias of the 
corneal surface, blurred vision, cylindrical dandruff of the eyelashes and chronic 
meibomian gland dysfunction. Keratitis is a severe but uncommon complication that 
can lead to the formation of nodular scars and sterile ulcers of the corneal surface which 
cause visual impairment. Figure 1.5 provides an example of the grading system used by 
physicians (Wilkin et al., 2004).Three cases of ocular rosacea are graded A-C with A 
representing a mild case and C representing the severe ocular manifestations of rosacea. 
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Figure 1.6 Erythematotelangiectatic Rosacea 
[Taken from Powell, (2005)] 
 
 
Figure 1.7 Picture of Papulopustular Rosacea symptoms. Severe papulopustular 
rosacea with moderate ocular involvement. 
[Taken from Powell, (2005)] 
Formation of 
inflammatory 
plaque. 
Inflammatory 
lesions on the 
eyelid. 
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Figure 1.8 Phymatous Rosacea 
[Taken from the website www.acne.org/facial-rosacea.html] 
 
 
Figure 1.5 Ocular Rosacea graded mild (A), moderate (B) and severe (C). 
[Taken from Wilkin et al., 2004] 
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1.3.5 Rosacea Variants 
The National Rosacea Society recognises one variant of the condition called 
Granulomatous rosacea. This condition is characterised by the appearance of papules or 
nodules on the cheeks and periorificial areas that are hard, yellow, brown or red in 
colour and can lead to severe scarring (Dahl et al., 2002). Skin underlying the nodules 
appears normal unlike in papulopustular rosacea where underlying skin is usually 
sensitive and prone to erythema. It has been suggested that ultraviolet radiation (UVR) 
exposure is a more prominent causative factor in granulomatous variant rosacea 
compared to non-granulomatous rosacea due to a measured up-regulation of matrix 
metalloproteinases (MMPs), (Jang et al., 2010). 
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Figure 1.6 Granulomatous Rosacea 
[Taken from the website http://dermis.net/bilder/CD008/550px/img0002.jpg] 
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1.4 Factors that trigger rosacea symptoms 
 
The classification and grading of rosacea is now well established (Dahl et al., 
2002; Wilkin et al., 2004) however there is no definitive agreement of the causative 
agents responsible for this condition or its pathogenesis. Factors such as alterations in 
the innate immune response, vascular changes and the presence of reactive oxygen 
species within the skin have been suggested as playing a role in the induction and 
persistence of the condition (Yamasaki & Gallo, 2009). Reports have suggested an 
underlying genetic susceptibility in those affected by rosacea (Bamford 2001) which is 
exacerbated by a number of triggers (Gupta & Chaudhry 2005). Individuals that suffer 
from transient flushing are said to be in the pre-rosacea stage and may benefit from 
identifying the factors that trigger symptoms so they can be avoided. The study by 
Gupta and Chaudhry, (2005) includes an extensive list of items known to trigger 
prolonged blushing or erythema (Figure 1.2) in rosacea patients. The list includes 
certain foods, alcoholic or hot beverages, skincare products, exposure to the sun, hot 
temperatures in saunas or humid environments, cold and windy weather, physical 
exertion or stress. Some of the triggers listed are not easy to avoid such as certain 
medications, vasodilators and topical steroids, or certain medical conditions, 
menopause, caffeine withdrawal syndrome or chronic cough (Gupta & Chaudhry, 
2005). The paper mentions a survey carried out by the National Rosacea Society of 
2083 rosacea patients in relation to avoidance of flare ups of symptoms that says 78% of 
patients said avoiding trigger factors that aggravate their condition had been effective in 
decreasing flare-ups (http://www.rosacea.org/rr/1999/spring/ article-3.php). Figure 1.7, 
is taken from a review article (Yamasaki & Gallo, 2009) which gives a comprehensive 
outline of triggers and contributing factors that ultimately cause dysregulation of the 
immune response leading to the appearance of chronic symptoms. 
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Figure 1.7 Schematic of environmental factors involved in rosacea and the immune 
changes that are triggered due to exposure to these factors. 
[Taken from Yamasaki & Gallo, 2009] 
  
13 
 
1.5 Demodex Mites (Demodex folliculorum and Demodex brevis) 
 
Demodex mites are dermal mites that colonise human skin and feed on sebum 
produced in the glands and were first described as a commensal organism in the 1840s 
(Vu & English, 2011). The German dermatologist Gustav Simon first located the mite 
upon examination of the contents of acne lesions which prompted interest in the 
pathogenesis of the mite (Lacey et al., 2011; Fell 1886). There are two species that 
inhabit humans, Demodex folliculorum are usually located in the hair follicles while 
Demodex brevis burrow deeper into the sebaceous and meibomian glands (Bonnar et 
al., 1993). Both mites were extensively re-examined by Desch and Nutting (1972). The 
mite body consists of gnathosoma (mouth parts), podosoma with four pairs of evenly 
spaced legs (inboth species) and the opisthosoma containing the abdomen (longer in D. 
folliculorum than D. brevis). A finding which may contribute to Demodex pathogenesis 
is that they have no anus (Lacey et al., 2011) therefore ingested material such as 
microbes are stored and can proliferate in an environment that is sheltered from the host 
immune system. 
Most individuals become colonised in childhood and numbers proliferate around 
the time of puberty when the sebum level is present in the skin increases (Desch and 
Nutting, 1972) the prevalence is said to be 80-100% in those over 50 (Vu & English 
2011). D. folliculroum can be found singly or in groups where as D. brevis is most 
likely to be found as a single specimen (Desch and Nutting, 1972). These mites ingest 
bacteria along with sebum and follicular epithelial skin cells and have been implicated 
in the transfer of bacteria from person to person or from one location on the host to 
another (Powell, 2005; Desch and Nutting, 1972). There life cycle (Figure 1.8) is said to 
be around 2.5 weeks (Lacey et al., 2011). At the end of the lifecycle mites could release 
bacteria into the hair follicle causing a localised innate immune response. Mites 
reportedly stay alive on their human host for up to 55 hours after death of the host 
therefore they are useful when determining time of death (Özdemir, 2003). 
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Figure 1.8 Life Cycle of the Demodex mite 
[Taken from the website www.thejamushop.com/demodex_faq.htm] 
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1.5.1 The pathogenic properties of Demodex mites 
Although the pathogenicity of Demodex species has been disputed since they are 
inhabitants of normal skin, localised inflammation is often seen in follicles containing 
mites particularly when mite density proliferates (Elston, 2010). Presence of Demodex 
has been linked to inflammation, blockage of follicles and foreign body granulomatous 
reactions (Figure 1.9) (Lazaridou et al., 2011). Since the discovery of these ubiquitous 
mites they were associated with acne (Fell 1886) and many other dermatological and 
ophthalmological conditions. The mite acts as a vector for surface microorganisms and 
endosymbionts, this characteristic is likely to contribute to its pathogenicity (Lacey et 
al., 2011). Demodex mites have been shown to carry Staphylococcus albus and transmit 
these from one hair follicle to another (Norn, 1972). Demodex have also been shown to 
carry Microsporon canis (Wolf et al., 1988). The Demodex mite or its secretions have 
been suggested as a causative agent for the inflammation seen in blepharitis (Kim et al., 
2011; Liu et al.,2010; Neiberg and Sowka, 2008). The study by Kim et al., (2011) 
indicated that the elevation of tear cytokines that contributes to lid margin and ocular 
surface inflammation was caused by increased Demodex density. Increased mite density 
is the causative factor in demodicosis and Demodex folliculitis (Hsu, and Lee 2009; 
Forton et al., 2005; Vu and English, 2011) both of these conditions have a rosacea like 
appearance. 
Demodex mites have been implicated in the induction of rosacea for over 50 
years (Ayres & Ayres, 1961). These mites have been seen follicles and biopsies of 
rosacea patients (Lacey et al., 2007). Individuals with rosacea have been shown to have 
a higher density of Demodex mites in their skin compared to controls (Bamford 2001; 
Bonnar et al., 1993) using a cyanoacrylate glue skin surface biopsy test. Sampling of 
eyelashes (Figure 1.10) is another popular method of counting Demodex density and 
this technique was employed to establish that the mite population is higher in the 
eyelashes of those with rosacea than those without the condition (Li et al., 2010). 
Although there is evidence of increased mite density in those with rosacea it has been 
disputed whether this is a contributing factor to the pathogenesis of the condition or 
simply a proliferation of mites due to sebum rich conditions (Dhingra et al., 2009). 
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Figure 1.9 Demodex mites associated with papules of Granulomatous 
rosacea 
Histopathology of a papule shows inflammatory infiltrate consisting of 
lymphocytes and neutrophils around a hair follicle with two mites present in the 
infiltrate indicated by the arrows 
[Taken from the website http://dermatology.cdlib.org/134/case presentations/ 
demodex/lee.html] 
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Figure 1.10 Demodex mites associated with the eyelashes of rosacea patients 
Image E shows a family of D. folliculorum mites adjacent to the lash follicle, 
including an egg (arrowhead), two larvae which had three to four pairs of poorly 
developed legs and a slender body (arrows), and an adult with four pairs of well-
developed legs (*) and a stumpy body. 
 
[Taken from Gao et al., 2005] 
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1.6 Endosymbiotic bacteria and bacterial antigens in human disease 
 
In a previous study bacterial samples were taken from the faces of individuals 
with papulopustular rosacea and controls which lead to the isolation of Bacillus 
oleronius (Delaney, 2004). This bacterium was isolated from a micro-dissected 
Demodex mite and was thought to be an endosymbiont of the hindgut of the mite. 
Demodex mites have no excretory anus therefore it was postulated that this bacterium 
could aid digestion in the mite (Delaney, 2004; Lacey, 2007). Peripheral blood 
mononuclear cells (PBMC) were isolated from rosacea patients and controls and the T-
cell reactivity to B. oleronius was present in 72% of rosacea patients and 29% of 
controls (p=0.01) (Lacey et al., 2007).  
Microbes are capable of adapting to niches in hostile environments that are 
uninhabitable to any other forms of life (Tehei et al., 2004). However the most popular 
habitat of microbes is within a living host which can be beneficial or detrimental to that 
host (Moran 1996). Several bacterial species maintain a symbiotic relationship with 
mites, ticks or insects which cause disease (Hoy and Jeyaprakash, 2005; Mathaba et al., 
2002; Oliveira et al., 2006). The study by Oliveira et al., (2006) described the 
occurrence of sheep scab caused by the mite Psoroptes ovis and suggests an association 
between Staphylococcus aureus and the disease causing mite. Bacterial enzymes have 
been associated with the pathogenic properties of house dust mites such as 
Dermatophagoides pteronyssinus and Dermatophagoides farina (Mathaba et al., 2002). 
Wolbachia was investigate as a possible endosymbiotic microorganism in Demodex 
mites but no association was proven (Lazaridou et al., 2011). Wolbachia has an 
endosymbiotic relationship with parasitic filarial nematodes that cause devastating 
diseases such as elephantiasis and river blindness in over 150 million people in some of 
the world’s poorest communities (Taylor, 2002). The inflammation seen in these 
conditions is associated with an endotoxin-like activity when upon death of the 
nematodes the bacteria are released into the blood stream. The bacteria are essential to 
their nematode host and are thought to be involved in protection from the human 
immune system via production of catalase (Taylor, 2002).  
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It is well established that antigens and superantigens produced by Streptococci 
and Staphylococci bacteria have been associated with the induction of a variety of 
diseases such as psoriasis, food poisoning, inflammatory disorders and shock 
syndromes (Lu, 2003; Nickoloff & Wrone-Smith, 1998; Valdimarsson et al., 1995). 
Antigenic material isolated from the bacterium Propionibacterium acnes has been 
implicated in the inflammation of acne since T-cell proliferation has been seen in 
response to bacterial culture supernatant (Jappe et al., 2002). These examples indicate a 
possible role for micro-organisms in the induction and persistence of these diseases. 
Therapy that eliminates micro-organisms can have the potential to reduce or clear the 
symptoms of these conditions. 
 
1.6.1 Role of Bacillus oleronius in the induction of rosacea 
The success of treating rosacea with antibiotics such as metronidazole, 
tetracyclines and erythromycin implies a role for bacteria in the condition, however no 
specific organism has been definitively proven as having a pathogenic role and it has 
been suggested that these antibiotics may act primarily as anti-inflammatory agents 
rather than by inhibiting a specific bacterium. Bacillus oleronius has been under 
investigation as a potential contributing factor to the pathogenesis of rosacea for the last 
10 years. The bacterium was isolated from a Demodex folliculorum mite from a rosacea 
patient (Delaney, 2004) which produced antigens that induced an inflammatory immune 
response in 72% of rosacea patients but only 29% of controls (p = 0.01) (Lacey et al., 
2007). B. oleronius was previously isolated from the digestive tract of a termite where it 
facilitates digestion (Kuhnigk et al., 1995). The bacterium has also proven susceptible 
to treatment with tetracycline, doxycycline, and minocycline, which are often used to 
treat rosacea (Lacey et al., 2007). Delaney, (2004) also highlighted the two stimulatory 
antigens (62 and 83 kDa) which were to become the focus of subsequent studies. A 
strong correlation has been established between ocular Demodex inflammation and 
serum reactivity to these antigens in patients with ocular rosacea. In addition eye lid 
margin inflammation (p = 0.040) and facial rosacea (p = 0.009) were found to correlate 
with reactivity to these antigens (Li et al., 2010). These two studies (Lacey et al., 2007; 
Li et al., 2010) suggest a possible role for bacterial antigens in the etiology of rosacea.  
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1.7 Treatment of Rosacea 
 
Although the etiology of rosacea remains ambiguous, there are a variety of 
successful treatment options (Powell, 2005). A systematic review of treatments for 
rosacea was published in 2007, based on data from 29 studies (van Zuuren et al., 2007). 
Findings of this review revealed that many of the studies investigating rosacea 
treatments were not well designed and very few assessed the important factor of the 
quality of life in participants. The review confirmed that systemic and topical antibiotics 
are the most popular therapies prescribed by physicians. A lot of emphasis has been put 
on the success of avoidance of ‘trigger factors’ in order to prevent the onset of flushing, 
erythema and inflammation (Gupta & Chaudhry, 2005). Rosacea patients often have 
extremely sensitive skin and therefore moisturizers and cosmetics must be chosen 
carefully and daily use of sunscreen (at least factor 15) is recommended (Pelle et al., 
2004). Without the identification of a causative agent in the condition the success of 
antibiotic treatments has been attributed to their anti-inflammatory properties rather than 
reducing bacteria (Monk et al., 2011). Many of the agents most commonly used to 
control rosacea such as tetracyclines, azelaic acid, retinoids and metronidazole inhibit 
reactive oxygen species (ROS) production and lead to a clearance of symptoms thus 
suggesting that control of the immune response is an important aspect of treatment 
(Monk, 2011). 
Topical treatments include metronidazole (0.75% gel or 1% cream) which is an 
effective treatment for moderate to severe rosacea (Crawford et al., 2004). This 
treatment is proven to inhibit the generation of ROS and reduce papules, pustules and 
erythema (Elewski et al., 2010), however it had limited effect on telangiectasia. Alzelaic 
acid is another effective topical treatment (15% gel, 20% cream) that has both 
antimicrobial and anti-inflammatory properties (Elewski et al., 2010). This treatment 
has also been proven to reduce ROS and can successfully reduce papules, pustules and 
erythema (Oltz & Check 2011). Sodium sulfacetamide 10% + sulfur 5% has proven 
effective as a topical emollient, antimicrobial, antifungal and antidemodectic properties 
have been recorded (Oltz & Check 2011). This treatment can also reduce inflammatory 
lesions and erythema (Gupta & Chaudhry, 2005). Effective oral antibiotics include 
doxycycline, minocycline, erythromycin and metronidozole which are generally used at 
sub-antimicrobial levels for up to 4 months (Powell, 2005). Currently the only FDA 
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approved oral treatment for papulopustular rosacea is a 40 mg per day anti-
inflammatory dose of doxycycline which comes in the form of a slow release capsule 
(Oltz & Check 2011).  
When treating ocular rosacea physicians often prescribe a combination of oral 
medication and one of the topical antibiotics can also be applied to the lid margin 
(Elewski et al., 2010). The use of tea tree oil (TTO) for ocular rosacea has also proven 
successful (Gao et al., 2005; Kheirkhah et al., 2007; Liu et al., 2010). This treatment is 
proven to reduce Demodex mite numbers as well as having antibacterial and anti-
inflammatory effects on the eye-lids and corneal surface. The proposed method of 
treatment is weekly lid scrubs with 50% tea tree oil and a daily lid scrubs with tea tree 
shampoo for a minimum of six weeks (Gao et al., 2005). This method can eradicate 
Demodex mites from the lashes, decrease inflammation, vascularisation and reduce 
phlyctenule-like lesions in some cases. Kheirkhan et al., (2007) described a case study 
of an ocular rosacea patient who underwent amniotic membrane transplant but had a 
relapse in symptoms. After following the TTO treatment the patient’s symptoms and 
vision had improved (Figure 1.11) and there was no evidence of limbal stem cell 
deficiency. 
In severe cases of phymatous (Wollina 2011) and ocular (Kheirkhah et al., 
2007) rosacea surgery is required in the latter stages of treatment. In the case of 
phymatous rosacea or rhinophyma surgical techniques such as, excision of excess tissue 
under general anesthesia, dermabrasion or carbon dioxide laser vaporization may be 
used (Wollina 2011). Advanced cases of ocular rosacea can lead to partial or complete 
limbal stem cell deficiency. In the case of partial limbal stem cell deficiency amniotic 
membrane transplantation can effectively restore a stable corneal epithelium. Where 
limbal stem cell deficiency affects the whole limbus, transplantation of limbal tissue 
from the individuals healthy eye (autologous) or from a HLA matched allogenic donor 
or a non-matched cadaver can be used to obtain a stable corneal epithelium (Ahmad et 
al., 2010; Elewski et al., 2010; Kheirkhah et al., 2007). All of the subtypes of rosacea 
can incorporate vascular changes such as erythema and formation of telangiectactic 
vessels direct treatment of these symptoms can be achieve with intense pulsed light 
(IPL) systems and lasers (Kautz & Kautz, 2008). 
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Although there are many proven anti-inflammatory agents derived from natural 
sources these have not been investigated extensively in rosacea (Emer et al., 2011). This 
study describes the hydrating and anti-inflammatory effects of phenolic compounds 
derived from colloidal oatmeal which are proven to be UV absorbent and capable of 
reducing IL-8 in keratinocytes in vitro. Nicotinamide or vitamin B3 was also mentioned 
for its ability to reduce sebum and liquorice extract can inhibit ROS and has soothing 
properties (Emer et al., 2011). To become established as part of the regular treatment of 
rosacea these ingredients would need to be researched further and perhaps would serve 
to augment the effects of the typical antibiotic treatments. 
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Figure 1.11 Photographs demonstrating a case study of an individual with rosacea 
and ocular Demodex infestation.  
Top line represents symptoms before treatment both eyes are affected by peripheral 
scarring, conjunctival involvement and vascularisation of the corneas. 
Bottom line represents the outcome of treatment with Tea Tree Oil; vascularisation and 
scarring have decreased.  
[Adapted from Kheirkhan et al., 2007] 
  
24 
 
1.8 Neutrophils and the innate immune response 
 
 The innate immune response is the first line of defence that the body employs in 
response to pathogens (Segal 2005). Neutrophils are highly active and motile 
phagocytes that respond to molecular signals from invading pathogens or damaged host 
cells by travelling rapidly to sites of infection or damaged tissue to engulf potential 
threats by phagocytosis (Figure 1.12). Chemokines and cytokines are important 
components of the innate immune response involved in recruitment and activation of 
neutrophils. IL-8 is particularly important in the early stages of infection, it binds LPS 
and its production can be triggered by other cytokines (Kenny and O'Neill, 2008). 
Neutrophils are recruited to the site of infection (Figure 1.13 & 1.14) and begin to 
change their morphology in response to cytokines, they express adhesive molecules so 
they can cling to the walls of blood vessels and enter the site of infection (Appelberg, 
2007). TNF-α is also important in the induction of inflammation. 
Upon exposure to certain stimulants such as microbes, the neutrophil becomes 
activated and increases its oxygen uptake leading to a ‘respiratory burst’ (Manara et al., 
1991). The molecular oxygen consumed during this burst is utilised in the oxidative 
mechanism of killing carried out by the neutrophil (Curnutte et al., 1987). Following the 
closure of the phagocytic vacuole that internalises the pathogen, NADPH oxidase 
located on the membrane of the phagosome is activated (Segal, 2005). This mechanism 
is characterised by the production of reactive oxygen species (ROS) facilitate by 
NADPH oxidase. The membrane bound NADPH oxidase enzyme causes the single 
electron reduction of oxygen to superoxide anion (O2
-
) (Curnutte et al., 1987). The 
superoxide anion is then involved in the generation of ROS such as, hydrogen peroxide 
(H2O2), hydroxyl radical (OH-) or peroxynitrite resulting from an interaction with 
nitric oxide (NO) (D’Agostino et al., 1998). 
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Figure 1.12 Schematic representation of Neutrophil phagocytosing a pathogen 
Yellow oval represents pathogen. Neutrophil granules are depicted forming part of the 
lysosome and releasing antimicrobial peptides into the extracellular space. 
[Taken from Levy, 2000] 
 
 
Figure 1.13 Schematic representation of Neutrophil response to pathogens 
Recognition of pathogens triggers migration of neutrophils and signaling from cells of 
the innate immune response that leads to inflammation. 
[Taken from the website http://www.nature.com/nm/journal/v7/n10/fig_tab/nm1001-
1105_F1.html] 
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Degradation of the ingested microbe in the phagocytic vacuole by non-oxidative 
mechanisms due to neutral serine proteases, hydrolytic enzymes and cationic proteins 
can also occur (Segal 2005; Pham 2008). These proteolytic enzymes are packaged 
within cytoplasmic granules that are released upon cell activation in the process of 
degranulation. Degranulation accompanies the process of ROS production following a 
lag of around 20 seconds (Segal, 2005). Degranulation involves the fusion of 
membranes and release of the granular contents into the phagosome and the 
extracellular space (Manara et al., 1991). Neutrophils contain primary azurophilic, 
secondary, gelatinase and lysosome granules (Figure 1.12) which contribute to the 
killing of internalised microbes. 
There is a vast array of proteins released by neutrophil granules; among them is 
Myeloperoxidase (MPO), Matrix metalloproteinase 9 (MMP-9) and Human cathelicidin 
18 (hCAP-18). These three granule components are investigated in Chapter 4. MPO is a 
component of primary granules and in the presence of hydrogen peroxide produces 
hypochlorous acid (Reeves, 2003). MPO comprises approximately 25% of granule 
protein and around 5% of the whole neutrophil proteome (Segal, 2005). This heme 
enzyme utilizes hydrogen peroxide to generate hypochlorous acid (HOCl) thus 
providing a protective mechanism against pathogens and contributes to oxidative injury 
of host tissue (Jantschko et al., 2005). 
Matrix metalloproteinase enzymes (MMPs) are components of the gelatinase 
granules and are responsible for degradation of extracellular matrix components during 
inflammation (Lu & Wahl, 2005). MMPs are implicated in many inflammatory diseases 
(Manicone & McGuire 2008) including rosacea (Jang et al., 2010), where they are 
implicated in vascularisation in rosacea (Yamasaki & Gallo, 2009). The effectiveness of 
treatments such as tetracyclines is attributed mainly to anti-inflammatory properties 
associated to the inhibition of MMP production (Federici 2011).  
Human cathelicidin (hCAP-18) or its peptide form LL-37 are associated with the 
secondary or specific granules of the neutrophil which are readily secreted into the 
extracellular space (Levy 2000) (Figure 1.12). Cathelicidin promotes the release of IL-8 
and therefore the recruitment of neutrophils and has been implicated in the 
inflammatory processes of psoriasis, atopic dermatitis and rosacea (Morioka et al., 
2008). 
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Figure 1.14 Image representing Neutrophils migrating from the blood vessels to 
phagocytose and degranulate pathogens in surrounding tissue. 
[Taken from the website http://www.rmgh.net/wiki/images/d/dc/Active_neutrophils.jpg] 
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1.9 Innate immunity of the ocular surface 
  
As a vital sensory organ that is almost continually exposed to our surrounding 
environment the eyes have a number of defence mechanisms. Mechanical protection 
from pathogens and debris is provided by blinking and by the action of tears. Tears also 
contain proteins including bactericidal agents (e.g., IgA, lysozyme, lactoferrin in tear 
fluids, and all isoforms of human beta defensins) that act directly to kill pathogens (Ueta 
& Kinoshita, 2010). If pathogens successfully adhere to the ocular surface, the 
protective role of epithelial cells is activated (Hozono et al., 2006). The ocular surface is 
covered by two distinct epithelial cell types the conjuctival and corneal epithelia 
separated by the limbal region (O'Sullivan, 2007) (Figure 1.15). In 1989, Cotsarelis et 
al., demonstrated that slow cycling cells located in the basal layer of the limbus could 
be stimulated to proliferate in response to wound healing and suggested that these cells 
represent a stem cell niche that renews corneal epithelial cells (Cotsarelis et al., 1989). 
These limbal stem cells are responsible for maintenance and re-population of the 
corneal epithelium (O’Sullivan & Clynes, 2007; Boulton & Albon, 2004; Ahmad et al., 
2010). Limbal stem cells maintain clarity of the cornea by acting as a barrier between 
conjunctival and corneal epithelia. This function is affected in those who develop limbal 
stem cell deficiency (Baylis et al., 2011; Ahmad et al., 2010) which can occur in severe 
cases of ocular rosacea (Kheirkhah et al., 2007). 
Toll like receptors (TLRs) are found on all epithelial surfaces and act as the cells 
main method for pathogen recognition through binding of pathogen-associated 
molecular patterns (PAMPs) (Chang et al., 2006; Philpott et al., 2001). In addition to 
being expressed on the epithelial surface TLRs are present on the endothelia, antigen 
presenting cells and lymphocytes (Redfern & McDermott, 2010). In response to 
recognition of pathogen by the PAMPs the ocular surface epithelium can produce 
inflammatory cytokines (Lam et al., 2009). Once activated cytokines and chemokines 
play a role in determining the balance of the acquired immune response. They can up-
regulate the acute inflammatory response, recruit immune cells, enhance intracellular 
killing and are involved in maturation of dendritic cells (McGettrick and O'Neill, 2010; 
Redfern & McDermott, 2010). In a study of cytokine levels in the tear fluid of 
individuals with blepharitis it was found that IL-7, IL-12, and IL-17 were increased in 
those with Demodex infestation compared to those patients with non-Demodex related 
blepharitis (Kim et al., 2011). 
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Figure 1.15 The structure of the human eye. 
[Taken from the website http://www.jpte.co.jp/english/business/Regenerative/cultured-
corneal-epithelium.html] 
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Corneal epithelial cells represent an excellent model for studying the interaction 
of pathogens with the corneal surface (Hozono et al., 2006; Maltseva et al., 2007). 
Hozono et al., (2006) investigated the response of corneal epithelial cells to flagellin 
isolated from pathogenic and non-pathogenic bacteria. Human corneal epithelial cells 
expressed higher levels of TLR-5 mRNA and protein in response to flagellin isolated 
from ocular pathogens (e.g. Pseudomonas aeruginosa) compared to non-pathogenic 
bacteria (e.g. Bacillus subtilis). Pro-inflammatory cytokines IL-6 and IL-8 were also 
induced at higher levels in response to pathogenic flagellin. Maltseva et al., (2007) 
characterised the response of human corneal epithelial cells (exposed to contact lenses) 
to P. aeruginosa supernatant proteins. Corneal epithelial cells normally up-regulated 
expression of the antimicrobial peptide human β-defensin-2 (hBD-2) in response to P. 
aeruginosa, however in cells that were previously exposed to contact lenses in vitro this 
up-regulation was blocked. 
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1.10 Results of previous studies 
  
In a previous study bacteria were isolated from the faces of people with 
papulopustular rosacea and control patients and this lead to the isolation of Bacillus 
oleronius, (Delaney, 2004). To establish which bacteria caused immunoreactivity in 
rosacea patients, peripheral blood mononuclear cells were isolated from rosacea patients 
and controls and the level of T-cell proliferation was tested. This resulted in 72% of 
rosacea patients and 29% of controls reacting significantly to B. oleronius antigens. 
This bacterium was isolated from a micro-dissected Demodex mite and was thought to 
be an endosymbiont which aids lipid digestion in the mite which has no excretory anus. 
The work by Delaney, (2004) also highlighted the two stimulatory antigens (62 and 83 
kDa) which were to become the focus of subsequent studies. The study by Lacey, 
(2007) included the identification of these antigenic proteins by MALDI ToF mass 
spectrometry, the 62 kDa protein was found to have homology to a protein involved in 
the phosphoenolpyruvate phosphotransferase sensory system and the 83 kDa protein 
was found to be homologuous to a heat shock protein (Lacey et al., 2007). Upon 
treatment of human neutrophils with Bacillus antigens, there was inhibition of 
phagocytosis recorded indicating the ability of the bacterium to affect the innate 
immune response. This work also involved the purification of the 62 kDa antigen by 
ÄKTA-FPLC, which was used to generate an anti-62 kDa rabbit antibody. The 
immortalised human sebaceous cell line (SZ95) was employed to study the effects of 
antibiotics used to treat rosacea, a proteomics approach was used and the effects varied 
with each antibiotic. This work also attempted to establish a PCR based assay for the 
presence of B. oleronius which showed limited successful. Both previous studies 
(Delaney, 2004; Lacey, 2007) provided evidence that Demodex associated bacteria may 
play a role in the pathogenesis of rosacea and established important techniques for the 
continued research of the condition. 
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1.11 Aims of this study 
 
 The primary aim of the work presented here was to expand on previous studies 
by Delaney, (2004) and Lacey, (2007) by investigating the role of Demodex associated 
Bacillus oleronius antigens in the development of the chronic inflammatory condition, 
rosacea. 
 
The aims of this study were: 
1. To assess the reactivity of serum taken from individuals with ocular (type 4) and 
erythematotelangiectatic (type 1) rosacea to the Bacillus olerionus antigens by 
Western blotting. 
2.  Purification of a 62 kDa stimulatory antigen was performed in a similar fashion 
to the previous technique by Lacey, (2007) using ÄKTA-FPLC. The product 
was utilised to investigate the possibility of establishing an ELISA based 
immunoreactivity assay. 
3. To expose human neutrophils to purified Bacillus proteins in order to establish 
the effect that B. oleronius has on the innate immune response. 
4. To expose human corneal epithelial cells to purified Bacillus proteins in order to 
establish the effect that B. oleronius has on the ocular innate immune response. 
5. To establish the effect of environmental conditions on the proteomic profile of 
B. oleronius using 2 Dimensional SDS-PAGE and Liquid Chromatography mass 
spectrometry to establish which growing conditions lead to immunogenic 
proteins being produced. An anti-62 kDa rabbit antibody was utilised to assess 
the environmental culture conditions required by B. oleronius to produce high 
quantities of the antigen by Western blotting. 
 
 
 
CHAPTER 2 
 
 
 
Materials and Methods 
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2.1 Study Population 
 
2.1.1 Ocular Rosacea Study Population  
 Peripheral blood (5 mls) was collected from ocular rosacea patients and healthy 
controls by staff at the Ocular Surface Center (OSC), Miami, Florida. 
Participants (n=59, 34 men and 25 women) were age but not gender matched 
and had a mean age of 60.4±17.6 (range, 17-93) (Li et al., 2010). Blood was 
centrifuged at 3500 x g for 10 minutes. Serum was transferred to a sterile 
container under a lamellar flow and stored at -80° C.  
 Tear fluid was also collected by staff at the OSC, Miami from participants 
(n=59). Tear fluid is collected by placin a polyester rod at the conjuctival fornix 
of the eye. Samples were stored at -80° C. 
 Serum and tear fluid samples were prepared at the OSC, Miami and shipped to 
Ireland on ice then immediately returned to -80° C.  
 Serum immunoreactivity was determined (NUI Maynooth) by blind testing 
serum samples sent from the OSC (Miami) for reactivity to B. oleronius 
proteins. 
2.1.2 Erythematotelangiectic Rosacea Study Population 
 Peripheral blood (5 mls) was collected from erythematotelangiectic rosacea 
patients and healthy controls attending the Servico de Dermatologia do 
Centro Hospitalar de VN de Gaia Espinho, Portugal, and shipped on ice to 
Ireland.  
 Participants in the study had Fitzpatrick skin types II-III. Patients (n=26, 9 
males, 17 females) with an average age of 48.3 years (range 20-83) and 
controls (n-21, 9 males and 12 females) with an average age of 54.3 (range 
28=80) were given a dermatological examination and had blood taken. 
 When the blood samples were received in NUI Maynooth; they were 
centrifuged at 3500 x g to sediment the clot and the serum layer was 
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removed under lamellar flow then stored at -80° C before being blind tested 
for serum immunoreactivity B. oleronius proteins.  
2.1.3 Neutrophils 
Human neutrophils were isolated from healthy volunteers (Ethical permission 
granted by NUI Maynooth Ethics Committee). 
 
2.2 General Chemicals and Reagents 
 
All chemicals and reagents were of the highest quality and purity. Unless otherwise 
stated chemicals were purchased from Sigma Aldrich Chemical Co. Ltd, Dorset, UK. 
Buffers were prepared using distilled H2O which was purified using a Millipore Milli-Q 
apparatus. 
 
2.3 Sterilisation Procedure 
 
All equipment, growth media and buffers were sterilised by autoclaving at 121° C 
with 15 lb per square inch of pressure for 15 minutes. Any chemical or reagent that was 
unsuitable for autoclaving was filter sterilised using 0.2 μm pore filter discs. 
 
2.4 Culture Media 
2.4.1 Nutrient Agar 
Nutrient agar (Oxoid) (28 g) was dissolved by stirring in 1 litre of dH2O. This 
solution was autoclaved and allowed to cool before pouring into 9 cm petri dishes under 
sterile conditions. Plates were stored at 4° C until needed. 
2.4.2 Nutrient Broth 
Nutrient broth (Oxoid) (13 g) was dissolved by stirring in 1 litre of dH2O. The 
solution was autoclaved and stored at room temperature until needed. 
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2.4.3 2XYT Broth 
Tryptone (Difco) (16 g), Yeast extract (Oxoid) (10 g) and NaCl (BDH Laboratory 
supplies, England) (5 g) were dissolved in 1 litre of dH2O. The solution was autoclaved and 
stored at room temperature until needed. 
 
2.5 Culture Conditions 
 
All bacterial strains (Table 2.1 below) were maintained on nutrient agar plates and 
sub-cultured every 6-8 weeks using aseptic techniques. Freshly sub-cultured plates were 
grown overnight at 30° C or 37° C depending on strain then stored at 4° C. Liquid cultures 
were grown to stationary phase in nutrient broth (100 ml) at 30° C and 200 rpm, for 24-48 
hours depending on strain. 
 
Table 2.1 Bacterial Strains 
 
Strain Genotype/Origin Reference 
Bacillus oleronius Demodex mite Delaney, 2004 
 
2.6 Glycerol Stocks 
 
A bacterial culture was grown over night and 500 μl was mixed with 500 μl of 
sterile glycerol and stored at -70° C. 
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2.7 Phosphate Buffered Saline (PBS) 
 
PBS tablets were dissolved in the relevant amount of distilled water according to the 
manufacturer’s guidelines then sterilised by autoclaving. 
 
2.8 Bacillus Lysis Buffer (pH 7.2) 
 
Piperazine (20 mM) and 5 mM NaCl were dissolved in dH2O and autoclaved. 
Triton x100 (0.2% v/v) was added and the buffer was stored at 4° C. Protease inhibitors (10 
μg/ml of Leupeptin, Pepstatin A, Aprotinin and TLCK) were added on the day of the 
extraction. 
 
2.9 FPLC Binding Buffer (pH 4.8) 
 
Piperazine (20 mM) and 10 mM NaCl were dissolved in dH2O, autoclaved and 
stored at 4° C. The buffer was filtered through a 2 μm disc before application to the AKTA 
FPLC. 
2.10 FPLC Elution Buffer (pH 4.8) 
 
Piperazine (20 mM) and 1 M NaCl were dissolved in dH2O, autoclaved and stored 
at 4° C. The buffer was filtered through a 2 μm disc before application to the AKTA FPLC. 
2.11 Bradford Protein Assay 
 
2.11.1 Bio-rad dye reagent concentrate (Bio-rad) was diluted 1:5 with dH2O to give 
a working solution which can be stored at 4° C overnight. Extracted proteins 
were diluted in sterile PBS and 20 μl was added to a 1.5 ml cuvette. To this 
1ml of the working solution of bio-rad was added and allowed to stand for 5 
minutes at room temperature. The protein concentration was read in a 
spectrophotometer (Eppendorf, Biophotometer) at 595 nm. 
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2.11.2 When sample volume was low a microplate assay was employed to 
determine the protein concentration. Bovine serum albumin (BSA) was 
dissolved to a concentration of 1 mg/ml and stored at -20° C to prepare the 
standards as outlined in Table 2.2 below. 
 
To read the assay 5 µl of standards and samples were added to a 96 well 
plate in duplicate followed by 250ml of bio-rad working solution then left to 
stand at room temperature for 5 minutes. Plates were read at 595nm on a 
Biotek Synergy HT plate reader. 
 
Table 2.2 Dilution of BSA for protein quantification standards 
 
Tube Dilution  Reagent 
1 1 1 mg/ml BSA stock 
2 0.8 32 μl from tube 1+8 μl of lysis buffer 
3 0.6 12 μl from tube1+8 μl of lysis buffer 
4 0.4 20 μl from tube 2+20 μl of lysis buffer 
5 0.2 10 μl from tube 4+10 μl of lysis buffer 
6 0 Lysis buffer only 
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Figure 2.1 Typical standard curve of Bovine Serum Albumin (BSA) for the 
determination of protein concentration in samples. 
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2.12 Protein extraction from Bacillus oleronius 
 
Liquid medium (100 ml) was inoculated with a loopful of bacterial culture, 
aseptically taken from a fresh plate and grown over night with shaking (200 rpm) at 30° C. 
This culture was then used to inoculate fresh media so the effect of varying environmental 
conditions on protein expression could be assessed. Cells were grown in rich medium 
(2XYT) and minimal medium (Nutrient Broth) at 30° C and 37°C with and without 
agitation. NaOH and HCl were used to adjust the pH of nutrient broth to pH6-9. The effect 
of hydrogen peroxide on the bacterium was also examined by adding 5-10 mM to 100 ml 
cultures for between 1-24 hours. 
Cultures between 100-200 ml were grown to late stationary phase and cells were 
harvested by centrifugation at 3000x g for 20 minutes (Beckman GS-6 Centrifuge). The 
supernatant was discarded and cells were washed with PBS. Cells were re-suspended in 
lysis buffer (section 2.8) and stirred at 4° C for 1hr. The volume of lysis buffer used was 
dependent on the size of the cell pellet; approximately 1ml per 100ml of starting culture 
was used.  
Sonication was also employed as a method to extract proteins from the cell surface 
of the bacteria. Cell suspensions were sonicated with 3 x 10 second blasts using a soniprobe 
sonicator (Bandelin Sonopuls, HD 2200). Suspensions were stored on ice between 
sonications to avoid excessive overheating of the proteins. 
Following treatment with Triton-X 100 or sonication the protein suspension was 
obtained by centrifuging cells at 6000 x g for 2 minutes at 4° C. The supernatant containing 
proteins was retained and the protein concentration was determined using Bradford protein 
assay (section 2.11). Protein samples were acetone precipitated when necessary or 
alternatively 5X sample buffer was added directly to the protein suspension which was 
boiled for 3 minutes at 95° C before storage at -20° C until analysis with SDS-PAGE was 
carried out as described in section 2.17.  
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2.13  Preparation of bacteria for confocal microscopy 
 
Cells cultured in various environmental conditions were also viewed by 
confocal microscopy. Cultures (approx 50 mls) were grown overnight or longer in the 
case of static conditions. Cells were harvested by centrifugation 3000 x g for 20 
minutes and washed twice in PBS. Cells were resuspended in fresh PBS (amount 
dependent on size of pellet) and allowed to adhere to a glass slide by air drying. They 
were then heat fixed at 37° C for 5 minutes after which slides were immersed in PBS. 
Cells were fixed with 3.7% formaldehyde for 10 minutes. The slide was immersed in 
PBS again and the cells were blocked with 1 X TBS-Tween with 1% BSA for two 
hours. Slides were immersed in PBS before the primary antibody (1:5000 of the rabbit 
anti bacillus antibody in the blocking buffer) was added and incubated at 4° C 
overnight. The secondary antibody (TRITC labelled anti-rabbit IgG, Jackson 
laboratories, USA) diluted 1:200 in the blocking buffer was added for 2 hours in the 
dark at room temperature. Slides were washed once more with PBS and allowed to dry 
before a cover slip was applied. Cells were viewed using the Olympus Fluoview 100 
confocal microscope. 
2.14 Fractionation by Q-Sepharose charge separation 
 
The Triton-X soluble outer membrane proteins of B. oleronius (section 2.12) were 
purified and chromatographed by Q-sepharose charge separation using an AKTA Purifier 
100 system (Amersham Biosciences, UK). The starting material was inverted with washed 
Q-sepharose beads at 4° C for at least 1 hour. This material was loaded to make a column 
of 2 cm x 5 cm. The column was washed with binding buffer (section 2.9, pH 4.8) for 30 
minutes prior to 500 μl fractions being eluted per minute with a 30 ml linear gradient of 1M 
NaCl in eluting buffer (section 2.10, pH 4.8). Peak frations containing the antigens of 
interest were identified by SDS-PAGE and Western blot analysis. Fractions containing the 
antigens of interest (62 and 83 kDa) were pooled and concentrated using Amicon filters. 
The semi-purified antigen preparation was then precipitated using acetone and resuspended 
at a concentration of 1µg/10µl in PBS with added protease inhibitors. The antigen 
preparation was then ready for use in neutrophil and corneal cell assays. 
41 
 
2.15 Development of ELISA for testing reactivity of Human serum to B. 
oleronius antigens 
 
5X Concentrated Coating Buffer 
Sodium Carbonate Na2CO3 (9.54 g), Sodium Hydrogen Carbonate NaHCO3 (34.44 g) and 
Sodium Azide (0.2 g) and were dissolved in 1 Liter of dH2O and adjusted to pH 9.3 using 5 
M NaOH and storred at 4° C. Immediately before use the buffer was diluted 1:5 with dH2O 
and pH was adjusted to 9.6, stored at 4° C for up to 4 days. 
 
Preparation of ELISA plate 
Antigen isolated from B. oleronius and purified as described in section 2.15 was mixed 
with the 1X coating buffer to achieve a concentration of 1 µg/ml. This solution was coated 
onto 96 well plates (100 µl/well) and stored overnight at 4° C. The buffer was aspirated and 
the plate was washed 4 times with PBS-Tween. Blocking buffer (200 µl/well) consisting of 
0.5% (w/v) BSA and 5% (w/v) Sucrose in PBS was added and the plates were incubated at 
37° C for 1 hour. After this time the blocking buffer was decanted and the plates were 
allowed to dry overnight at 37° C. 
 
Assay Procedure 
Serum diluted 1:10-1:1000 (100 µl) was added to the wells and incubated for 1 hour at 
room temperature. Serum was aspirated and wells were washed 4 times with 200 µl of 
PBS-Tween. Secondary anti-human IgG diluted 1:1000 (100 µl) was added per well. Plate 
was washed again with PBS-Tween 4 times and blotted well on paper towel to remove all 
liquid. TMB substrate (50 µl) was added and the blue colour was allowed to develop for 
10-15 minutes. The assay was stopped by adding 50 µl of 1 N H2SO4 and the optical 
density of the assay was read at 450 nm on a plate reader. 
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2.16 Acetone Precipitation 
 
Three times the volume of 100% (v/v) ice-cold acetone was added to protein samples 
and incubated at -20° C for a minimum of 2 hours. Precipitated protein was centrifuged at 
20000 x g for 30 minutes at 4° C. The acetone was discarded and the pellet was allowed to 
air dry before the protein was re-suspended in 5X sample buffer (section 2.19).  
 
2.17 Sodium Dodecyl Sulphate-Poly acrylamide (SDS-PAGE) Gel 
Electrophoresis 
 
Stacking Gel Buffer 
Tris base (Sigma, 30.25 g) was dissolved in 450 mls of dH2O. 5M HCl was added 
until pH6.8 was achieved, the final volume was adjusted to 500 ml with dH2O. The solution 
was autoclaved and stored at 4° C. 
Separating Gel Buffer 
Tris base (Sigma, 90.75 g) was dissolved in 450 mls of dH2O. HCl solution (5 M) 
was added until pH8.9 was achieved, the final volume was adjusted to 500 ml. The solution 
was autoclaved and stored at 4° C. 
Sodium Dodecyl Sulphate (SDS) (10%, w/v) 
SDS (Sigma, 10 g) was dissolved in 100 ml dH2O and stored at room temperature. 
Ammonium Persulphate (APS) 
APS (Sigma, 1 g) was dissolved in 10 ml dH2O and divided into 500 μl aliquots 
which were stored at -20° C. 
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Table 2.3 Constituents of Separating gel for SDS-PAGE electrophoresis. 
 
Reagent 10% Acrylamide 12.5% Acrylamide 15% Acrylamide 
30% Acrylamide 
(ml) 
5 6.3 7.5 
1.5 M Tris (ml) 3.8 3.8 3.8 
10% SDS (μl) 150 150 150 
dH2O (ml) 6 4.8 3.6 
10% APS(μl)  75 75 75 
Temed (μl) 5 5 5 
 
Table 2.4 Constituents of Stacking gel for SDS-PAGE electrophoresis. 
 
Reagent 5% 
30% Acrylamide (ml) 1 
0.5 M Tris (ml) 1.5 
10% SDS (μl) 60 
dH2O (ml) 3.6 
10% APS(μl)  60 
Temed (μl) 6 
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Pouring the SDS-Polyacrylamide Gel 
Glass plates (1.0mm) were cleaned with ethanol prior to placement in a gel casting 
rig. The separating gel was poured between the plates and a layer of 0.1% SDS was sprayed 
on the top to ensure the top of the gel was straight and to remove air bubbles. The gel was 
allowed to set for approximately 30 minutes the SDS was removed and the top of the gel 
washed with dH2O. Filter paper was used to remove any excess water. The stacking 
solution was poured on top and a 10 toothed comb was inserted. Once the stacking gel was 
set the gel was placed in a gel rig (Bio-rad) which was filled with 1X running buffer. The 
comb was removed slowly and protein samples were loaded into the wells. A pre-stained 
protein marker (6-175 kDa, New England Biolabs) was run in the first lane of each gel to 
identify the molecular weights of the protein bands. Gels were run at 60 volts using a 
Power-pac 300 (Bio-Rad) until the sample had left the stacking gel and increased to 80-120 
volts through the separating gel. 
 
2.18 10X running buffer, pH8.9 
 
Tris base (Sigma, 30g) Glycine (Sigma, 144g) and SDS (Sigma, 10g) were 
dissolved by stirring in 1 litre of dH2O. The solution should not require adjustment to 
pH8.9; it was stored at room temperature. 
 
2.19 10X Sample Buffer 
 
SDS (2g), Dithiothreitol (DTT, 1.54g), 200 mM EDTA (pH7), 3 M Tris-HCL (pH 
6.7) and 2ml (0.2% Bromophenol blue, 50% Sucrose) were dissolved by stirring in a final 
volume of 10 mls of dH2O. The solution was divided into 500 μl aliquots and stored at -20° 
C. 
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2.20 Staining of SDS-PAGE Gels 
 
Coomassie Staining Solution 
Brilliant Blue R (0.2%, w/v) was dissolved in acetic acid (10%, v/v), methanol (45%, v/v) 
and dH2O (45%, v/v) 
Detain Solution 
Acetic acid (10%, v/v), methanol (20%, v/v) and dH2O (70%, v/v) 
Colloidal Coomassie Fixer 
Ethanol (50%, v/v), phosphoric acid (3%, v/v) and dH2O (47%, v/v) 
Colloidal Pre-Incubation Buffer 
Ammonium Sulphate (17%, w/v) was dissolved in ethanol (34%, v/v), phosphoric acid 
(3%, v/v) and dH2O (46%, v/v) 
Colloidal Coomassie Protocol 
Gels were placed in the fixing solution for a minimum of 3 hours. Following 2 x 30 
minute washes in water the gels were covered in the pre-incubation buffer for 1 hour before 
a spatula tip of SERVA Blue powder was added. Gels were incubated in this solution 
overnight or until the proteins were visible. The gels were then washed in distilled water 
until the background blue stain was removed at this point the gels were ready to be scanned 
and prepared for Mass spec analysis. 
  
46 
 
2.21 Two-Dimensional Gel Elextrophoresis 
 
IEF Buffer 
 
Urea (8 M), 2 M thiourea, CHAPS (4% w/v), Triton-X 100 (1% v/v) and 10 mM 
tris base were dissolved in deionized H2O. The solution was divided into 1 ml aliquots and 
stored at -20° C. Ampholytes (0.8%, v/v) and DTT (65 mM) were added to the defrosted 
aliquots on the day of use. 
 
Isoeletric focusing (IEF) in the first dimension 
 
Bacterial protein was extracted, quantified and precipitated using acetone. For 7 cm 
IPG strips 150µg of protein was resuspended in 125µl of IEF buffer and for 13 cm IPG 
strips 500µg was resuspended in 250µl of IEF buffer. A small amount of bromophenol blue 
tracking dye was added to the sample and it was incubated at room temperature for 1 hour. 
The sample was applied to a ceramic strip holder at the anodic end. The IPG strip (pH 4-7, 
7 cm or 13 cm) was placed gel face down into the sample. Dry strip cover fluid (1 ml for 7 
cm or 2 ml for 13 cm) was applied over the strip. Proteins were isoelectrically focused 
using and Ettan IPGphor II focusing system (Ambersham biosciences, England) according 
to the program below. 
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Table 2.5 Isoelectric Focusing Protocol. 
 
Time Volts Mode 
8 hours 50 V Gradient 
15 minutes 250 V Gradient 
2 hours 1000 V Gradient 
4 hours 4000 V Gradient 
4 hours 8000 V Gradient 
4 hours 8000 V Hold 
 
Following IEF, strips were equilibrated in reducing buffer (50 mM Tris-HCL, 6 M 
Urea, 2% (w/v) SDS, 30 % (v/v) Glycerol, 1% (w/v) DTT, pH 6.8) for 15 minutes at room 
temperature, followed by equilibration in alkylation buffer (50 mM Tris-HCL, 6 M Urea, 
2% (w/v) SDS, 30 % (v/v) Glycerol, 2.5 % iodoacetamide (IAA), pH 6.8) for 15 minutes. 
Strips were then placed on top of 12.5% SDS-PAGE gels and overlaid with hand warm 
sealing solution. Gels were electrophoresed on the PROTEAN PLUS Dodeca cell system 
(Bio-rad) with temperature maintained at 6° C using a cooling system for 20 hours at 100V 
or until the bromophenol indication layer was at the bottom of the gel. Gels were fixed and 
stained using Colloidal Coomassie. Gels were produced in triplicate for each treatment and 
scanned on a HP scanjet 5400C. 
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2.22 Liquid Chromatography Mass Spectrometry 
 
Destaining Buffer (100mM Ammonium Bicarbonate/Acetonitrile) 
Ammonium bicarbonate (0.79 g) was dissolved in 100ml of ddH2O and diluted 1:1 
with acetonitrile. This buffer was made fresh on the day of use. 
Digesting buffer 
Trypsin (20 µg) was diluted in 100 μl of reconstitution buffer. For every 10 μl of 
buffer 500 μl of 50mM ammonium bicarbonate was added. If not required the reconstituted 
trypsin can be stored in 10 μl aliquots at -20° C for up to 1 month. 
Extraction Buffer 
Formic acid (5%, v/v) and acetonitrile were mixed 1:2 (v/v)  
Preparation of excised protein bands and spots for LC/MS analysis (Shevchenko et al., 
2006) 
All reagents used were HPLC grade and all 1.5 ml microfuge tubes were washed 
with acetonitrile before use. Colloidal coomassie stained protein bands or spots were 
chosen from SDS-PAGE gels using Progenesis
TM
 same spot software. Gels were washed 
with water before spots/bands were picked using a clean scalpel or 200 µm pipette tip. Gel 
pieces were placed in pre-washed microfuge tubes. Gel pieces were incubated in 100 µl of 
destaining buffer for 30 mins (or until stain was removed) shaking at room temperature. 
Then 500 µl of acetonitrile was added for 10 mins shaking at room temperature. Gel plugs 
turned white and shrank and most of the coomassie stain was removed at this stage. 
Samples were then subjected to in-gel trypsin digestion. Approximately 50µl of 
trypsin buffer (or enough to cover the gel matrix) was added to the samples and they were 
stored on ice for 30 mins. If all the trypsin solution was absorbed at this point more was 
added to cover the matrix. Gel pieces were incubated on ice for a further 90 mins to saturate 
them with trypsin. Then 20 µl of 50 mM ammonium bicarbonate was added to ensure the 
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gel pieces did not become dehydrated during the trypsin digestion. Finally to digest the 
peptides the microfuge tubes were placed in a 37° C air circulating incubator over night.  
To extract the peptide digestion products the contents of the microfuge tube after 
trypsin digestion were removed to a fresh eppendorf. Extraction buffer (100 µl) was added 
to each tube and incubated for 15 mins at 37° C in a shaker. The supernatant from this 
extraction was added to the trypsin digestion supernatant. Extracts were dried in a vacuum 
centrifuge over night. Dried extracts could be stored at -20° C for a few months. 
Immediately prior to Mass spec analysis, dried peptides were resuspended in 20 µl of 0.1% 
(v/v) formic acid. The microfuge tubes were placed in a sonication bath for 5 mins and then 
centrifuged for 15 mins at 7,000 x g at 4° C. Samples were filtered using spin filters in a 
centrifuge for 2 mins at 7,000 x g and added to acitonitrile washed glass vials (Agilent). 
Analysis of digested peptides was achieved using an Agilent 6340 Ion Trap Liquid 
Chromatography Mass Spectrometer.  
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2.23 Western Blotting 
 
10X Tris Buffered Saline (TBS) pH 7.6 
Tris HCl (0.5 M, 157 g) and NaCl (1.5 M, 175.3 g) were dissolved in 2L of dH2O 
and the pH was brought to 7.6 with the addition of NaOH pellets. 
1X TBS-Tween 
10X TBS (100 ml) and tween-20 (500µl) were added to 900 ml dH2O. 
Transfer Buffer 
Tris-base (6.06 g) and glycine (28.8 g) were dissolved in 400 ml Methanol and1600 
ml dH2O. 
Blocking Buffer 
Dried skimmed milk powder (Marvel, 15 g) and albumin from bovine serum (BSA, 
5 g were dissolved in 1X TBS-Tween (500 ml) 
Transfer proceedure 
Transfer of protein onto nitrocellulose membrane was performed by electro-blotting 
using a wet blotter (Mini Trans-Blot Cell, Bio-Rad). Prior to transfer Whatman filter paper, 
nitrocellulose membrane and sponge inserts were soaked in transfer buffer. The blot 
sandwich was arranged inside the transfer cassette as follows; a sponge insert was placed 
on the black side of the cassette followed by a piece of filter paper, the nitrocellulose 
membrane was place on top and the gel was placed on the membrane followed by more 
filter paper and the other sponge insert. The sandwich was rolled gently to remove air 
bubbles. The cassette was placed in the tank along with an ice cooling block and the 
apparatus was run at 100V for 70 minutes.  
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To assess the quality of the transfer the membrane was stained using Ponceau-S-
Red solution, which stained transferred proteins pink. Non-specific binding was inhibited 
by incubating the membrane in blocking solution for 1 hour at room temperature or 
overnight at 4° C.  
Membranes were incubated in primary antibody (Table 2.6) overnight at 4° C on an 
orbital shaker, followed by washing with 1X TBS-Tween for 1 hour changing the TBS 
frequently. The membrane was incubated in the appropriate anti IgG-HRP labelled 
secondary antibody for 2 hours at room temperature. The wash step was repeated and 
antibody labelled protein bands were visualised by enhanced chemiluminescence (ECL) 
using the Perkin Elmer Supersignal ECL kit as per the manufacturer’s instructions. Blots 
were incubated in the substrate before being covered with an acetate and overlaid with X-
ray film (Kodak Biomax MS) and exposed for 1-10 minutes inside a cassette (Kodak). X-
ray films were developed in 1:5 developing solution (Polymax RT, Kodak) followed by a 
rinse with water and then placed in 1:4 fixing solution (Polymax RT, Kodak) and allowed 
to air dry.  
Some blots were also developed using diaminobenzidine tetra-hydrochloride (DAB), 
were the washed blot was incubated in the DAB solution (1 tablet in 15 mls of 100 mM 
Tris-HCL (pH 7) and 12 µl of hydrogen peroxide) for 5-10 minutes followed by washing in 
dH2O and allowing to air dry. 
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Table 2.6 Antibody Dilutions 
Primary 
Antibody 
Source Western 
Blot 
Dilution 
Immuno/Confocal 
Dilution 
Company Reference 
Anti 62 kDa 
(B. 
oleronius) 
Rabbit 1:5000 1:2000 Generated in 
DCU 
Lacey, 
(2007) 
Patient 
Serum 
Human 1:100 -   
MPO Rabbit 1:500 - Genway  
MMP-9 Goat 1.1000 - - Dr. Emer 
Reeves, 
RCSI 
IL-37/Hcap Rabbit 1:1000 - - Dr. Emer 
Reeves, 
RCSI  
CK19 Mouse 1:1000 1:100 Chemicon - 
GAPDH Mouse 1:2000 - Sigma - 
β 1-Integrin Mouse 1:1000 1:2000 Chemicon - 
Vinculin Rabbit 1:500 - Cruz 
Biotechnology 
- 
CK3 Mouse 1:1000 1:100 Chemicon - 
CK12 Rabbit 1.1000 1.100 Chemicon - 
E-cadherin  Mouse 1:2000 1:500 Chemicon - 
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2.24 Trypan blue exclusion assay 
 
This assay was used to assess the viability of cells. Healthy cells will exclude the 
dye from passing through the membrane whereas unhealthy cells will allow the dye to 
penetrate the membrane. Cells were combined with trypan blue solution (0.4%, v/v) in a 
ratio of 1:1. If the cell number was too high to count a further dilution was made. Cells 
were mixed thoroughly and counted using a haemocytometer. 
 
2.25 Assessing the effect of Bacillus antigens on Neutrophils 
 
Neutrophil extraction buffers 
All buffers were allowed to come to room temperature and heparinised (5 μl/ml) to 
prevent coagulation. 
1 X Saline 
NaCl (0.9% w/v) dissolved in dH2O before autoclaving. 
2 X Saline 
NaCl (1.8%w/v) dissolved in dH2O before autoclaving. 
Dextran sulphate 
Dextran (10% w/v) dissolved in 1 X saline before filter sterilising. 
 
2.26 Isolation of human neutrophils 
 
Human neutrophils were isolated from healthy volunteers (Ethical permission 
granted by NUI Maynooth Ethics Committee), separated from blood collected in 10 ml 
vacuumed heparinised tubes (BD Vacutainer Systems, Plymouth, UK) by dextran 
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sedimentation and Ficoll-Hypaque (Axis-Shield PoC AS, Oslo, Norway) centrifugation as 
previously described (Reeves et al., 2002). Blood (20 ml) was added to 25ml of 1X saline 
(0.9% (w/v) NaCl in dH2O) and 5ml of a 10% dextran sulphate salt solution was added to 
the mix to stimulate sedimentation. Each aliquot was inverted and left standing for 30 
minutes. Neutrophils will not sediment therefore the top lighter coloured layer is removed 
to a fresh 50ml falcon tube. Samples were pooled if required to obtain 40ml in the tube 
which is then under laid with 5ml of lymphoprep (Axis-Shield) and centrifuged at 200 x g 
for 10 minutes without the break. Erythrocytes were removed by hypotonic lysis in water 
and brought back to osmolarity using a 1.8% (w/v) NaCl solution. This step was carried out 
quickly to prevent lysis of the neutrophils. Neutrophils were centrifuged at 200 x g for 5 
minutes. The cells were resuspended in Phosphate Buffered Saline (PBS, pH 7.4) 
containing 5 mM glucose and used immediately. Viability was assessed using the Trypan 
Blue exclusion assay (Eichner et al., 1986). 
 
2.27 Neutrophil Migration assay 
 
Neutrophils (1x10
6
/ml) were resuspended in RPMI-1640 media containing 2mM L-
glutamine and 5% FCS. Cells were treated with the bacterial protein (2 and 6μg/ml of 
purified antigen or 2μg/ml) for one hour along with untreated cells as a control. Treated 
medium (500 μl) was applied to a 24 well plate and either a 3 or 8μm porous insert (BD 
Falcon) was added to the well before 500 μl of the treated cells were placed inside the 
insert. The plate was incubated for 24 hours in a humidified 5% CO2 incubator at 37° C. 
Inserts were removed and washed three times with PBS before staining with crystal violet 
(0.25% w/v). A cotton bud was used to remove unattached cells from inside the insert and 
remaining cells adhering to the underside of the insert were allowed to dry before images 
were taken with an Olympus camera. The cells were then eluted using 33% glacial acetic 
acid and a colorimetric assay was carried out using a (Biotek plate reader) set at 570nm. 
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2.28 Quantification of release of MPO MMP-9 and hCAP-18 (LL-37) as 
markers of degranuation. 
 
Neutrophils (1 x 10
7
 ml
-1
) were resuspended in PBS containing 5 mM glucose and 
protease inhibitors as described. Following coincubation with Bacillus antigens (2 and 
6μg/ml) in a stirred chamber, an aliquot was removed at t = 0, 3, 6 and 9 minutes. Cells 
were removed by centrifugation (800 x g). The protein content of the supernatant was 
precipitated and prepared for electrophoresis and immuno-blotting. 
Samples were separated by SDS-PAGE (12.5% (w/v) acrylamide), and protein 
profiles were visualized by colloidal coomassie staining. For Western blotting, the protein 
was transferred to a nitrocellulose membrane using a wet blotter. Antibodies were applied 
as outlined in section 2.23 and Table 2.6. Reactivity of degranulated proteins to 
Myeloperoxidase antiserum, MMP-9 antiserum and IL-37 antiserum were characterised. 
 
2.29 Production of neutrophil culture supernatants for cytokine assays 
 
Isolated cells (1x10
6
/ml) in RPMI-1640 media containing 2mM L-glutamine and 
5% FCS were distributed into 24 well flat bottomed tissue culture plates (BD Falcon) and 
incubated for 3, 15 and 24 hrs. Cells were treated with 2 and 6μg/ml of purified antigen and 
2μg/ml of crude Bacillus lysate. Culture supernatants were harvested at the indicated time 
points and stored at -80° C until assayed. 
IL-8 and TNF-α levels were measured using commercial ELISA kits (Human IL-8 
ELISA, R&D Systems and Human TNF-α mini ELISA, Peprotech) according to the 
manufacturer’s guidelines. 
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2.30 General Cell Culture Techniques 
 
2.30.1 Cell Preservation 
Long-term storage of cells was carried out using liquid nitrogen (-195
0
C). Cells in 
the exponential phase of growth were harvested and resuspended in freezing medium [10% 
DMSO (v/v), 10% FBS (v/v), 80% DMEM] at a cell density of approximately 1 x 10
6
 
cells/ml. 1 ml aliquots of the cell suspension were dispensed into cryovials (Nunc) and 
frozen in a styro-foam freezing box (Nunc) at –700 C over night. Vials were immediately 
placed into a liquid nitrogen chamber. 
 
2.30.2 Cell Recovery 
Cells were recovered from liquid nitrogen by rapid thawing at 37
0
C in warmed 
PBS. Following thawing, cell suspension was dispensed into 9 ml of fresh medium (5% 
FBS (v/v), 95% DMEM) and centrifuged at 1000 x g for 5 mins. Cells were resuspended in 
fresh keratinocyte growth medium (Lonza, 500 ml of KGM™2 Basal medium was 
supplemented with 2 ml Bovine Pituitary extract, 0.5 ml hEGF, 0.5 ml Insulin, 0.5 ml 
Hydrocotisone, 0.5 ml Transferrin, 0.5 ml Epinephrine and 0.5 ml GA-1000.) and seeded in 
culture flasks and incubated at 37
0
C in a humidified atmosphere containing 95 % air, 5% 
CO2. 
 
2.30.3 Cell counting and viability testing 
Cell counts were performed using a haemocytometer counting chamber under an 
inverted microscope. Cellular viability was estimated by exclusion of the vital dye, trypan 
blue (0.4% w/v). Viable cells exclude the dye while dead cells stain blue. Cell suspension 
(30 l) was added to 30 l of trypan blue and incubated for 5 minutes. A 10 l aliquot of 
the solution was loaded into both counting chambers and cells were counted in the four 
corner squares (each with 16 subsquares). The average count from the two chambers was 
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multiplied by the dilution factor and finally by 10
4
 to account for the chamber volume. In 
this manner, a value representing the number of cells per volume was obtained. 
 
2.30.4 Harvesting and subculture of cells 
 
The cell line used in this study was adherent and required trypsinization prior to 
subculture. For sub-culture, the spent medium was removed and the cells were washed with 
sterile PBS (pH 7.4). Cells were detached by the addition of 2 ml trypsin solution [0.025 % 
(w/v) trypsin, 0.53mM (w/v) EDTA in PBS, pH, 7.4]. The flasks were then incubated at 
37
0
C until the cells were fully detached. Trypsinization was terminated by the addition of 8 
ml of complete medium (DMEM and 5% FBS). Disaggregated cells were harvested by 
centrifugation at 1000 x g for 5 minutes in a bench top centrifuge. The resultant pellet was 
resuspended in 2 ml of fresh media (KGM) and seeded into new flasks. 
 
2.31 Assays using Human corneal Epithelial Cells (hTCEpi) 
 
The human telomerase immortalized corneal epithelial cell line (hTCEpi) was 
generated by infecting primary cultures of human corneal epithelial cells with a retroviral 
vector encoding telomerase reverse transcriptase (hTERT). The purpose of this cell line 
was to provide a model for the study of molecular mechanisms involved in human corneal 
cell differentiation (Robertson et al., 2005). Following a review of corneal epithelial cell 
culture models the method used to generate the hTCEpi cell line was deemed an efficient 
way to generate epithelial cell lines (Castro-Muñozledo 2008). The cell line was recently 
used to investigate the role of plasma membrane calcium-ATPase expression in a wound 
healing model (Talarico 2010).  
hTCEpi cells were maintained in Keratinocyte Growth Medium-2 (KGM-2) 
supplemented with KGM-2 Single Quot Kit Supplements  & Growth Factors  (Clonetics-
BioWhittaker, Inc., Walkersville, MD), in a humidified 5% CO2 incubator at 37°C, and 
passaged every 7 to 10 days. 
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2.31.1 Toxicity Assay 
hTCEpi cells were cultured to approximately 90% confluency and trypsinised, cell 
concentration was calculated and 4x10
4
 cells/ml were added to a 24 well culture dish. Cells 
were allowed to adhere. The following day they were washed and KMG-2 media (Lonza) 
was added to the wells. Normal media as well as media with Bovine Serum Albumin 
(Sigma) (2 and 6μg/ml) were employed as controls. Media with increasing concentrations 
of the antigen preparation (0.5-6μg/ml) was added to relevant wells and incubated for 5 
days at 37° C in a humidified 5% CO2 incubator. Growth media was supplemented every 2 
days. The assay was evaluated by staining with 0.05% crystal violet (w/v). Cells were 
incubated in the dye at room temperature for 30 minutes then excess dye was washed off 
with H2O. Plates were allowed to dry and cells were eluted with 200 μl of 33% (v/v) glacial 
acetic acid. Cells in suspension were transferred to a 96 well plate and read on a 
spectrophotometer at 570nm. 
 
2.31.2 Wound healing assay 
To test the effect of the bacterial antigens on wound healing, hTCEpi cells (6x10
4
) 
were cultured in 6 well plates and supplemented with KGM-2 until a confluent layer was 
achieved. A scratch wound, the length of the whole well was made across the cell layer 
using a 200μm pipette tip. The plate was washed with PBS to remove cell debris and then 
incubated in the presence of the antigen preparation (2, 4, 6 μg/ml). Cells without any 
treatment were used as a control. The progress of cell migration into the scratch wound was 
photographed at 0, 24, 48, 72 and 96 hour time points. 
 
2.31.3 Corneal cell Migration assay  
hTCEpi cells were treated with the bacterial protein (2, 6μg/ml) for 4 days along 
with untreated cells as a control. Cells were trypsinized and resuspended at a concentration 
of 4x10
4/ml in 500 μl of the relevant treated media. Treated media (500 μl) was applied to a 
24 well plate and an 8 μm porous insert (BD Falcon) was added to the well before the cells 
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were placed inside the insert. Cells were incubated for 24 hours in a humidified 5% CO2 
incubator at 37° C. Inserts were removed and washed three times with PBS before staining 
with crystal violet (0.25% w/v). A cotton bud was used to remove unattached cells from 
inside the insert and remaining cells adhered to the underside of the insert were allowed to 
dry before counting. 
 
2.31.4 Invasion Assay 
Cells (4x10
4
) were treated identically as in the case of the migration assay but were 
placed in an 8 μm matrigel invasion chamber insert (BD BioCoat). The same staining 
protocol was followed as for the migration assay outlined above (section 2.31.3) 
 
2.31.5 Adhesion Assay 
 The lids of 96 well plates were coated with components of the ECM (Collagens I, 
IV, V, Lamanin, Fibronectin and Gelatin). hTCEpi cells were pre-incubated with the 
antigen preparation (2,4 and 6 µg/ml), trypsinised and applied at a concentration of 1 x 10
4
 
cells/ml onto the different ECMs. The cells that adhered were stained using crystal violet 
dye (0.25% w/v) and counted using a Leica microscope. 
 
2.32 Isolation of protein from corneal cells 
 
hTCEpi cells were exposed to the bacterial antigen (2, 6μg/ml) for five days in 6 
well culture dishes. Lysis buffer consisting of 0.25M Tris HCl (pH 7.2) and 2.5% SDS was 
added in a volume dependent on the consistency of the lysate (approx 500 μl). Following 
protein determination using Bradford reagent the protein was mixed with Lamelli sample 
buffer (Biorad) and frozen at -20° C until required. 
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2.33 Electrophoresis and Western Blotting 
 
To carry out electrophoresis the sample was boiled for 3 minutes and cooled to 
room temperature before application of 20μg of protein to the well. Gels were transferred to 
nitrocellulose membrane using a semi dry blotter (Biorad) in Towbin transfer buffer 
(25mM Tris, 192mM Glycine, 20% Methanol in dH2O, pH 8.3).  
Membranes were then blocked using 1 % dried milk powder (Marvel) in TBS-tween 
for 1 hour at room temperature. Primary antibodies were diluted according to Table 2.6 and 
incubated at 4° C overnight. 
The relevant horseradish peroxidase-linked secondary antibody diluted 1:1000 was 
applied and incubated at room temperature for 2 hours. Enhanced chemiluminescence 
(Perkin-Elmer) was used to develop reactive protein bands and image-J software was used 
to perform densitometry analysis. 
 
2.34 Gelatin Zymography of MMP-9 activity 
 
 This work was contributed by Dr. Clair Gallagher and Dr. Finbarr O’Sullivan, 
collaborators from the NICB, DCU. SDS-PAGE gels were prepared according to standard 
procedure with the addition of 0.1% gelatin. Protein was extracted from the antigen treated 
hTCEpi cells using a denaturing buffer and mixed with the sample buffer but not boiled. 
Protein (20 µg/ml) was added to each well and separated by eletrophorises. After running 
the gel was incubated in zymogram renaturing buffer for 30 minutes at room temperature. 
The gel was then placed in zymogram developing buffer and equilibrated for 30 minutes at 
room temperature before being incubated overnight at 37 °C. The zymogram was stained 
with coomassie blue and then destained so the area of protease activity could be visualized. 
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2.35 Immunofluorescence 
 
hTCEpi cells were cultured at a concentration of 4x10
4
 on circular glass coverslips 
(0.2μm) in 24 well dishes. Antigen treated and control cells were incubated at 37° C in a 
humidified incubator (5% CO2) for 4 days. They were then washed with PBS-tween and 
fixed in methanol for 5 minutes at -20° C. Methanol was removed and the coverslips were 
stored at -20° C. Cells were blocked for 1hr at 37° C in 5% goat serum (Biorad) diluted in 
PBS (Accugene). The primary antibodies were diluted (Table 2.5) in 1% goat serum and 
incubated at 4° C overnight. Fluorescently labeled secondary antibodies (Alexafluor, 
Invitrogen) were diluted to 1:1000 and applied out of direct sunlight and incubated for 1 
hour at room temperature. DAPI nuclear stain (1:5000) was added for 1 minute and then 
cells were washed with PBS before the cover slips were mounted onto glass slides using 
ProLong® Gold antifade reagent (Invitrogen). Images were taken using a Nickon Eclipse 
microscope and Metamorph software. 
 
2.36 Generation of Primary Corneal cell cultures from Limbal stem cells 
using 3T3 fibroblast feeder cells 
 
Primary cultures were generated from donor corneal tissue (obtained from a cadaver 
donor from America) specifically the residual corneo-sceral rings after keratoplasty and 
maintained in optisol media until arrival at the NICB. Limbal tissue was isolated from 
either side of the corneo conjunctival junction. This tissue was diced approximately into 1 
mm cubes. The tissue was transferred to gelatin coated 6 well plates and treated with a few 
drops of pre-warmed media. Limbal cell media consisted of, DMEM:F12 (3:1), 10% FCS, 
5 µg/ml Insulin, 10 ng/ml rhEGF, 100 ng/ml Cholera Toxin A Subunit, 0.4 µg/ml 
Hydrocortisone, Triiodothyronine (2 x 10
-9
 ml
-1
) and irradiated 3T3 cells (2 x 10
3
).  
Irradiation of 3T3 fibroblast cells was carried out by Dr. Kishore Reddy Katikireddy 
(NICB, DCU). The 3T3 fibroblasts were routinely maintained in DMEM supplemented 
with 5 % fetal calf serum (FCS) (Hyclone, Logan, UT). Cells were trypsinised at 60-70% 
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confluency, washed and carried in HBSS buffer for irradiaton. Inactivation of 3T3 
fibroblasts was achieved by lethal irradiation 60 Gray. Irradiated 3T3 cells were stored in 
liquid nitrogen with freezing medium (10% DMSO). Irradiated 3T3 cells were used for 
culture of limbal-corneal cells, with density of 2.4×10
4
/cm
2 
cells per well/ insert.  
Due to the infrequent availability of primary culture tissue, these experiments were 
carried out using tissue from a single donor and are therefore considered as technical 
replicates. The tissue was maintained with medium and irradiated 3T3 cells until a 
confluent layer of corneal epithelial cells was achieved. At this point the cells were 
removed from the culture plate surface using trypsin. These primary culture cells were then 
used for some of the assays outlined using the same procedure as for the immortalized cell 
line. 
 
2.36.1 Wound healing in Limbal epithelial cells 
Limbal epithelial cells (6x10
4
) were cultured in 6 well plates and supplemented with 
conditioned media described above (Limbal cell media) until a confluent layer was 
achieved. A scratch wound was made in the cell layer across the whole length of the well 
using a 200μm pipette tip. The plate was washed with PBS to remove cell debris and then 
incubated in the presence of the antigen preparation (2 & 4 μg/ml) in the culture medium. 
Cells without any treatment were used as a control. The progress of cell migration into the 
scratch wound was photographed at 0, 24 and 48 hour time points. 
 
2.36.2 Preparation of Limbal epithelial cells for Western blotting 
Limbal epithelial cells (6x10
4
) were seeded to 6 well plates and allowed to adhere 
over night. The plate was washed with PBS and incubated in the presence of the antigen 
preparation (2 & 4 μg/ml) in the culture medium. Cells without any treatment were used as 
a control. After 3 days protein was extracted from the cells using a lysis buffer consisting of 
0.25M Tris HCl (pH 7.2) and 2.5% SDS was added in a volume dependent on the 
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consistency of the lysate (approx 500 μl). Following protein determination using Bradford 
reagent the protein was mixed with Lamelli sample buffer (Biorad) and frozen at -20° C 
until required. Western blotting was carried out as described in section 2.33. 
 
2.37 Statistical Analysis 
 
 All experiments were performed on at least three independent occasions. Results 
presented are mean ± standard error.  
For comparisons between two treatments, a 1-tailed, 2-sample equal variance 
(homoscedastic) Student’s t-test was performed and samples with a p value ≤ 0.05 
(indicated by *) or ≤ 0.01 (indicated by **) were deemed significant. 
For the comparison of ocular rosacea patients (group 1) and control (group 2) sera 
reactivity using ELISA (Figure 3.15 A & B) the data was analyzed using a 2-way anova 
test. 
 
 
 
 
 
CHAPTER 3 
 
 
 
Fractionation of the stimulatory proteins 
from Bacillus oleronius and 
characterisation of those proteins which 
elicit an immune response in rosacea 
patient sera 
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3.0 Introduction 
 
Prior to the work by Delaney (2004), the role of Bacillus oleronius in the 
induction of an immune response in rosacea had not been investigated. It was 
discovered following a screen of several bacterial isolates that B. oleronius caused 
significant (p=0.01) PBMC stimulation in 73% of rosacea patients compared to 29% of 
controls (Lacey et al., 2007). Delaney (2004), used fractionation of the bacterial 
proteins and Western blotting to identify antigenic proteins including the 62 and 83 kDa 
proteins that caused immune reactivity in rosacea serum but not controls. Lacey (2007) 
continued the study of these antigens, using 2D-electrophoresis coupled with MALDI-
ToF analysis to characterise their functions. Although B.oleronius has not been 
sequenced, the 62 kDa protein was found to have homology to a protease involved in 
carbohydrate metabolism and signal transduction and the 83 kDa protein showed 
similarity to a heat shock protein. It was evident that both these proteins have the 
potential to be involved in the induction of inflammatory reactions (Lacey et al., 2007).  
The aim of the work presented in this Chapter was to (1) analyse the reactivity 
of sera and tear fluid samples to the whole cell protein lysate of B. oleronius using 
Western blotting, (2) fractionate the bacterial proteins and use LC mass spectrometry in 
order to identify their possible functions (3) pool antigenic proteins, in particular the 62 
and 83 kDa antigens, for investigations using human cells and (4) determine if reactivity 
to these pooled antigens could be captured in a simple ELISA assay to aid in the 
diagnosis of rosacea. 
3.1 Preparation of Bacillus proteins 
  
Bacillus protein extracts were obtained by sonication and use of a detergent 
(0.2% Triton-X 100) containing buffer to discover which method provided adequate 
amounts of the stimulatory antigens. Western blotting was performed using a rabbit 
antibody generated towards fractionated B. oleronius proteins that is particularly 
reactive to the 62 kDa antigen. Following Coomassie staining of the SDS gel the protein 
extracts (Figure 3.1 A) appear similar. Figure 3.1 B represents an immunoblot probed 
with positive rosacea sera (pooled from 5 patients). The blot shows increased expression 
in the 62 kDa protein when cells were subjected to Triton-X detergent extraction 
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(section 2.12) compared to cells subjected to sonication (2.8 fold) or a combination of 
both (1.6 fold). The combination of detergent and sonication extraction lead to a higher 
yield of the 83 kDa protein of 1.4 fold compared to Triton-X and 3.8 fold compared to 
sonication alone. Subsequently the combination of both methods was used where the 
cells were suspended in the detergent lysis buffer for 30 mins-1 hr followed by 3 x 10 
second blasts of sonication at 20% power. This method was used to obtain the 
maximum amount of both proteins in the extracts used to test patient sera reactivity. 
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 (A) 
   (B) 
 
Figure 3.2 SDS-PAGE (A) and Western blot (B) coupled with densitometric 
analysis of B. oleronius protein extracted using different methods 
‘Son’ represents the protein extract obtained by sonication alone as described in section 
2.12. ‘Tri’ represents the protein extract obtained with the use of a detergent buffer. The 
third lane of the gel represents a combination of the 2 methods. 
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3.2 Testing reactivity of individual patient sera to Bacillus antigens using 
Western blotting 
 
 A previous study used 16 papulopustular rosacea patient serum samples and 
100% showed reactivity to the 62 kDa antigen while the 83 kDa protein induced an 
immune response in 50% of patients. By comparison 25% of control sera reacted to the 
62 kDa antigen and no controls responded to the 83 kDa protein (Lacey, 2007). 
Therefore it was established that B. oleronius produced 2 immune stimulatory proteins 
that could be detected in a serological assay when tested on the sera of Papulopustular 
rosacea patients. In this study involving 59 blind tested sera samples included patients 
with ocular rosacea (Ocular Surface Research Centre in Miami) and 18 blind tested sera 
samples including patients with erythematotelangiectatic (type one) rosacea (Sengio 
Dermatologia Portugal). Bacillus protein lysate (20 µg/well) was prepared as described 
in section 2.12, separated by SDS-PAGE and transferred to nitrocellulose membrane. 
These membranes were cut into individual strips and Western blots were carried out 
using serum diluted in blocking buffer (1:100). The membranes were then incubated for 
2 hours at room temperature in a HRP-linked anti-human secondary antibody diluted 
1:1000 in blocking buffer. Reactivity was visualised using DAB substrate (section 
2.23). Serum immunoreactivity to B. oleronius in some of the ocular rosacea patients is 
shown in Figure 3.2 A, Figure 3.2 B represents control sera responses. Serum reactivity 
in a sample of the type one rosacea cases is represented in Figure 3.3 A, while Figure 
3.3 B shows a sample of the controls from that study. Western blot analyses from all 
participants in both studies are presented in the Figures 8.1-8.6.  
 
3.2.1 Testing for reactivity to Bacillus antigens using Western blotting assays in Ocular 
rosacea 
Ocular rosacea is difficult to diagnose since symptoms involving the eyes 
reportedly manifest in up to 20% of cases prior to any cutaneous symptoms (Dahl et al. 
2002; Jansen & Plewig 1997; Starr &  a Macdonald 1969; An et al. 2005). Diagnosis is 
achieved by careful examination of the eye however common ophthalmic signs of 
rosacea such as blepharitis and conjunctival inflammation may be confused with other 
conditions such as seborrhoeic dermatitis, cylindrical dandruff, blepharitis or 
68 
 
conjunctivitis (Jansen & Plewig 1997; Gao et al., 2005; Neiberg & Sowka 2008). More 
serious ocular manifestations are rare but can include iritis and keratitis leading to sight 
threatening opacification of the cornea or limbal stem cell deficiency (Jansen & Plewig 
1997; Kheirkhah et al. 2007; Oltz & Check 2011). Ocular manifestations occur in up to 
50% of cases of rosacea and reports suggest that up to 33% of those may involve 
corneal symptoms (Starr &  a Macdonald 1969). The lack of agreement on the etiology 
of rosacea indicates that further work is needed to establish a diagnostic assay for the 
condition. 
Results from the study of serum immunoreactivity to 2 stimulatory Bacillus 
proteins formed the basis for a publication (Li et al., 2010) with 66% (14/21) of patients 
positive for facial rosacea also proving positive for serum immunoreactivity to one or 
more of the antigens. The 59 patients were subdivided into 2 groups according to serum 
immunoreactivity, positive (n=21) and negative (n=38) (Figure 3.2 A&B). Comparison 
of these 2 groups showed that positive serum immunoreactivity was significantly 
correlated with ocular Demodex infestation (p=0.048), facial rosacea (p=0.009), and lid 
margin inflammation (p=0.040) (Li et al., 2010). Of those individuals in the serum 
positive group 100% (21/21) had antibodies towards the 62 kDa protein and 61% 
(13/21) showed serological reactivity to the 83 kDa protein. Sixty eight % (26/38) of 
those in the negative serum group were controls. Thirty three % (7/21) of the control 
sera reacted to the Bacillus antigens.  
Those individuals who show reactivity to Bacillus proteins but are negative for 
rosacea symptoms may have generated antibodies due to previous exposure to the 
bacterium since it is thought to be an endosymbiont of Demodex mites which are 
ubiquitous in the skin of all adults(Bonnar et al., 1993). The pattern of serum reactivity 
in Figure 3.2 A (Ocular rosacea patients) is clearly distinguishable from the reactivity 
seen in Figure 3.2 B (Control sera). Sera from rosacea patients is generally more 
reactive than control sera and the 62 kDa band is clearly visible in cases 1, 6, 7, 12 & 
23. Reactivity to the 83 kDa protein is present in four (cases 1, 6 ,7 & 23) of the blots 
presented here. Cases 16, 17, 20, 21 & 25 represent controls, weak reactivity to the 83 
kDa band is seen in cases 16 & 17. Case number 25 showed weak reactivity to both 
antigens but was still distinguishable as a control. 
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1  6  7  12  23 
Figure 3.2 A Western blot analysis of sera from ocular rosacea patients to B. 
oleronius protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with ocular rosacea. 
 
 
      
15  17  20  21  25 
Figure 3.2 B Western blot analysis of control sera to B. oleronius protein extract 
These blots represent sera from controls that showed no or very weak reactivity to the 
stimulatory antigens. 
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3.2.2 Testing for reactivity to Bacillus antigens using Western blotting assays in 
Erythematotelangiectatic rosacea 
Erythematotelangiectatic (type one) rosacea is characterised by flushing in the 
central region of the face rosacea patients describe their flushing to last longer than 10 
minutes therefore it differs from the flushing seen in response to embarrassment, 
exercise, or hot environments (Crawford et al., 2004). Individuals presenting with 
prolonged flushing and sensitive irritated skin may be assessed for symptoms of rosacea 
using clinical classification and grading guidelines (Dahl et al., 2002; Wilkin et al., 
2004), however no diagnostic assay exists. In this section it was sought to investigate 
the possibility that a serological reaction to Bacillus antigens might occur in type one 
rosacea patients. Immunoblotting was carried out as described in section 3.2. 
Blind testing of control and patient sera was carried out on samples donated 
from Dr. Nuno Menezes (Servico Dermatologia, Lisbon, Portugal). Following analysis 
of clinical data the results were devided into two groups, 26 individuals were positive 
for type one rosacea and 22 were controls. Twentyone serum positive individuals were 
present among the type one rosacea patients (80%, 21/26). Of these 85.7% (18/21) of 
sera samples reacted to the 62 kDa antigen, 42% (9/21) reacted to the 83 kDa antigen 
while six patients (6/21, 28.5%) demonstrated reactivity to both proteins (Figure 3.3 A). 
Of the 22 samples later revealed to be controls 40% (9/22) showed weak reactivity to 
the 62 kDa antigen(Figure 3.3 B). Figure 3.3 A presents five rosacea positive cases (A, 
B, D, E & H) that all show a reactive band at the 62 kDa region, case B is also reactive 
to the 83 kDa protein. Control sera represented by cases; C, G, N & O (Figure 3.3 B) 
show no reactivity to either band, while case F is reactive to the 62 kDa protein but is 
still distinguishable as a control. Data from this study were analysed using a Chi-
squared test and a significant correlation (p=0.004) between serum reactivity to the two 
bacillus proteins and the occurrence of type one rosacea was established. 
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A  B  D  E  H 
Figure 3.3 A Western blot analysis of sera from type one rosacea patients to 
B. oleronius protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with type one rosacea. 
 
 
      
C  F  G  N  O 
Figure 3.3 B Western blot analysis of control sera to B. oleronius protein 
extract 
These blots represent sera from controls that showed no or very weak reactivity to the 
stimulatory antigens. 
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Study Population 
Positive for 
Serum 
Reactivity 
and rosacea 
Negative 
serum 
response in 
rosacea 
patients 
Positive 
serum 
response in 
controls 
Negative 
Serum 
response 
from 
controls 
Ocular Rosacea 14/21 (66%) 12/38 (31%) 7/21 (33%) 26/38 (68%) 
Erythematotelangietatic 
Rosacea 
21/26 (80%) 5/26 (19%) 9/22 (40%) 13/22 (59%) 
 
Table 3.1 Summary of Serum reactivity results 
Sera were blind tested for reactivity to 2 stimulatory Bacillus proteins and predicted 
positive or negative for rosacea. Following clinical examination patients were diagnosed 
and a correlation between serological reactivity and rosacea status. 
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3.3 Testing reactivity of tear fluid to Bacillus antigens 
 
Samples received from the Ocular Surface Research Centre, Miami were from 
controls and patients with some degree of ocular involvement in their rosacea. In 
conjunction with the serum samples, tear samples were also received and tested for 
reactivity to the bacterial antigens. Tear fluid was extracted from the conjuctival fornix 
of the eye using polyester wicks. The samples were sent on ice and stored at -80°C. In 
order to test the tear fluid the wicks were soaked in DTT sample buffer (section 2.19) to 
solubilise the proteins. This protein was separated by SDS-PAGE and visualized using 
colloidal Coomassie blue dye. The sample method did not allow the protein to be 
quantified however following staining of the gels (Figure 3.4 A) it was evident that 
there were high levels of extractable protein in the tear fluid. 
It was decided that Western blotting analysis would be carried out so the 
proteins were transferred to a nitrocellulose membranes. For this experiment an anti-B. 
oleronius antibody generated in rabbit was used for the primary incubation. Normal 
Western blotting procedure was followed and the membranes were developed using 
ECL chemiluminesence reagents (Perkin Elmer). Although gels revealed sufficient 
proteins there was minimal success in detecting reactivity to Bacillus antigens from 
rosacea positive patients with this method. Figure 3.4 B shows six representative cases 
where faint traces of reactivity to the Bacillus antibody were detected in the tear fluid. 
In cases 16, 18, 22, 23 & 40 reactive bands were identified in tear fluid at the 62 kDa 
region and case number 45 showed reactivity at the 83 kDa region. All six individuals 
were positive for ocular rosacea (Figure 6.4 C) and four (22, 23, 40 & 45) had initially 
tested serum positive showing reactivity to both Bacillus proteins. The remaining 2 (16 
& 18) had weak reactivity and were labelled as possible patients.  
 Since up to 90% of ocular rosacea patients show no facial symptoms, diagnosis 
of the disease can be difficult. An et al, (2005) proposed a mass spectrometry based 
assay for detection of oligosaccharides which were more abundant in the tear fluid of 
those with ocular rosacea than controls. Western blotting of tear fluid proved to be an 
unreliable detection method for the detection of the stimulatory bacterial antigens. The 
accuracy of a tear fluid based assay for the detection of bacterial antigens in the tear 
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fluid of rosacea patiens could be improved with the use of a more sensitive technique 
such as Mass spectrometry or ELISA. 
 
3.3.1 Summary 
Western blotting analysis has confirmed the presence of antibodies that are 
reactive to B. oleronius proteins (62 and 83 kDa) in the serum and tear fluid of rosacea 
patients. In a study of individuals with ocular rosacea 66% of patients had reactivity to 
one or both of the stimulatory proteins in their serum and 68% of controls showed a 
negative response. Reactivity of patient tear fluid using a rabbit antibody for the 62 kDa 
protein was detected in 6 individuals who were positive for ocular rosacea. In a study of 
individuals with erythmatotelangietatic rosacea 92% of patients showed a positive 
serum response while 100% of controls showed a negative serum response. These 
results indicate the possible use of Bacillus proteins in the diagnostic detection of 
rosacea. 
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 (A) SDS-PAGE  
  (B) Tear Immunoblots 
 (C) Sera Immunoblots 
16 18 22 23 40 45 
 
Figure 3.4 SDS-PAGE (A) and Western blot (B) analysis of tear fluid proteins 
Reactive bands were identified in tear fluid samples from 6 ocular rosacea patients (case 
numbers 16, 18 22, 23, 40 & 45).  
(C) Serum reactivity in patients which showed reactivity in their tear fluid 
These blots represent cases where the sera showed positive reaction to both of the 
stimulatory antigens (62 & 83 kDa) and had some level of tear fluid ractivity. 
 
Marker 16 18 22 23 40 45 
62 
62 kDa 
62 
83 
83 kDa 
83 
175 
83 
17 
62 
46 
30 
25 
76 
 
3.4 Fractionation of B. oleronius proteins by Q-Sepharose charge 
separation using Fast Performance Liquid Chromatography (FPLC) 
 
When rosacea patient sera was tested for reactivity using crude B. oleronius 
extracts there was reactivity to two antigenic proteins (62 and 83 kDa) in particular. 
Fractionation of B. oleronius protein was carried out (Lacey, 2007) in order to generate 
an antibody against the antigenic proteins of the bacterium. This antibody was raised in 
rabbit and is primarily reactive to the 62 kDa protein. It was postulated that this protein 
was more stable than the 83 kDa antigen during the fractionation process and therefore 
present at a higher concentration in the protein mixture used for inoculation to generate 
the antibody. The 62 kDa protein is reactive in a higher amount of rosacea patients 
compared to the 83 kDa protein (section 3.2). 
The aim of this section was to fractionate the reactive proteins for use in assays 
with human cells and to investigate the potential to generate a diagnostic assay. Large 
amounts of bacteria (up to 5 Litres) were grown in rich medium (2XYT broth) at 30°C 
and 200 rpm, for several days to give a dense culture. Cells were then inverted with a 
lysis buffer containing 0.2% Triton-X 100 detergent for at least one hour at 4°C to 
ensure minimal protein degradation occurred. The cells were also subjected to 
sonication to ensure the maximum protein concentration was obtained in the lysate 
(section 2.12). 
Fractionation was performed using the ÄKTA Purifier 100 system (Amersham 
Biosciences) and a Q-sepharose column, the system is automated and monitored by the 
Unicorn 5.01 programme. It was previously established (Lacey, 2007) that Bacillus 
proteins bound favourably to the positively charged Q-sepharose beads and that 
inverting the beads in the lysate prior to preparation of the column gave maximum 
binding. The column was attached to the ÄKTA system so that the beads (5-10 mls) 
could be equilibrated prior to mixing with the lysate, which was achieved by pumping 
binding buffer (section 2.9) through the column at 1 ml/minute with a 0% gradient for 
five minutes, then elution buffer (section 2.10) was pumped at the same flow rate with 
100% gradient for five minutes, followed by a repeat wash with the binding buffer for 
five minutes. At this point the beads were removed from the column and inverted with 
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the filter sterilised protein mixture at 4 °C for at least 1 hour. This process was 
continued overnight in some cases. 
The beads were loaded back onto the column which was reattached to the 
ÄKTA system. At this point the protein sample that remained was injected back onto 
the column at a rate of 0.5 ml/min followed by the binding buffer (section 2.9) until the 
absorbance reading returned to zero. The elution buffer containing 1 M NaCl was 
washed through the column to elute the protein (section 2.10) and 0.5 ml fractions were 
collected per minute by an automatic fraction collector. Figure 3.5 (A) represents a 
chromatograph generated by the Unicorn 5.01 computer programme from one run of the 
ÄKTA system. In the magnified image (Figure 3.5 B) the blue peak corresponding to 
the UV 280 absorbance reading represents protein being eluted from the column and the 
vertical red lines represent the fractions as they are labelled on the fraction collector. 
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     Time (Minutes) 
 
Figure.3.5 Chromatographs from ÄKTA-FPLC fractionation of B. oleronius 
protein 
(A) Represents a chromatograph generated by the Unicorn 5.01 computer 
programme as the anion exchange purification was performed. 
(B) Represents the protein eluted (blue peak) from the column and the fractions (500 
µl/min) collected (vertical red lines). All fractions were analysed by SDS-PAGE 
and those corresponding to the peak contained the highest concentration of 
protein. 
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3.4.1 SDS-PAGE and Western blot analysis of the FPLC fractions 
In order to identify the presence of the antigens of interest, 50 µl was taken from 
each fraction and mixed 1:1 with 10 x sample buffer (section 2.19) and boiled before 
application to 1D SDS gels. Gels were duplicated so one could be stained with 
Coomassie while the other was transferred to nitrocellulose membrane for Western 
blotting. The figures below (3.6-3.8) represent the results of one fractionation 
procedure. This procedure was carried out multiple times to obtain the semi purified 
protein product. The wash was collected after the column was attached during the 
equilibration with binding buffer and there was minimal protein in this lane (Figure 3.6 
A & B) of the gel because the protein was bound to the Q-sepharose beads on the 
column. The sample was re-applied to the column after inversion with the beads and the 
flow through was collected at this point. Samples of the wash and flow through (lanes 1 
and 2) were applied to the SDS gel to ensure that large amounts of protein were not 
being lost as waste during the procedure. The B. oleronius cells post-protein extraction 
where applied to lane 3 (Figure 3.6 A & B) there was some residual protein seen on the 
gel and Western blots however the yield of protein in the fractions was also high. Cells 
were sometimes retained and stored at -20 °C for subsequent fractionations. 
The fractions (F11-F19) represented in Figure 3.7 A & B contain multiple 
proteins. At fraction 17 the 62 kDa band becomes the predominant protein in the SDS 
gels and in Figure 3.8 (A) there appears to be a single band present in the fractions. The 
Western blot analysis reveals other proteins or perhaps breakdown products of that 
protein are also present (Figure 3.8 B). Western blotting can be more sensitive therefore 
the 83 kDa protein does not appear to be present on the gel (Figure 3.8 A) however is 
visible in some fractions on the blot (Figure 3.8 B). Fractions containing the proteins of 
interest were pooled, in this case fractions 17-54, then concentrated using amicon filters, 
re-suspended at a concentration of 1 µg/10 µl and stored at -20 °C until required. 1D 
SDS-PAGE analysis was used to identify the fractions containing proteins of interest 
each time more protein was needed for the assays to ensure the make-up of the ‘purified 
preparation’ remained constant and assays were reproducible. Figure 3.9 represents the 
Bacillus protein extract prior to ÄKTA purification and the product the results from 
pooling fractions that show reactivity to the 62 kDa antibody. 
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Figure 3.6 (A)  
SDS-PAGE analysis of flow 
through, wash, bacteria cells and 
Q-sepharose fractions 1-10 
Figure 3.7 (A) 
SDS-PAGE analysis of Q-
sepharose fractions 11-19 
Figure 3.6 (B)  
Western blot analysis of flow 
through, wash, bacteria cells and 
fractions 1-10 
Probed with rabbit antibody  
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Figure 3.7 (B) 
Western blot analysis fractions 11-19 
Probed with rabbit antibody 
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Figure 3.8 (A) 
SDS-PAGE analysis of Q-sepharose 
fractions 22-54 
Figure 3.8 (B) 
Western blot analysis of fractions 
22-54 
Probed with rabbit antibody  
83 
62 
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Figure 3.9 Representation of ‘Crude lysate’ and ‘Purified protein preparation’ 
following ÄKTA fractionation 
Bands indicated in the crude lysate at the 62 and 83 kDa regions were excised and 
subjected to LC/MS analysis (Table 3.2). 
All bands present in the purified preparation were excised and subjected to LC/MS as 
indicated in Figure 3.10 and Table 3.3. 
 
ID Protein Species Accession Mass pI Z-
score 
Coverage 
% 
62 groEL 
chaperonin 
Bacillus 
subtilis 
1906220B 57470 4.75 375 15% 
83 aconitate 
hydratase 
Bacillus 
sp. SG-1 
ZP_01858967 99213 4.94 358 9%. 
Table 3.2 Proteins identified by LC/MS corresponding to the two stimulatory 
Bacillus proteins 
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3.4.2 Liquid Chromatography Mass Spectrometry analysis of fractionated proteins 
It has been previously demonstrated that B. oleronius produces proteins that 
cause serum immune reactivity in rosacea patients (Lacey et al. 2007; Li et al. 2010). 
To analyse the effect that this bacterium has on human neutrophil and corneal epithelial 
cells a protein lysate was prepared and purified using ÄKTA FPLC (section 3.4.1). 
Figure 3.9 shows the SDS-PAGE profile of bacterial protein ‘crude lysate’ before and 
the ‘purified protein’after fractionation (section 3.4). Protein bands from the 62 kDa and 
83 kDa regions of the crude lysate (Figure 3.9) were excised and subjected to Liquid 
Chromatography Mass Spectrometry and the identified proteins are presented in Table 
3.2. The antigenic protein at the 62 kDa region showed homology to a groEL 
chaperonin protein from Bacillus subtilis (accession number 1906220B) with a score of 
375 and sequence coverage of 15%. This protein is said to be located in the cytoplasm 
and is a member of the chaperonin family of heat shock proteins (Hsp) expressed in 
many bacterial species. Chaperonins assist the folding of newly synthesized 
polypeptides and its cofactor GroES may be required for proper folding (Khor et al 
. 2004). The 83 kDa band was identified as aconitate hydratase from Bacillus sp. SG-1 
(accession number ZP_01858967) with a score of 358 and sequence coverage of 9%. 
This is an enzyme of the tricaboxylic acid (TCA) cycle.  
The protein bands present in the ‘purified preparation’ (Figure 3.9 & 3.10) were 
also excised from the gel, trypsin digested (section 2.22) and analyzed by LC/MS. 
Peptides were identified by peptide mass finger printing using the Matrix Science 
Mascot Ions search engine. The proteins are identified in Table 3.4. Band one showed 
homology to Kat E1 and band three was identified as vegetative catalase both of these 
proteins have enzymatic properties that function to protect the bacterial cells against 
reactive oxygen species (ROS). Catalase converts hydrogen peroxide water and oxygen. 
H2O2 is a component of ROS produced by the host immune system in response to 
pathogens. Catalase from Mycobacterium tuberculosis has previously been described as 
a tissue antigen indicated in the induction of granulomatous inflammation in sarcoidosis 
(Song et al., 2005). Band two was identified as a hypothetical protein involved in 
petidoglycan synthesis. Peptidoglycan is a component of the bacterial cell wall and has 
been implicated as a pathogen associated molecular molecule (PAMP) which are 
recognised by cells of the innate immune response (Vance et al., 2009). Only a select 
group of bacterial molecules act as PAMPs however sensing of bacterial replication or 
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local alterations in host amino acid and nutrient levels can act as triggers for an immune 
response (Vance et al., 2009). Band four was homologous to aminopeptidase an enzyme 
that catalyses the removal of amino acids from the N-terminus of peptides and proteins. 
Aminopeptidases are involved in the ATP-dependent steps during cytosolic protein 
degradation in bacteria (Chandu 2003). Band five was identified as an elongation factor 
which catalyses the GTP dependent ribosomal translocation step during elongation. 
Bacterial elongation factors have been implicated in interactions with the human 
immune system via TLR signalling (Kyungwoo, 2011; Nieves et al., 2010; Sharma et 
al., 2011). Band six was identified as alanine dehydrogenase which is involved in the 
generation of pyruvate and NADH during respiration. Band seven was homologous to 
malate dehydrogenase; which catalyses the oxidation of malate to oxaloacetate. 
Enzymes such as those corresponding to bands 6, 7 and 10 involved in metabolism and 
respiration within bacterial cells may cause localised changes as they obtain nutrients 
for cell growth within the host tissue and this may contribute to the stimulation of an 
immune response (Vance et al. 2009). Band eight was identified as flagellin which is 
produced by bacterial cells to aid flagellar motility. Flagellin is recognised by the host 
immune response as a PAMP and it can stimulate the production of cytokines via 
interactions with TLR-5 (Vance et al. 2009; Hozono et al. 2006). Superoxide dismutase 
(SOD) was identified as the protein corresponding to band nine and it is involved in 
protecting the bacterial cells from oxidative stress. Band 10 was identified as alkyl 
hydroperoxide reductase (AHP) which, is involved in the maintenance of the redox 
environment within bacterial cells. SOD and AHP are enzymes which can protect 
bacterial cells against the host immune responses production of oxygen radicals 
(Cabiscol et al., 2000; Seaver et al., 2001). Both APH and SOD from Helicobacter 
pylori have been implicated as antigenic proteins (Every et al., 2011; Olsen et al., 2000; 
Pourakbari et al., 2011). 
 
3.4.3 Summary 
B.oleronius proteins were successfully fractionated and analysed by SDS-PAGE 
in order to identify fractions which contained proteins reactive to the 62 kDa rabbit 
antibody. These fractions were then pooled and protein bands present in the preparation 
were trypsin digested and subjected to LC/MS in order to identify the types of proteins 
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present. Since this protein preparation was to be exposed to human neutrophils and 
corneal epithelial cells, the ability of individual proteins in the preparation to interact 
with these cell types was investigated. The purified protein was also used in an to 
investigate the possibility of developing a diagnostic ELISA for reactivity to B. 
oleronius proteins in sera from individuals with rosacea. 
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Figure 3.10 SDS-PAGE separation of ‘Purified protein preparation’ following 
ÄKTA fractionation 
Table 3.3 Proteins identified by LC/MS corresponding to the 10 bands indicated in 
Figure 3.10 
Proteins identified in Figure 3.10 and Table 3.3 are listed in further detail in Table 3.4. 
 
 
Band 
ID 
Protein 
1 KatE1 
2 Hypothetical peptidoglycan 
synthase 
3 Vegetative Catalase 
4 Aminopeptidase 
5 Elongation Factor G 
6 Alanine dehydrogenase 
7 Malate dehydrogenase 
8 Flagellin  
9 Superoxide Dismutase 
10 Alkyl Hydroperoxidase 
175 
83 
17 
62 
46 
30 
25 
Purified B. 
oleronius 
Extract 
kDa 
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Band 
ID 
Protein Accession Mass pI value 
Mascot Z- 
score 
Coverage 
% 
Uniprot Function 
1 KatE1 YP_093702 54541 5.48 181 7 
Response to 
oxidative stress 
2 
Hypothetical 
Protein 
Noc_2222 
YP_344212 40113 5.63 71 4 
Peptidoglycan 
Biosynthetic 
process 
3 
Vegetative 
Catalase 1 
YP_081190 54801 6.03 287 22 
Decomposes 
hydrogen 
peroxide 
4 aminopeptidase YP_081153 48162 8.63 272 10 
Catalyzes the 
removal of amino 
acids 
5 Elongation factor G YP_077397 76499 4.83 189 9 Tanslocation 
 
Table 3.4 ‘Purified Proteins’ from Bacillus oleronius identified by LC-MS 
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Band 
ID 
Protein Accession Mass pI value 
Mascot Z- 
score 
Coverage 
% 
Uniprot 
Function 
6 
alanine 
dehydrogenase 
ZP_01859623 39777 5.04 74 6 Metabolism 
7 
malate 
dehydrogenase 
YP_080204 33634 4.99 380 40 Metabolism 
8 Flagellin BAB58982 26512 5.09 189 20 
Ciliary or 
flagellar 
motility 
9 
Superoxide 
dismutase 
YP_079829 22530 5.33 171 25 
Destroys 
oxygen radicals 
10 
Alkyl 
Hydroperoxide 
Reductas 
YP_081364 20874 4.66 237 27 
Maintenance of 
redox 
environment 
 
Table 3.4 (Continued) ‘Purified Proteins’ from Bacillus oleronius identified by LC-MS 
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3.5 Use of fractionated proteins to investigate of the possibility of 
establishing an ELISA based assay for rosacea 
 
The Enzyme-Linked Immunosorbent Assay (ELISA) technique was developed 
in the 1970s by Peter Perlman and Eva Engvall (Engvall & Perlmann 1971). Since then 
it has become a extremely important technique in the research and clinical setting 
(Lequin 2005) and can be used to test an large number of protein interactions. In the 
assay format proposed in this work the purified B. oleronius protein (1 µg/ml) was 
coated to a 96 well plate and its antigenic potential to bind antibodies in rosacea patient 
and control sera was analysed using a tetramethylbenzidine (TMB) substrate to detect 
horseradish-peroxidase bound to the secondary anti-human IgG antibody (diluted 1 in 
2000). Reactivity was read using a spectrophotometer at 450 nm. 
 
3.5.1 Investigation of reactivity of Rabbit 62 kDa antibody to purified B. oleronius 
protein in an ELISA format 
In order to investigate the potential to develop an assay for use as a diagnostic 
aid, the fractionated protein was used to coat 96 well plates to form the basis for an 
ELISA test as described in section 2.15. Firstly the specificity of the bacterial protein 
was investigated (Figure 3.11). A serial dilution of the anti-62 kDa antibody (Lacey et 
al., 2007) was made in 1% PBS-tween starting with a neat sample of the antibody then 
adding a dilution factor of 10 until a 1/100000 was reached, a detectable signal was 
achieved with the 1/1000 dilution and the more concentrated samples caused a signal to 
high to be read on the spectrophotometer. Increased binding of the antibody to the 
protein was detected as the dilution factor of the antibody decreased which signified that 
the protein used to coat the ELISA plate was reactive with the anti 62 kDa antibody. A 
1% BSA solution made in PBS was added to the plate to test for unspecific binding to 
the Bacillus protein which was minimal in this assay when compared to the signal 
observed in when the rabbit antibody was tested. To further investigate the unspecific 
binding of the 62 kDa antibody to BSA an assay comparing a Bacillus protein coated 
plate and a 1% BSA coated plate was performed (Figure 3.12). However the unspecific 
binding of the antibody to 1 % BSA increased as the dilution factor decreased.  
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Figure 3.11 Reactivity of the Anti-62 kDa rabbit antibody to the Bacillus protein 
used to coat ELISA plates. 
The results show binding of the anti-62 kDa antibody to the protein on the plate 
increased as the dilution factor decreased. 
 
 
Figure 3.12 Reactivity of the Anti-62 kDa rabbit antibody to the Bacillus protein 
used to coat ELISA plates. 
The results show binding of the anti-62 kDa antibody to the protein on the plate 
increased as the dilution factor decreased. However the unspecific binding of the 
antibody to 1 % BSA also increased as the dilution factor decreased.  
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3.5.2 Investigation of reactivity of rosacea patient sera and control sera to purified B. 
oleronius protein in an ELISA format 
It was decided to investigate the response of rosacea patient and control sera in a 
number of formats to investigate if the specificity would be improved compared to the 
rabbit antibody assay. The format of the test remained the same as that described in 
section 2.15 and section 3.5.1 where 1 µg/ml of the fractionated protein was coated to a 
96 well plate and binding of serum antibodies was detected using TMB. Initial results 
proved encouraging as there was a statistically significant increase of 2 fold (p=0.023) 
in binding of serum antibodies to antigen coated plates when rosacea positive sera 
(Figure 3.13) was compared to control sera (Figure 3.14), these results were observed 
when a 1/1000 dilution of the serum was used. Patient sera diluted 1/100 showed 
increased binding compared to controls of 1.4 fold however this was not statistically 
significant (p=0.09).  
There was also no significant difference between binding of patient and control 
sera to the BSA coated wells. The serum immunoblot in Figure 3.14 indicates two 
issues that could be detrimental to the ELISA assay format performed in this work. The 
red ovals (Figure 3.14) indicate (1) that sera that can be correctly distinguished as 
control with the immunoblot due to the absence of the 62 kDa band could still show 
reactivity to the 83 kDa band and (2) the protein preparation did not contain the 62 kDa 
protein alone (section 3.4, Table 3.4). Therefore the strong reactivity indicated to bands 
below the 62 kDa region could have caused detection of reactivity from control sera 
with the ELISA. There was an increase of 3.4 fold (p=0.01) detected in case 3 compared 
to case 10 diluted 1/1000 and an increase of 3.2 fold (p=0.02) detected at the 1/100 
dilution. 
It was decided to investigate the use of 1% BSA as a diluent for the sera to try to 
decrease the unspecific binding thought to be causing increased reactivity in some 
control cases. Patient sera did not show a statistically significant increase in binding to 
Bacillus protein (p=0.073) or BSA (0.044) when compared to controls. The highest 
absorbance recorded among the patient sera was in sample 7 (OD 450 = 0.9) (Figure 
3.14 B) and this was reduced only slightly with the used of the BSA diluent compared 
to in Figure 3.13 were an OD 450 of 1 was recorded. Sample 2 showed the highest OD 
in the controls when this was compared to patient sample 7 a 3 fold (p=0.013) increase 
was recorded. 
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 6  7 Serum Immunoblot 
Figure 3.13 Reactivity of two serum positive rosacea patients (case 6 & 7) to 
purified Bacillus protein in an ELISA assay 
Detection of patient sera antibodies bound to Bacillus protein was 2 fold (p=0.023*) 
increased in patient sera compared to control sera (Figure 3.14) diluted 1/1000.  
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 3  10 Serum Immunoblot 
Figure 3.14 Reactivity of two controls (case 3 & 10) to purified Bacillus protein in 
an ELISA assay 
There was no significant difference when a comparison was made between binding of patient 
and control sera to BSA with 1/100 or 1/1000 dilutions of sera. Possible causes for increased 
reactivity in control case 3 compared to control 10 are highlighted in the red circles (1 & 2). In 
this case control sera showed reactivity to the 83 kDa (1) protein and to a band (2) below the 62 
kDa protein which may be present in the semi-pure protein preparation. There was an increase 
of 3.4 fold (p=0.01*) detected in case 3 compared to case 10 diluted 1/1000. 
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 A 
 B 
Figure 3.14 Reactivity of six control (A) and six rosacea patient (B) sera diluted in 
1% BSA to purified Bacillus protein and BSA in an ELISA assay 
Patient sera did not show a statistically significant increase in binding to Bacillus 
protein (p=0.073) or BSA (0.044) when compared to controls. 
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Despite the promising initial results that prove this assay is capable of detecting 
reactivity in rosacea patient sera the high reactivity detected among some of the controls 
suggests the assay is not suitable as a diagnostic in its current format. Following trials to 
identify the optimum diluents with a small amount of samples, the assay was tested on 
49 sera samples from the ocular rosacea study (Li et al., 2010). All sera were diluted 
1/100 in PBS-T with 1% BSA and divided into group 1 (Positive serum reactivity with 
Western blot) and group 2 (Control sera). The ELISA was carried out as described in 
section 2.15. It is evident in Figures 3.15 A & B that some of the sera obtained from 
rosacea patients was only weakly reactive in this assay while some of the controls 
showed strong reactivity to proteins present on the ELISA plates. The average reactivity 
at OD 450 recorded from the pooled positive samples was 0.933 while the average 
absorbance detected from the control sera was 0.869 there was no statistical significance 
between the 2 groups (p=0.27). Proof that B. oleronius antigens could be used as a 
diagnostic marker remains unclear however the use of a completely pure sample of the 
62 kDa antigen obtained with recombinant techniques could potentially improve the 
outcome of the assay. 
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Figure 3.15 (A) ELISA representing reactivity of sera samples obtained from 
Ocular Rosacea (Group 1) patients to the ‘purified’ Bacillus protein. 
 
Figure 3.15 (B) ELISA representing reactivity of sera samples obtained from 
controls (Group 2) to the ‘purified’ Bacillus protein. 
A fold change of 1.07 was detected using a 2-way anova test between the average 
absorbance of the controls (0.0869) compared to the average absorbance of the rosacea 
patients (0.933) (p=0.027). 
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3.6 Discussion 
  
In this Chapter the Western blot method employed previously by Delaney, 
(2004) and Lacey, (2007) was used to blind test serum samples for reactivity to Bacillus 
oleronius antigens. In section 3.4.2 the 62 kDa protein was identified as a groEL 
chaperonin protein from GroEL is analogous to the human chaperonin hsp60 which is 
said to have pro-inflammatory cytokine like properties and has a role in folding of 
essential oxygen scavenging enzymes such as manganese superoxide dismutase (Khor 
et al., 2004). Bacterial Hsps are known to have antigenic properties and proteins 
homolgous to GroEL have been identified in, Escherichia coli, Mycobacterium 
tuberculosis, Pseudomonas aeruginosa and Burkholderia pseudomallei (Shinnick et al., 
1988; Woo et al., 2001). The 83 kDa band was identified as aconitate hydratase. The 
function of this protein is in the utilization of glucose to obtain energy for the cell the 
TCA cycle is active in times of low glucose availability and is repressed by excessive 
glucose (Hecker et al., 2008). Aconitate hydratase has been identified in Salmonella 
enterica cells responding to H2O2 exposure (Kim et al., 2010). 
Serological reactivity to these proteins in rosacea patients indicated prior 
exposure to B. oleronius. Sera samples were analysed for reactivity to stimulatory 
Bacillus proteins and after establishing the presence of antibodies towards the 62 or 83 
kDa proteins, the identity of the serum was predicted as either control or patient. 
Collaborating clinicians then revealed the case numbers for the sera that originated from 
patients and controls and correlations were recorded. In a study of individuals with 
ocular rosacea 66% of patients had reactivity to one or both of the stimulatory proteins 
in their serum and 68% of controls showed a negative response. In a study of 
individuals with erythmatotelangietatic rosacea 92% of patients showed a positive 
serum response while 100% of controls showed a negative serum response. When 
results of both the ocular rosacea (section 3.2.1) and the erythematotelangiectatic 
rosacea (section 3.2.2) studies were considered 76% of patients were serum positive and 
72% of controls were serum negative. In the case of at least some of the serum negative 
cases that were later revealed to be rosacea patients it has been postulated that these 
patients may have received treatments that reduced the density of Demodex in their skin 
and therefore the presence of bacteria. These results indicate a positive correlation 
between serum immune response to B. oleronius proteins in rosacea patients. Results 
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from the ocular rosacea study involving 59 individuals were published in Li et al., 
(2010) and significant correlations between positive serum immunoreactivity and facial 
rosacea (p=0.009) and ocular Demodex infestation (p=0.048) were reported. Lid margin 
inflammation was graded in patients and a significant correlation between it and 
positive serum reaction was recorded (p=0.040). Patients in the study with facial 
rosacea were also found to have significantly higher Demodex counts than those without 
(p=0.014) (Li et al., 2010). These findings link serum reactivity to the 62 and 83 kDa 
Bacillus antigens to ocular Demodex infestation and ocular surface inflammation for the 
first time and add to the evidence that bacterial antigens may be responsible for the 
dysregulated immune response and chronic inflammation seen in rosacea. 
 Detection of specific proteins expressed in human tear fluid has been suggested 
as an indicator of ocular surface disease (Cheng et al., 1996; Spurr-Michaud et al., 
2007; An et al., 2005; Määttä et al., 2006; Pong et al., 2010). The protein hemopexin 
was detected at increased levels in the tear fluid of patients with the ocular 
inflammatory disease vernal keratoconjunctivitis (VKC) compared to controls. Analysis 
of tear fluid using 2D-electrophoreisis and ELISA were used in the study (Pong et al. 
2010). Elevated tear fluid levels of MMP-8 have been detected in rosacea patient 
compared to controls (Kari & Kari, 2005) using immunofluorometric and 
immunobloting assays. Analysis of reactivity of tear fluid to Bacillus antigens was 
difficult to assess using the Western blot method. Although reactivity was found in 6 
cases (numbers 16, 18, 22, 23, 40 & 45) that were all later revealed to be patients 
(Figure 3.4), these results were not reproducible due to the small amount of sample 
available. Cases 22, 23, 40 and 45 were all positive for both the 62 and 83 kDa antigens 
using the immunoblotting technique and had been predicted as patients. Cases 16 and 
18 showed weak reactivity to only the 62 kDa antigen using immunoblotting and were 
labelled as controls however upon clinical examination these individuals were 
diagnosed as rosacea positive. This result may indicate that detection of B. oleronius 
proteins in the tear fluid could occur prior to the detection of the proteins in patient sera. 
Although the Western blotting technique employed for this work was not successful in 
detecting all patient samples, an altered assay format for the testing of B. oleronius 
proteins in ocular rosacea patient tear fluid such as an ELISA could be useful. 
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 Due to the work outlined in this Chapter and the previous work by Delaney 
(2004) and Lacey (2007) there is evidence that bacterial antigens contribute to the 
inflammation seen in rosacea. In order to further analyse which bacterial antigens could 
be inducing the immune response, B. oleronius proteins were subjected to Liquid 
Chromatography Mass Spectrometry (section 3.4). Bacterial outer membrane proteins 
were solubilised using a lysis buffer containing Triton-X 100 detergent coupled with 
sonication. The proteins were then fractionated (section 3.4.1), separated by SDS-PAGE 
and individual bands were excised and their peptide make up analysed by LC-MS 
(section 3.4.2). Previous studies (Delaney, 2004; Lacey, 2007) had identified the 62 and 
83 kDa proteins as causing serum reactivity in rosacea patients and an antibody that was 
reactive to these proteins was generated. Therefore the fractionated proteins were 
blotted for reactivity to this antibody (Figure 3.6 A-3.8 B) in order to identify which 
fractions should be pooled for use in human cell and serum ELISA assays. 
Streptococcal antigens or superantigens have been implicated in inflammatory 
guttate psoriasis (Leung et al., 1995), it is thought that the increase infiltration of T-cells 
observed in psoriasis lesions is mediated by these bacterial super antigens. Antigenic 
material isolated from the bacterium Propionibacterium acnes has been implicated in 
the inflammation of acne since T-cell proliferation has been seen in response to 
bacterial culture supernatant (Jappe et al., 2002). LC/MS analysis revealed that a 
number of the Bacillus proteins identified were capable of interacting with the host 
immune response and some had been implicated as serum antigens in human disease 
caused by bacteria. Flagellin was one of the proteins identified and is a known ligand 
for TLR-5 and therefore can stimulate neutrophils to produce cytokines such as IL-8 
and TNF-α and contribute to the induction of inflammation (Vance et al., 2006). The 
human immune system is designed to recognize a number of molecules produced by 
microbes that are termed pathogen-associated molecular patterns (PAMPs). Recognition 
of these molecules leads to stimulation of the innate and eventually the adaptive 
immune responses. However PAMPs are not always associated with pathogenic 
microbes (Cookson et al., 2001; Gallo & Nizet, 2008). Peptidoglycan recognition is a 
trigger for the innate immune response (Dziarski 2004) a hypothetical Noc protein 
identified in the ‘purified antigen preparation’ was identified as a peptidoglycan 
synthesis protein. A study by Travis (2000), has highlighted the use of drugs to disrupt 
metabolic pathways as a new target for treatment of pathogenic bacteria. Several 
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enzymes involved in metabolic pathways were identified by the LC/MS analysis 
including; aminopeptidase, alanine dehydrogenase, malate dehydrogenase these proteins 
could contribute to the induction of inflammation by altering the local homeostasis of 
the pilo-sebaceous unit within the host (Vance et al. 2009).  
A number of the proteins identified were involved in the bacterial response to 
oxidative stress, such as Kat E1, vegetative catalase 1, superoxide dismutase (SOD) and 
alkyl hydroperoxide reductase (AHP). Increased production of ROS has been implicated 
in rosacea patient skin (Tisma et al., 2009; Yamasaki & Gallo, 2009) therefore it is 
possible that bacteria such a B. oleronius present in the pilo-sebaceous unit could 
produce increased levels of these oxidative response proteins thus triggering an 
antigenic response. A study by Jeavons et al., (1998) describes the isolation of proteins 
from Penicillium marneffei which caused immunoreactivity in human sera one of which 
had homology to catalase. Catalase from Mycobacterium tuberculosis has also been 
detected as an antigenic protein in individuals affected by sarcoidosis a disease which is 
characterized by granulomatous inflammation (Song et al., 2005). SOD from 
Mycobacterium paratuberculosis has been suggested as an antigen that could be used as 
a potential vaccine for cattle (Mullerad et al., 2002) due to detection of serum reactivity 
in mice infected with the bacterium. Proteins such as SOD and AHP have been 
suggested as vaccine components for Helicobacter pylori infection which can cause 
gastric cancer (Every et al. 2011; Pourakbari et al. 2011; I. Olsen et al. 2000). These 
proteins represent good targets in this case because they are essential to the survival of 
the cell in the hostile environment of the stomach (Every et al. 2011). The use of AHP 
protein in an assay for the detection of H. pylori infection in human stool was 
investigate using a purified recombinant rabbit antibody which detect the presence of a 
26 kDa antigen in stool of 83.3% (40 ⁄ 48) positive samples (Pourakbari et al., 2011). 
Elongation factor G was also among the identified proteins and several studies 
have reported proteins with elongation and translational functions in the ribosome as 
antigenic (Shin et al., 2007; Shin et al., 2009). An elongation factor (EF-Tu) from 
Francisella novidica which causes severe pulmonary disease was detected in the serum 
of mice vaccinated with an attenuated form of the bacteria suggesting an antigenic role 
for this protein (Sharma et al. 2011). The study also described the ability of a 
recombinant EF-Tu from F. novidica to induced macrophages to produce inflammatory 
cytokines in a TLR4 dependent manner suggesting an immune stimulatory role for the 
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protein. A study of the pathogenic bacterium Burkholderia pseudomallei has also 
identified EF-Tu as a potential vaccine to protect against melioidosis which is endemic 
in Southeast Asia (Nieves et al. 2010). 
The identification of specific antibodies in patient serum samples can provide a 
tool for the diagnosis of disease (Engvall & Perlmann 1971). As mentioned previously 
the exact etiology of rosacea is not fully understood and diagnosis of the condition can 
also be difficult due to the similarities to other conditions such as acne, dermatitis and 
conjuctivits. Oltz & Check, (2011) contains a Table of the differential diagnoses for 
rosacea that lists16 of the conditions that can be mistaken as rosacea. If patients are 
misdiagnosed with one of these conditions and do not receive prompt treatment for 
ocular rosacea they are at risk of developing serious symptoms that can lead to 
ulceration of the cornea and visual impairment. To investigate the potential to provide a 
diagnostic assay for rosacea Fast Performance Liquid Chromatography was employed 
to fractionate immune stimulatory proteins in particular the 62 kDa protein (Table 3.2). 
Fractionated Bacillus proteins (Table 3.4) were coated onto 96 well plates so that an 
ELISA protocol could be employed to analyse the response of serum to the antigens. As 
discussed previously several of the proteins identified in section 3.4 have the potential 
to interact with components of the immune response. A protein homologous to GroEL 
(detected in this work at the reactive 62 kDa region) has been indicated as a possible 
marker for Burkholderia pseudomallei (Woo et al. 2001) in individuals suffering from 
melioidosis. 
ELISAs provide a more quantitative analysis technique than Western blotting 
and only 1 µg/ml of the antigen preparation was required to coat the plates (section 
2.15). Initial tests showed reactivity with the rabbit antibody generated towards the 62 
kDa B. oleronius protein (Lacey, 2007) proving that the ELISA format was suitable for 
binding of the antigen (ie: the Bacillus protein preparation section 3.4) to the antibody 
(Figure 3.11 & 3.12). When this was established testing of human serum was carried out 
(Figures 3.13 – 3.15). When human serum was tested for reactivity in the ELISA format 
it was difficult to distinguish patients from controls in some cases. Diagnostic ELISAs 
usually employ recombinant monoclonal proteins while the assay described in this work 
was performed using a protein preparation purified by fractionation that contained 
multiple potentially serum reactive proteins. In the clinical setting such a test could 
potentially provide a distinction between ocular rosacea and other ocular inflammatory 
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conditions such as blepharitis. The results described in this work suggest that a more 
refined ELISA format could potentially provide a useful diagnostic tool.  
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CHAPTER 4 
 
 
 
An investigation of the effect of 
Demodex-associated Bacillus oleronius 
proteins on human neutrophils 
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4.0 Introduction 
  
Rosacea is a chronic inflammatory disorder that involves lack of regulation of 
the innate immune system, but the exact etiology of the condition is not fully 
understood (Crawford et al., 2004). According to the National Rosacea Society over 16 
million Americans suffer with rosacea and 70% of patients surveyed in 2006 reported 
low self esteem due to the condition (Fimmel et al., 2008). Symptoms usually occur 
around the central region of the face and vary across the four subtypes (papulopustular, 
erythematotelagiectatic, ocular and phytamous) of the condition (Wilkin et al. 2004). 
Patients usually present with one of the following; erythema (transient or persistent), 
papules and pustules or telangiectasia, in conjunction with secondary features such as 
edema, burning and stinging skin or ocular manifestations (Dahl et al. 2002). A better 
understanding of the molecular mechanisms involved in the condition is emerging and 
the action of neutrophils has been linked to the development of many symptoms 
observed in this condition (Yamasaki & Gallo, 2009). 
In this Chapter the effects of Demodex-associated Bacillus antigens on 
neutrophils were examined. Demodex are saprophytic mites located in the pilosebaceous 
unit of the skin and the eyelashes. Two species are found to inhabit the human skin, 
Demodex folliculorum in the hair follicles and eyelashes and Demodex brevis deeper in 
the sebaceous glands and meibomian glands of the eyes (Kheirkhah et al., 2007). There 
is support in the literature for a correlation between increased mite density and the 
occurrence of rosacea (Bonnar et al., 1993; Gao et al., 2005; Li et al., 2010). However 
these mites remain non-pathogenic to most people and there is no definitive proof that 
the high level of Demodex in rosacea patients is an etiological correlation rather than a 
coincidence (Dhingra et al., 2009). It could be the case that the skin of individuals with 
rosacea is favourable for the proliferation of these mites and that in turn leads to the 
high density which could lead to a pathogenic role in rosacea. 
Previous work by Delaney (2004) lead to the isolation of a bacterium from a 
Demodex mite from the face of a papulopustular rosacea patient. This bacterium, 
Bacillus oleronius, produces antigens that can initiate peripheral blood mononuclear cell 
(PBMC) proliferation in 73% of rosacea patients compared to 29% of controls (p = 
0.0105) (Lacey et al., 2007). Interestingly the growth of this bacterium was found to be 
104 
 
susceptible to metronidazole and tetracycline which are used in the treatment of rosacea 
(Lacey et al., 2007). Proteins expressed by Bacillus oleronius were examined using 
Liquid Chromatography-Mass Spectrometry (Section 3.4.2). The function of these 
proteins was outlined (Table 3.2) and the antigenic potential of many of these proteins 
was discussed (Section 3.6). 
Bacterial superantigens have previously been implicated in the induction of the 
inflammatory skin disorder psoriasis (Leung et al., 1995). Many reports have focused 
on the possibility that microbes lead to the exacerbation of the innate immune response 
seen in rosacea patients (Elewski et al., 2010; Whitfeld et al., 2011, Yamasaki et al., 
2009). Bacteria such as Staphylococcus epidermidis and Helicobacter pylori have been 
discussed as possible contributors to the exacerbation of inflammation in rosacea 
(Whitfeld et al., 2011, Utaş, et al., 1999). Interestingly S. epidermidis isolated from 
rosacea patients were consistently β-hemolytic while bacteria from controls were non-
hemolytic when cultured on blood agar (Dahl et al., 2004). In addition, this bacterium 
has been isolated from the pustules of patients with papulopustular rosacea and from the 
eyelids of patients with ocular rosacea indicating a possible role for this bacterium in 
the induction of these conditions (Whitfeld et al., 2011). 
The evidence for microbial involvement in the condition is augmented by 
investigating the typical treatments that are effective against the four subtypes of 
rosacea. Traditional therapies for treatment of rosacea include tetracyclines, 
metronidazole and doxycycline which are well known antibiotics but also have highly 
effective anti-inflammatory properties (Bartholomew et al., 1982; Monk, et al., 2011; 
van Zuuren, et al., 2007). Tetracyclines are known inhibitors of matrix 
metalloproteinases (MMPs), over expression of which has previously been linked to 
rosacea (Jang, et al., 2010; Monk et al., 2011). Treatment with these drugs can also 
reduce inflammation by inhibition of neutrophil chemotaxis and regulation of cytokine 
production. Another primary treatment for rosacea is azelaic acid which can be applied 
as a 15% gel to relieve inflammation by reducing reactive oxygen species (ROS) 
produced by neutrophils (Oltz & Check 2011). 
Neutrophils are part of the first line of defence of the body against harmful 
stimuli. The innate immune response is delicately balanced in healthy individuals, 
however over expression of its components have been implicated in a range of 
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inflammatory conditions such as psoriasis and atopic dermatitis (Bevins & Liu, 2007). 
Neutrophils are granular leukocytes that can engulf and kill microorganisms (Vance et 
al., 2009). Their killing mechanism can prove harmful to the surrounding tissue due to 
the release of ROS which are generated during the oxidative burst triggered by 
activation of NADPH oxidase ( Curnutte et al., 1987; Boh, 1996; Segal, 2005). Higher 
levels of ROS have been reported in rosacea skin and these free radicals can damage the 
skin by decreasing collagen synthesis and mediating cytokine release (Monk et al. 
2011). Infiltration of neutrophils followed by the accumulation of pro-inflammatory 
mediators such as cytokines and reactive oxygen species along with proteolytic 
enzymes lead to the development of inflammatory lesions (Elewski et al. 2010). The 
tissue damage caused in the area surrounding the inflammation could induce erythema 
and angiogenesis, which contributes to the development of telangiectasia, one of the 
main symptoms of rosacea. 
The aim of the work presented here was to investigate the response of 
neutrophils to antigens from B.oleronius as it was hypothesized that this Demodex-
associated bacterium could be involved in the induction of rosacea. The goal was to 
elucidate whether these antigens could stimulate neutrophils and so lead to the localised 
inflammation that is key to rosacea pathogenesis. Throughout the work described here 
phorbol myristate acetate (PMA) was employed at a concentration of 2 µg/ml as a 
positive control. PMA is capable of modulating NADPH oxidation in human 
neutrophils (Van Epps et al., 1985) which facilitates the uptake of oxygen and the 
generation of superoxide radicals during phagocytosis and degranulation. Therefore 
comparisons could be made between activated neutrophils and neutrophils exposed to 
the Bacillus proteins. The purification of Bacillus proteins is described in Chapter 3 and 
LC/MS identification of ‘purified proteins’ in this preparation was outlined in Table 
3.4.4. When exposure to ‘crude protein’ is mentioned this refers to the protein extracted 
from B. oleronius prior to fractionation. 
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4.1 The effect of Bacillus antigens on human neutrophil migration 
 
Neutrophils are motile cells that migrate toward the site of infection or tissue 
damage in the body in response to a number of signals including cytokines. Blood 
vessels become dilated during an inflammatory response which allows blood flow to 
slow down and ligands are expressed on the endothelial cells on the surface of the 
vessels that attract surface molecules on the neutrophils. The result of these changes is 
the recruitment of neutrophils into the tissue (Hague & Jones 2008). For this experiment 
neutrophils were isolated (section 2.26) from whole blood of healthy donors and pooled 
in order to examine the effects of the Bacillus oleronius protein extract (section 2.14) on 
cell migration using porous membranes to similar to the endothelial surface. The cells 
were treated with 2 or 6 µg/ml of the purified Bacillus protein (section 3.4.2, Table 3.3) 
or 2 µg/ml of the crude protein and incubated at 37 °C with 5% CO2 for 1 hour. During 
this incubation period 24 well culture plates were set up as described in section 2.27 
before addition of the treated cells and further incubation for 24 hours. After 24 hours 
the cell migration was quantified using a crystal violet dye elution method described in 
section 2.27. Cells were also photographed using an Olympus camera.  
Results from experiments that used both 3 and 8 µm porous inserts showed 
increased migration of neutrophils across the membrane when treated with the Bacillus 
protein compared to control cells. Initial results (Figure 4.2) were promising, in images 
A-F it can be seen that there are more cells present on the membrane following 
treatment with the bacterial antigens. In this case the assay was incubated for only 1 
hour and the 8 µm inserts were used, when the cells were eluted there was a significant 
increase in the amount of migrated cells p<0.05 with two of the antigen treatments (4 
µg/ml purified antigen and 1 µg/ml crude antigen). It was decided that the assays would 
be incubated over night and Figure 4.2 shows that the number of cells migrating 
increased more uniformly as the treatment concentration increased. However the assay 
was not completely reproducible and one reason for this may be the elution of crystal 
violet that was staining the insert rather than the cells may have lead to an increase in 
the absorbance reading. The 2 µg/ml purified treatment caused an average increase of 2 
fold (p=0.031) across 3 replicates of the assay which was statistically significant. 
Images of the stained cells before elution show increased numbers of cells had migrated 
following treatment with the Bacillus antigens. 
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In order to examine if the lack of reproducible result was due to the pore size 
being too big for the cells a 3 µm porous insert was employed. Results represented in 
Figure 4.3 show migration of treated cells compared to controls was significantly 
increase by 4.3 fold (p = 0.02) and 6 fold (0.001) respectively following exposure to 2 
µg/ml and 6 µg/ml of purified antigens and a 7 fold increase was recorded following 
exposure to 2 µg/ml (0.027) of the crude antigens. The images in Figure 4.3 also 
compliment the statistical analysis by showing increased numbers of migrated cells on 
the membranes following treatment with the bacterial protein. 
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 (A) Control   (B) 2 µg/ml Pure 
 (C) 4 µg/ml Pure  (D) 6 µg/ml Pure 
 (E) 1 µg/ml Crude  (F) 2 µg/ml Crude 
 
Figure 4.2 Migration of neutrophils through 8 µm porous membrane following 
treatment with Bacillus oleronius proteins after 1 hour 
(A-F) Images of stained neutrophils (denoted by the white arrow) that had migrated 
through the porous membrane viewed at x 20 magnification. 
In the control image (A) few neutrophils have migrated through the membrane.  
Images (B-D) represent cells exposed to 2, 4 & 6 µg/ml of the purified protein. The 
amount of migrated cells has increased. 
Images (E & F) represent cells exposed to 1 & 2 µg/ml of the crude protein extract, 
migration of these cells has increased compared to the control image. 
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(A) Control     (B) 2 µg/ml Pure 
   
(C) 6 µg/ml Pure    (D) 2 µg/ml Crude 
Figure 4.2 The effect of B. oleronius proteins on migration of human neutrophils 
through 8 µm porous membranes after 24 hours 
(A-D) Images of stained neutrophils (white arrows) that had migrated through the 8 µn 
membrane and the pores visible on the membrane (black arrows) viewed at x 40 
magnification. 
The graph represents fold change in number of crystal violet stained cells eluted using 
33% (v/v) glacial acetic acid where * denotes p<0.05 and ** denotes p<0.01. 
These data represent 3 biological repeats of the assay. 
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(A) Control     (B) 2 µg/ml Pure 
   
(C) 6 µg/ml Pure    (D) 2 µg/ml Crude 
Figure 4.3 The effect of B. oleronius in the migration of human neutrophils 
through 3 µm porous membranes after 24 hours 
(A-D) Images stained neutrophils (white arrows) that had migrated through the 3 µm 
membrane and the pores visible on the membrane (black arrows) viewed at x 40 
magnification. 
The graph represents fold change in number of crystal violet stained cells eluted using 
33% (v/v) glacial acetic acid where * denotes p<0.05 and ** denotes p<0.01. 
These data represent 3 biological repeats of the assay. 
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4.2 The effect of Bacillus antigens on human neutrophil degranulation 
  
When neutrophlis become activated they undergo an oxidative burst which 
increases their uptake of oxygen leading to the generation of reactive oxygen species 
(ROS), this process is accompanied by degranulation (Manara et al., 1991). 
Degranulation is the process by which leukocytes (neutrophils in particular) release the 
contents of the granules contained in their cytoplasm. Neutrophils have four types of 
granules (secretory, gelatinase, specific, azurophil) each containing a variety of 
enzymes, anti-bacterial peptides, complement molecules and membrane receptors 
(Nuutila et al. 2009). Degranulation can be triggered in many ways such as hypoxia, 
cellular stress, formyl peptides produced by invading microorganisms (Deree et al., 
2006; Lekstrom-Himes et al., 2005), isolation of the neutophil, temperature changes or 
a difference in anti-coagulant type (Nuutila et al., 2009). Upon stimulation of the 
neutrophil the granules translocate and fuse to the phagosomal or plasma membrane 
where the contents are released (Lacy 2006).  
The aim in this section was to examine whether neutrophil degranulation was 
induced by treatment with the antigenic Bacillus proteins, thus adding to the body of 
evidence that suggests neutrophils and the array of proteins and proteolytic enzymes 
they produced play a critical role in inducing symptoms of rosacea such as erythema, 
edema and telangiectasia. 
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4.2.1 Analysis of the effect of Bacillus antigens on MPO production by human 
neutrophils. 
Myeloperoxidase (MPO) is contained primarily in the azurophil granules of 
neutrophils; it is an enzyme that produces hypochlorous acid from hydrogen peroxide 
and chloride anion. Azurophil granules combine with the phagocytic granules in order 
to kill microbes that have been engulfed (Bellocchio et al., 2004), MPO has not been 
previously linked to tissue damage in rosacea however it has the potential to contribute 
to a pro-inflammatory state in the tissue (Wang et al., 2008). In order to evaluate the 
effect of Bacillus antigens on MPO production a stirred chamber based assay was used. 
Healthy control neutrophils were exposed to the B. oleronius antigen preparations and 
cell free supernatants were isolated at 0, 3, 6 and 9 minute time points and resolved by 
1-D SDS-PAGE. Western blot analysis (Section 2.28) of these supernatants 
demonstrated there was an increase in the levels of MPO suggesting that neutrophils 
degranulate in response to the bacterial antigens. Reactivity to the MPO antibody 
increased by 3.9 fold following 6 minutes of treatment with 2 µg/ml of the bacterial 
antigen (p=0.003). When the crude lysate (2 µg/ml) was tested a 4.27 fold increase was 
seen at the zero minute time point compared to control cells (p=0.04). 
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Figure 4.4 Western blot analysis of secreted MPO 
A-E Western blots of Neutrophil secreted proteins at time points 0-9 miuntes following 
treatment with purified or crude Bacillus extract at 2 or 6 µg/ml.  
The graph represents densitometric analysis of the blots using Image J software. There 
is a significant increase in reactivity to the MPO antibody in 2 µg/ml purified and crude 
treatments over the 9 minutes (p = 0.043, p = 0.098 respectively). 
These data represent 3 biological repeats of the assay. 
Minutes 
0 3 6 9 
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4.2.2 Analysis of the effect of Bacillus antigens on MMP-9 release by human 
neutrophils. 
In a study by McAleer, (2010) it was stated that there was no correlation 
between the prevalence of rosacea and UV damage. However UV damage was linked to 
many of the pathological changes seen in rosacea through ROS mediated increase of 
matrix metallopoteases (MMPs) production in keratinocytes (Shin et al., 2008; 
Yamasaki & Gallo, 2009). ROS released by infiltrated neutrophils destroys collagen by 
inactivation of MMP inhibitors (Bakar et al., 2007; Monk et al., 2011). MMP-9, also 
known as gelatinase B, it is produced in gelatinase granules of the neutrophil and is 
responsible for the degradation of collagens IV and V (Murphy & Gavrilovic 1999). It 
is also the primary matrix degrading enzyme produced by the corneal epithelium and it 
has been detected in higher than normal levels in the tear fluid of ocular rosacea patients 
(Kari et al., 2006). Degradation of the collagen of the connective tissue leads to 
weakening of the vasculature and further recruitment of neutrophils which could 
potentially contribute to the edema and erythema seen in rosacea. MMP-9 is directly 
involved in the induction of angiogenesis (Ardi et al., 2007), up-regulation of this 
process can lead to telangiectasia which is a characteristic symptom of rosacea. The 
enzyme is also capable of converting IL-8 and TNF-α to their active forms (Manicone 
& McGuire 2008). 
Neutrophil supernatants were generated as previously described (Section 2.28) 
and probed for reactivity to an MMP-9 antibody raised in goat in the same fashion as 
the MPO analysis was performed (section 4.2.1). An increase was detected in the levels 
of MMP-9, a marker secreted by neutrophils during degranulation, when neutrophils 
were treated with the Bacillus antigens (Figure 4.5). There was a 2.9 fold increase in 
release of MMP-9 from neutrophils treated with 2 µg/ml of the purified antigen after 3 
minutes when compared to the controls (p=0.001). Following 9 minutes of treatment 
with 6 µg/ml of the antigen there was a 2.7 fold increase (p=0.002). These results 
indicate that exposure of neutrophils to the crude or purified B. oleronius antigen 
preparations leads to significantly elevated rates of degranulation.  
 
  
115 
 
 
 
A Control 
B 2 µg PMA 
C 2 µg Purified Antigen 
D 6 µg Purified Antigen 
E 2 µg Crude Antigen 
Treatment
D
en
si
to
m
et
ri
c 
U
n
it
s
C
on
tr
ol
g 
PM
A
2 2
 µ
g 
Pu
re
6 
µg
 P
ur
e
g 
C
ru
de
2 
0
50000
100000
150000
200000
Control
2 g PMA
2 µg Pure
6 µg Pure
2 g Crude
*
* *
** **
** *
**
**
**
*
*
*
*
*
Figure 4.5 Western blot analysis of secreted MMP-9 
A-E Western blots of Neutrophil secreted proteins at time points 0-9 minutes following 
treatment with purified or crude Bacillus extract at 2 or 6 µg/ml.  
The graph represents densitometric analysis of the blots using Image J software. There 
is a significant increase in reactivity to the MMP-9 antibody in the control compared to 
2 and 6 µg/ml purified and 2 µg crude treatments over the 9 minutes where * denotes 
that the treatment means are significantly different at p<0.05 and ** denotes highly 
significant difference at p<0.01. 
These data represent 3 biological replicates of the assay. 
Minutes 
0 3 6 9 
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4.2.3 Analysis of the effect of Bacillus antigens on hCAP-18 release by human 
neutrophils. 
Neutrophil supernatants were employed to examine the level of hCAP-18 
produced in response to B. oleronius antigens. Cathelicidin has been implicated in the 
pathogenesis of roseacea in recent studies (Ogawa, 2005; Yamasaki, et al., 2007). 
Cathelicidins are produced in neutrophils and are important components of the innate 
immune response across many species were they have anti-microbial and pro 
inflammatory roles. In a study by Yamasaki (2007) it was demonstrated that the 
expression of human cathelicidin (hCAP 18) was increased in the skin of rosacea 
patients compared to controls. Cathelicidin is cleaved into an active peptide (LL-37) by 
the stratum corneum tryptic enzyme, which was also increased in the skin of rosacea 
patients compared to controls. To verify that the changes in rosacea skin could be 
caused by increased levels of hCAP-18 and its active peptide human keratinocytes were 
treated with LL-37 and increased secretion of IL-8 was observed. Sub-cutaneous 
injection of LL-37 caused induction of erythema, vascular dilation and neutrophil 
infiltration in mice, which are all characteristics of rosacea (Yamasaki et al., 2007).  
Neutrophil supernatants were generated as previously described (Section 2.28), 
resolved by 1D SDS-PAGE, transferred to a nitrocellulose membrane and probed for 
reactivity to a hCAP-18 antibody raised in rabbit. As shown in Figure 4.6 there is a 
clear increase in the reactivity to the hCAP-18 antibody following treatment with the 
bacterial antigens. At the zero minute time point when 2 µg/ml of purified antigen was 
used there was a 3.8 fold increase of hCAP-18 release compared to control cells 
(p=0.002), following 6 minutes of incubation with the antigens a 2.4 fold increase was 
noted (p=0.037). These results suggest that the Bacillus antigens induce hCAP-18 to be 
released from neutrophils as part of a degranulation response. 
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Figure 4.6 Western blot analysis of secreted hCAP-18 
A-E Western blots of Neutrophil secreted proteins at time points 0-9 minutes following 
treatment with purified or crude Bacillus extract at 2 or 6 µg/ml.  
The graph represents densitometric analysis of the blots using Image J software. There 
is a significant increase in reactivity to the hCAP-18 antibody in the control compared 
to 2 and 6 µg/ml purified and 2 µg crude treatments over the 9 minutes where * denotes 
that the treatment means are significantly different at p<0.05 and ** denotes highly 
significant difference at p<0.01. 
These data represent 3 biological replicates of the assay. 
Minutes 
0 3 6 9 
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4.3 The effect of Bacillus antigens on cytokine production by human 
Neutrophils 
  
Cytokines are produced in response to the detection of infection and injury, their 
presence in the blood is one of the key factors that mediate neutrophil migration to the 
affected area during an inflammatory response (Retini et al., 1996), this is usually a 
tightly regulated response (Yamasaki & Gallo, 2009). Cytokines have previously been 
detected in elevated levels in the tear fluid of individuals with Demodex blepharitis 
(Kim et al., 2011) which is an inflammatory condition exacerbated by elevated levels of 
Demodex mites in the eyelash follicles and the meibomian glands. Conversely the 
disruption of cytokine production has been implicated in causing susceptibility to 
infection in alcoholic patients (Taieb et al., 2002). Decreases in IL-8 and TNF-α were 
recorded when neutrophils were treated with ethanol. Increased cytokine levels have 
been implicated in disease such as psoriasis (Blaschke et al., 2000), following 
quantitative RT-PCR analysis of tissue sections IL-8 and TNF-α cytokines were found 
to be elevated compared to the level detected in normal skin. TNF-α mediates the 
keratinocyte proliferation and angiogenisis in psoriasis (Hitoshi et al., 1997; Duan et al., 
2001) and induces the production of IL-8. TNF-α inhibiting drugs have been developed 
to treat psoriasis (Ahdout et al., 2010), since TNF is a potent stimulator of the 
inflammatory response inhibiting its production is a viable treatment however many 
patients report adverse side effects to the drugs.  
In order to determine the effects of Bacillus antigens on cytokine production, 
neutrophils (1 x 10
6
 cells/ml) were seeded into 24 well plates and incubated in RPMI-
1640 culture medium containing 5% (v/v) FCS and 2 mM L-glutamine with the relevant 
concentration of bacterial protein. Culture medium was collected at 3, 16 and 24 hour 
time points and any cells present were removed by centrifugation (Section 2.29) before 
the media were employed in a sandwich-ELISA protocol. Chemoattractant (IL-8) and 
pro-inflammatory (TNF-α) cytokines were quantified (Figures 4.7 & 4.8). These 
cytokines have the potential to contribute to the chronic inflammation seen in rosacea in 
a similar way to the pathogenesis of psoriasis; by recruiting neutrophils, inducing 
angiogenesis and maintaining the inflammation by inducing further cytokine 
production. 
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4.3.1 Evaluating IL-8 production by Neutrophils in response to Bacillus proteins 
 Interleukin 8 (IL-8) is a proinflammatory cytokine produced by neutrophils in 
response to pathogen detection, the movement of neutrophils is mediated predominantly 
by this cytokine (Teranishi et al., 1995). The bacterium Propionibacterium acnes has 
been implicated in the inflammatory stage of acne vulgaris, this bacterium can induce 
the production of IL-8 in keratinocytes leading to the infiltration of neutrophils (Grange 
et al., 2009). There was a significant increase in IL-8 production by neutrophils (Figure 
4.7) treated with the bacterial antigens in this study, in vivo this could lead to similar 
effects to those seen in other chronic inflammatory disorder such as psoriasis. Following 
an exposure time of 3 hrs the highest (4 fold, p=0.01) increase of IL-production was 
recorded in cells exposed to 6 µg/ml of bacterial protein. Neutrophils exposed to 6 
µg/ml of the pure protein produced a 3.4 fold (p=0.022) higher concentration of IL-8 
compared to cells incubated in untreated medium. At the 24 hr time point an increase in 
production of IL-8 of 4.2 fold (p=0.003) was recorded. Reports have shown increased 
production of IL-8 by PBMCs in psoriasis patients (Teranishi et al., 1995) leading to 
infiltration of neutrophils and keratinocytes to generate the inflammatory lesion and 
plaques that are characteristic on rosacea skin. 
 
4.3.2 Evaluating TNF-α production by Neutrophils in response to Bacillus proteins 
 Neutrophil supernatants were further employed to assess the level of TNF-α 
produced in response to the bacterial proteins. TNF-α is a pro-inflammatory cytokine 
produced by cells involved in innate immunity, it induces the production of other 
cytokines including IL-8 (Teranishi et al., 1995). ROS which are said to be increased in 
rosacea lesions compared to control skin (Bakar et al., 2007) can mediate the release of 
TNF-α in human keratinocytes. The greatest increase in TNF-α production was evident 
in neutrophils exposed to 2 µg/ml crude Bacillus antigen preparation for 3 hours (2.9 
fold increase p=0.0008) or 16 hours (2.8 fold increase P=0.0002) (Figure 4.8). These 
results indicate that exposure of neutrophils to crude or purified material from Bacillus 
lysate leads to cytokine production; which in vivo could have the effect of recruiting 
neutrophils to the sites of antigens exposure and provoking inflammation. 
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Figure 4.7 The effect of B. oleronius proteins on IL-8 secretion by human 
neutrophils 
The results are expressed as pg/ml of cytokine and represent three biological replicates 
of the assay where p≤0.05 is denoted by * and ** is p≤0.01. 
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Figure 4.8 The effect of B. oleronius proteins on TNF-α secretion by human 
neutrophils. 
The results are expressed as pg/ml of cytokine and represents three biological replicates 
of the assay where p<0.05 is denoted by * and ** is p<0.01. 
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4.4 Discussion 
 
 Recently the Demodex associated bacterium Bacillus oleronius has been shown 
to induce serum immunoreactivity in papulopustular (Lacey et al., 2007) and ocular (Li 
et al., 2010) rosacea patients. An elevation in the density of Demodex mites has been 
reported in both facial (Diazperez, 1994; Bonnar et al., 1993) and ocular (Gao et al., 
2005; Czepita et al., 2007; Kheirkhah et al., 2007) rosacea. Common effective 
treatments for rosacea such as doxycycline do not eradicate mites from the face (Monk 
et al., 2011) however it is possible that these antibiotics reduce the bacterial associated 
with the mites therefore relieving the symptoms. Tea tree oil (TTO) is an effective 
treatment which can eradicate Demodex mites in patients with cylindrical dandruff (Gao 
et al., 2005) and ocular rosacea (Kheirkhah et al., 2007). TTO has multiple benefits in 
that treatments that utilize this oil have acaricide, antimicrobial, antifungal and anti-
inflammatory properties (Gao et al., 2005). The focus of this Chapter was to investigate 
the effects of proteins isolated from the Demodex associated bacterium on the host’s 
immune response by characterizing the effect on human neutrophils. 
B. oleronius protein was purified using ÄKTA fast performance liquid 
chromatography to obtain a semi-purified preparation. This purified protein along with 
a crude lysate was exposed neutrophils in a range of assays to investigate the potential 
scenario that the cells migrate towards areas where this antigen may be present in the 
skin of rosacea patients (ie: the pilo-sebaceous units, eyelash follicles and tear fluid) 
leading to the production of cytokines and degranulation of proteins that induce 
inflammation and tissue damage. Following LC-Mass Spectrometry analysis it was 
found that the purified Bacillus protein preparation contained a wide range of proteins 
(section 3.4.2, Table 3.2) which could potentially interact with and activate the immune 
response in rosacea patients. Neutrophils are one of the most important cellular 
components of the innate immune response (Segal, 2005). It has been discussed at great 
length how dysregulation of the innate immune response is central to the pathogenesis 
of this rosacea (Dahl et al., 2002; Lacey et al., 2007; Li et al., 2010; Powell, 2005; 
Yamasaki & Gallo, 2009). 
The production of reactive oxygen species (ROS) has been implicated in the 
pathogenesis of rosacea (Yamasaki & Gallo, 2009), neutrophils produce ROS during the 
phagocytosis and killing of microorganisms (Reeves, 2003). Neutrophils can recognise 
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and respond to specific bacterial components (Vance et al. 2009) some of which were 
present in the protein preparation exposed to the neutrophils in this work. Among those 
was flagellin the protein monomer expressed in most species of bacteria which interacts 
with TLR-5 (Tapping 2009). TLR-5 signalling triggers activation of pathways that lead 
to the activation of NF-κB and other transcription factors involved in regulation of the 
immune response and stimulation of neutrophils (Hayashi et al., 2003). Therefore 
recognition of bacterial flagellin could be responsible the increased production of IL-8 
and TNF-α cytokines (Figures 4.7 & 4.8) and the increase in expression of 
degranulation proteins (Figures 4.4 – 4.6) observed in response the B. oleronius protein 
preparation. A protein involved in peptidoglycan synthesis was also identified (Section 
3.4, Table 3.4), recognition of peptidoglycan by neutrophils has been implicated in the 
induction of inflammation (Weiss 2003; Dziarski 2004). Tertiary neutrophil granules 
contain a peptidoglycan recognition protein which functions as an antibacterial granule 
protein (Dziarski 2004). Elevated expression of degranulation proteins MPO, MMP-9 
and hCap-18 were detected in response to the bacterial protein preparation (section 4.2). 
Peptidoglycan can also be recognised by TLR-2 and therefore could potentially 
contribute to the induction of inflammation in the tissue (Tapping 2009). 
Exposure of neutrophils to pro-inflammatory cytokines such as IL-8 and TNF-α 
can prime them for rapid degranulation (Nuutila et al., 2009). Neutrophils contain 
granules in their cytoplasm which produce cytotoxic super oxide species and 
antimicrobial peptides. The process of degranulation can be stimulated in many ways 
and leads ultimately to the release of the granular contents into the phagocytic vacuole 
or the surrounding tissue (Levy 2000). The level of MPO secreted by neutrophils in 
response to the bacterial antigens was quantified using Western blotting and revealed to 
be significantly increased (section 4.2.1). Western blotting revealed that MPO (Figure 
4.4) along with MMP-9 (Figure 4.5) and hCAP-18 (Figure 4.6) protein secretion 
increased when cells were treated with the antigen compared to control cells. These 
proteins have the potential to cause tissue damage in the skin and MMP-9 and hCAP-18 
have been implicated in the pathogenesis of rosacea in previous studies (Bamford, 2001; 
Kari , 2006; Monk et al., 2011; Yamasaki et al., 2007). Studies using epithelial cell 
lines and sebaceous cell lines have been performed in relation to rosacea. Yamasaki et 
al., (2007) stated that treating human keratinocytes with LL-37 (hCAP-18s active 
peptide) caused increased release of pro-inflammatory cytokines such as IL-8 by the 
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cells. LL-37 can also induce neutrophil chemotaxis of adaptive immune cells and 
angiogenesis which are processes that contribute to the pathogenesis of rosacea 
(Schauber & Gallo, 2009). The human cathelicidin peptide hCAP-18 is expressed in 
neutrophils and the keratinocytes of inflamed skin (Levy 2000). It has been reported 
that abnormal cathlecidin which caused increased inflammation was detected in the skin 
of rosacea patients compared to controls (Schauber & Gallo, 2009; Yamasaki et al., 
2007). Increased stratum corneum tryptic enzyme (SCTE) has been detected in the skin 
of rosacea patients which is thought to contribute to the processing of the abnormal 
cathelicidins (Yamasaki et al. 2007). Inflammatory neutrophils provide an important 
source of MMP-9 in the process of angiogenesis in tumour progression (Ardi et al. 
2007) angiogenesis is a process that occurs in the skin of rosacea patients and 
contributes to the erythema which causes the characteristic redness in the central region 
of the face (Elewski et al. 2010). 
Cytokines are also a contributing factor in relation to neutrophil migration; they 
are produced by neutrophils and epithelial cells in response to pathogen recognition or 
tissue damage in an area of inflammation (Okubo & Koga 1998; Ramos 2003). 
Exposure of human neutrophils to bacterial peptidoglycan from Bacterioids fragilis was 
shown to induce an increase in the migratory response of the white blood cells (Sperry 
& Burns 1987). IL-8 has a major role in the recruitment of neutrophils and in this study 
there was a significant increase in IL-8 (Figure 4.7) production by neutrophils exposed 
to B. oleronius protein. In section 4.5.1 it was demonstrated how the increase in IL-8 
production by neutrophils occurred in response to each concentration of antigen tested 
across a 24 hour period. TNF-α is involved in the induction of inflammation and has 
previously been implicated in chronic inflammatory disorders such as psoriasis (Hitoshi 
et al., 1997; Okubo & Koga, 1998; Deeva et al., 2010). Production of this cytokine was 
also significantly increased in response to bacterial antigen treatment (Figure 4.8). 
Again the effect was observed across all concentrations of antigen for a 24 hour period; 
detection was highest at the 16 hour time point and appeared to drop by 24 hours. Both 
of these signaling molecules could be produced initially at low levels in vivo followed 
by infiltration of higher levels of neutrophils and increased cytokine production in 
response to the bacterial antigens adding to the potential for a chronic inflammatory 
state to develop in the tissue. 
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Skin temperature is reported to be increased in people with rosacea (Whitfeld et 
al., 2011), this is said to be due to the long history of flushing and the altered 
vasculature which in turn leads to increased blood flow to the skin affected by rosacea. 
It is possible that the increased blood flow reported could predispose the skin of rosacea 
patients to having increased presence of immune cells such as neutrophils. To determine 
if Bacillus antigens had the potential to increase the migration of neutrophils, cell 
culture inserts (BD Falcon) with 3 and 8 µm polyethylene terephthalate (PET) 
membranes were used to set up migration assays (section 4.1). There was an increased 
migratory response in cells treated with the Bacillus protein compared to control cells as 
indicated in Figures 4.1-4.3. This was measured visually by taking images of the 
membranes with the migrated cells (which had been stained with crystal violet dye) 
intact and simply comparing the number of cells by eye (Figures 4.1-4.3). When using 
the 3 µm inserts, a mean increase of 4.3 fold (p = 0.02) was observed when cells were 
treated with 2 µg/ml of the purified antigens this rose to a 6.1 fold increase (p=0.001) 
with 6 µg/ml and a 7 fold increase when 2 µg/ml of the crude lysate (p=0.027) was 
used. The outcome of this reaction to Bacillus antigens in vivo could lead to infiltration 
of high numbers of neutrophils in the tissue surrounding the pilosebaceous unit and the 
lash follicles were the Demodex and their associated bacteria are present. Eventually 
this could lead to tissue damage in those areas due to the destructive nature of 
neutrophils.  
Neutrophils have been used extensively to study chronic inflammatory disorders 
(Bellocchio et al., 2004; Hartl et al., 2008; Morioka et al., 2008; Hayes et al., 2011). In 
a study by Wang et al., (2008) a recombinant Helicobacter pylori neutrophil activating 
protein (HP-NAP) was produced and used to assess the level of MPO activation in 
neutrophils. H. pylori has been implicated in chronic gastrointestinal inflammatory 
disorders and the ability of this protein to induce MPO production was suggested as 
playing a role in causing the tissue damage seen in the condition. In this Chapter an 
increase in MPO production following exposure of neutrophils to the bacterial protein 
was observed (section 4.2.1). The pathogenesis of cystic fibrosis is characterized by 
chronic inflammation of the lungs and increased infiltration of neutrophils, which are 
unsuccessful at clearing microbial infections (Hayes et al., 2011). In a study of chronic 
inflammatory lung disease and rheumatoid arthritis (Hartl et al., 2008) it was shown that 
infiltrated neutrophils expressed more chemokine receptors on their surface than 
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circulating neutrophils. Increased migration of neutrophils in response to B. oleronius 
protein was observed in vitro (section 4.1) therefore the presence of this bacterium in 
the pilo-sebaceous unit could induce infiltration of neutrophils in the surrounding area. 
Infiltration of neutrophils has been observed in the inflammatory lesions of 
granulomatous rosacea patients (Jang et al., 2010; Sánchez et al., 2008). 
The work outlined here has revealed some of the cellular changes that occur in 
neutrophils treated with Bacillus antigens. Demodex mites reside in the pilosebaceous 
units of the pores and in the eyelash follicles. Upon death the mites may cause local 
inflammation by release of bacterial endosymbyonts (eg: Bacillus oleronius) and their 
associated antigens into the surrounding tissue. It is possible that Bacillus antigens may 
be present at increased concentrations in the skin of people with rosacea due to the 
presence of higher numbers of Demodex mites. It was found that neutrophils treated 
with the Bacillus antigens showed increased cell motility, increased secretion of tissue 
damaging degranulation proteins (MPO, MMP-9 and hCAP-18) and up-regulation of 
cytokine (IL-8 and TNF-α) production. All of the cellular changes in response to the 
Bacillus antigens have been previously implicated in inflammatory responses, many 
have overlapping functions. The neutrophil responses described in this study provide 
strong evidence that Bacillus oleronius antigens could potentially contribute to the 
pathogenesis of rosacea.  
 
 
 
  
 
 
 
CHAPTER 5 
 
 
 
An investigation of the effect of Demodex 
associated Bacillus oleronius proteins on 
the corneal epithelial cell line hTCEpi 
and on primary limbal epithelial cells 
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5.0 Introduction 
 
The National Rosacea Society established a classification system in 2002 
(Wilkin et al., 2002) where the subtype under examination in this work was termed 
ocular rosacea. Some reports have stated that ocular involvement occurs in up to 50% of 
patients with rosacea and that ocular symptoms can manifest prior to any cutaneous 
symptoms (Oltz & Check, 2011). As mentioned previously the pathogenesis of rosacea 
is ambiguous; there are many possible contributing factors to this condition such as 
elevated Demodex mite density (Bonnar et al., 1993; Dhingra et al., 2009; Diazperez, 
1994; Gao et al., 2005; Kheirkhah et al., 2007), bacterial components (S. epidermidis 
and B. oleronius) (Lacey et al., 2007; Li et al., 2010; Whitfeld et al., 2011) and an 
underlying irregular innate immune response (eg: production of abnormal cathelicidin) 
(Yamasaki & Gallo, 2009). Ocular rosacea presents with a range of symptoms including 
irritated dry eyes, blepharitis, neo-vascularisation of the corneal surface and in severe 
cases complications such as corneal erosion and keratitis can develop (Dahl et al., 2002; 
Ramamurthi et al., 2006; Wilkin et al., 2004). Corneal thinning, development of 
phlyctenules, nodular infiltrates and ulcerations have all been observed as corneal 
complications linked to rosacea (Oltz & Check 2011; Kheirkhah et al. 2007; 
Ramamurthi et al. 2006) these can eventually cause scarring and corneal perforation 
leading to visual impairment. Differential diagnosis for rosacea include conjunctivitis 
and blepharitis treatment for these conditions without recognition of the underlying 
rosacea is often unsuccessful (Oltz & Check, 2011).  
The ocular surface is in constant contact with commensal bacteria however 
excessive inflammation is avoided due to an apparent difference between mucosal 
surfaces that are in contact with commensals and the convential immune response to 
pathogens (Ueta & Kinoshita 2010; Graham et al. 2007; Redfern & McDermott 2010). 
Corneal epithelial cells play a critical role in protecting the ocular surface from infection 
and are very selective in their response to microbial components (Kumar et al., 2007; 
Ueta & Kinoshita, 2010). The selective response is mediated by toll like receptors 
(TLRs) (Chang et al., 2006; Redfern & McDermott, 2010) which can induce the 
production of cytokines. It was recently reported that mRNA expression of TLRs 1-10 
(excluding TLR-8) was found in corneal epithelia cells and that corneal epithelial cells 
respond to ocular pathogenic but not non-pathogenic flagellin via TLR-5 (Chung et al., 
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2009; Hozono et al., 2006; Ueta & Kinoshita, 2010). Rosacea can manifest as an 
inflammatory ocular surface disease affecting the eyelids, conjunctival and corneal 
regions (Oltz & Check, 2011). The ocular surface epithelium could potentially be 
producing cytokines such as IL-8 and TNF-α in response to Bacillus oleronius 
components which initiate an immune response that becomes exaggerated and chronic 
as the condition progresses. Efficient distinction between pathogen and commensal is 
essential to avoid destructive inflammation of the corneal surface and this property may 
be impaired in those with ocular rosacea. 
Ulceration of the corneal surface in rosacea patients has been linked to Demodex 
infestation and has development of ulcers can potentially lead to visual impairment 
(Oltz & Check 2011; Wilkin et al. 2004; Elewski et al. 2010; Kheirkhah et al. 2007). 
Ulceration often begins with the development of phlyctenular keratoconjunctivitis 
which is usually considered more severe when it affects the cornea (Neiberg & Sowka, 
2008). It has been reported that 5-30% of patients with facial rosacea have corneal 
complications such as phlyctenule-like lesions (Bartholomew et al., 1982; Kheirkhah et 
al., 2007). The formation of phlyctenular lesions combined with neovascularisation, 
usually originates in the limbal region of the eye and can infiltrate the cornea (Neiberg 
& Sowka, 2008). Even in cases where treatment is sought, ulcers can develop on the 
cornea potentially leading to opaque scaring and perforation that can be sight 
threatening (Du & Oral, 2005; Monk et al., 2011; Oltz & Check, 2011).  
Matrix degenerating enzymes have been implicated in the formation of non-
infectious ulcers (Fini et al., 1998; Li et al., 2001; Yamasaki et al., 2007) such as those 
seen in severe cases of rosacea. Matrix mettaloproteinase 8 (MMP-8) and MMP-9 have 
previously been detected at an increased concentration in the tear fluid of ocular rosacea 
patients (Kari & Kari, 2006). Many reports have suggested that the success of 
tetracyclines for the treatment of ocular rosacea is largely due to their anti-inflammatory 
properties and ability to block the production and activation of MMPs (Du & Oral, 
2005; Gupta & Chaudhry, 2005; Kari & Kari, 2006; Monk et al., 2011; Oltz & Check, 
2011). Infiltration of inflammatory cells such as neutophils has been implicated in the 
formation of ulcers, these cells are reported to increase in numbers at the stromal matrix 
that underlies the corneal epithelium (Fini et al., 1998). It was previously shown in 
Chapter four that neutrophils treated with proteins extracted from Bacillus oleronius can 
induce the production of MMP-9 at an increased level during degranulation when 
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compared to untreated control cells. This result along with the reports of increased 
neutrophil infiltration could potentially lead to a scenario where the stromal matrix is 
exposed to high levels of tissue degrading enzymes, which induces vascularisation and 
ulceration if the chronic inflammation remains untreated.  
Severe cases of keratitis and ulceration can potentially lead to limbal stem cell 
deficiency in rosacea patients (Holland & Schwartz 2002). The corneal epithelium is 
maintained by stem cells located in the limbus which is located between the 
conjunctival and corneal epithelial tissues (Baylis et al., 2011; Kolli et al., 2010; Notara 
& Daniels, 2008). The stem cells are maintained in a niche at the inferior and superior 
regions of the limbus where they are supported by their proximity to the nutrient rich 
stromal region. As mentioned previously there have been reports indicating that the 
stroma is damaged as ocular rosacea progresses, this damage may contribute to limbal 
stem cell deficiency (Notara & Daniels 2008), which could potentially lead to visual 
impairment in rosacea patients. 
It has been described in Chapter four how proteins extracted from Bacillus 
oleronius were isolated (section 3.4.) and exposed to human neutrophils. In this Chapter 
the same extract was exposed to the corneal epithelial cell line (hTCEpi) and limbal 
epithelial cells. Limbal epithelial stem cells were isolated and cultured on gelatine 
coated plates to generate primary limbal epithelial cells for use in assays. Recently, a 
strong correlation has been established between serum reactivity to these Bacillus 
proteins and eye lid margin inflammation (p = 0.04), and ocular rosacea (p = 0.009) (Li 
et al., 2010). The aim of this work was to elucidate if the cellular changes caused by 
exposure to the bacterial proteins could contribute to the symptoms seen in ocular 
rosacea. It was hypothesised that corneal cells in vivo could potentially be exposed to B. 
oleronius proteins due to the presence of increased Demodex mites in the lash follicles 
of individuals with rosacea. Therefore the surrounding tissue and tear fluid could 
potentially contain immune triggering levels of B.oleronius antigenic proteins, thus 
contributing to the symptoms of rosacea. 
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5.1 The use of immortalized human corneal epithelial cell line (hTCEpi) 
as a model for the investigation of the role of Bacillus proteins in the 
development of ocular rosacea 
 
 The hTCEpi cell line was generated by infecting primary cultures of human 
corneal epithelial cells with a retroviral vector encoding telomerase reverse transcriptase 
(hTERT). The purpose of this cell line was to provide a model for the study of 
molecular mechanisms involved in human corneal cell differentiation (Robertson et al., 
2005). Following a review of corneal epithelial cell culture models the method used to 
generate the hTCEpi cell line was deemed an efficient way to generate epithelial cell 
lines (Castro-Muñozledo 2008). The cell line was recently used to investigate the role of 
plasma membrane calcium-ATPase expression in a wound healing model (Talarico, 
2010). Ocular symptoms are characteristic in up to 50% of rosacea patients so in this 
study we employed the corneal epithelial cell line to study the potential cellular changes 
that could contribute to the symptoms of ocular rosacea.  
 
5.2 The effect of Bacillus proteins on growth of hTCEpi cells 
  
Prior to studying the response of the hTCEpi cells to the Bacillus antigens more 
closely the toxicity of the antigen was assessed. Since the potential concentration of 
antigen present in vivo was not known, a concentration gradient from 0.5 µg – 6 µg/ml 
of antigen diluted in KGM-2 media was tested. The experiment was carried out in 
triplicate and 3 wells of a 24 well plate were assessed for each treatment. The growth of 
hTCEpi cells in the presence of the bacterial antigen was quantified using the crystal 
violet dye elution method as described in section 2.31.1 Results were expressed as a 
percentage of growth in comparison to growth of the control cells (Figure 5.1). As 
depicted in Figure 5.1, there was a statistically significant decrease in cell growth at the 
lowest antigen concentration where the cells dropped to 75% growth on average. BSA 
was employed as a control to ensure that addition of an arbitrary protein did not elicit 
the same effects seen with addition of the antigen. After 5 days of exposure to an 
antigen concentration of 2 µg/ml cell growth was inhibited by 26 % (p = 0.018) and at 
an antigen concentration of 6 µg/ml cell growth was inhibited by 75 % (p = 0.0003). It 
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was therefore decided that 2, 4 and 6 µg/ml of the purified protein preparation (section 
3.4.2, Table3.3) would be used and in some cases 2 µg of the crude lysate would be 
employed. 
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Figure 5.23 The effect of Bacillus antigens on the growth of the hTCEpi cell line 
The results presented here are a combination of three replicates with statistical 
significance calculated by comparing treatments to control. P < 0.05 is denoted by * and 
P < 0.01 by **. 
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5.3 The effect of Bacillus protein on wound healing in hTCEpi cells 
 
 In order to examine the wound healing response the hTCEpi cells were grown to 
confluency in 6 well culture plates. The assay was carried out as described in section 
2.31.2. Scratch wounds were generated using a 10-200 µl pipette tip. Results for these 
assays (Figure 5.2) showed that closure of the scratch wound was slower in control cells 
than in cells that were exposed to the Bacillus protein. However growth of the hTCEpi 
cells was seen to decrease in response to increasing concentrations of the proteins 
(Figure 5.1). Therefore the results are in agreement with previous studies using animal 
models that have shown corneal epithelial cells migrate to close superficial wounds 
(Jumblatt & Neufeld 1986). The results depicted in Figure 5.2, suggest that the proteins 
used to treat the corneal cells may be causing the ocular surface epithelium to migrate at 
the leading edge of the wound. Therefore the cells may become more motile and in vivo 
this could contribute to the loss of corneal surface integrity and in a chronic condition 
could lead to the formation of sterile ulcers. The production of the collagen degrading 
enzyme MMP-9 is increased in the tear fluid of rosacea patients (Kari & Kari, 2006). 
Over production of this protein by corneal epithelial cells at the leading edge of corneal 
surface wound has been linked to cell migration and sterile ulcer formation in humans 
(Li et al., 2001). 
 
  
134 
 
Control  2 µg/ml Purified Antigen 6 µg/ml Purified Antigen 
  0 hr 
  24 hr 
  48 hr 
  72 hr 
Figure 5.24 The effect of Bacillus proteins on the healing of a scratch wound in 
hTCEpi cells 
Images are representative of 5 repeats of this assay. Migration of cells at the leading 
edge of the wound was increased in cells treated with the antigen compared to control 
cells. 
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5.3.1 Investigating the effect of Bacillus antigens on wound healing using Immuno 
fluorescence microscopy 
In this section it was sought to establish if there was up-regulated expression of 
certain protein markers at the leading edge of the wound where cells were migrating 
(Figures 5.3 and 5.4). This was achieved by setting up a scratch wound assay as 
described in section 2.31.2 and a glass slide was placed in the culture dish before the 
cells were seeded. Several markers involved in cell-cell interactions, cell-matrix 
interactions and cell movement were examined. E-cadherin is a transmembrane protein 
associated with cell-cell junctions and actin containing filaments of epithelial tissues. 
Down regulation of cadherins has been implicated in some cancers because it causes 
cells to become less adherent to each other and to the basement membrane and this can 
result in increased motility that can lead to metastasis (Wijnhoven et al., 2000). 
Phalloidin is a mycotoxin derived from Amanita phalloides that is fluorescently tagged 
using rhodamine. Corneal epithelial cells were first incubated with the E-cadherin 
antibody then counter stained with phalloidin which binds to F-actin filaments 
(Verderame et al., 1980). Actin is a major component of the cytoskeleton therefore this 
staining allowed the visualization of the shape of the cells and at the leading edge of the 
wound. The actin filaments can be seen extending as the cells migrate in response to the 
bacterial antigens. Figure 5.3 highlights the movement of the cells when treated with the 
antigen. The actin filaments are stained using phalloidin (red) and the cellular junctions 
using E-cadherin (green) while the nucleus is stained with DAPI (blue). 
 
5.4 The effect of Bacillus protein on migration of hTCEpi cells 
 
 Migration assays were performed using 8 µm porous inserts as described in 
section 2.31.3. When hTCEpi cells were exposed to increasing concentrations of the 
bacterial antigens, migration through the porous membrane increased. The images 
(Figures 5.5) show higher numbers of cells stained on the membranes following 
treatment with the bacterial protein than in the untreated controls. Migration increased 
3.6 fold (p=0.001) in response to 2 µg/ml of the antigen and by 14.5 fold in response to 
6 µg/ml treatment (p=0.0001) when compared to control cells (Figure 5.6). 
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 (A) Control 
(B) 2 µg/ml purified antigen  
 (C) 6 µg/ml purified antigen 
 
Figure 5.25 Immunofluorescence of wound healing in hTCEpi cells stained with E-
cadherin (green), counterstained with Phalloindin (red) and DAPI (blue), following 
72 hours incubation in media supplemented with the Bacillus antigens 
(A) Represents untreated cell response to wound healing 
(B) Represents hTCEpi cells treated with 2 µg/ml of bacterial protein. The yellow 
arrow indicates the actin filaments (stained with phalloidin) stretching as the 
cells migrate 
(C) Represents hTCEpi cells treated with 6 µg/ml of bacterial protein that have 
migrated to close the scratch wound 
 
Scale bar is 100 µm 
Edge of the 
wound remains 
smooth 
hTCEpi cells at 
the edge of the 
wound migrate 
hTCEpi cells have migrated 
to close the wound in 
response to bacterial 
protein 
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Figure 5.26 Magnified image of E-cadherin (green) stained cells, counter stained 
with Phalloidin (red). 
The yellow arrow indicates the actin filaments extending as the hTCEpi cells migrate to 
close the scratch wound 
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5.5 The effect of Bacillus protein on invasion of hTCEpi cells 
 
 Cell invasion was tested as described in section 2.31.4 using similar 8 µm 
porous inserts that are coated with a matrigel that replicates the basement membrane 
matrix. Invasive cells detach from the matrix migrated through the gel and the 8 µm 
pores so the cells can be stained and counted. Results of these assays revealed an 
increase in hTCEpi cell invasiveness of 1.7 fold (p=0.003) in response to 2 µg/ml of the 
antigen and by 1.8 fold (p=0.01) in response to 6 µg/ml when compared to control cells 
(Figure 5.7). Invasion assays indicate a more active response than that seen in migration 
assays since the cells pass through the barrier of the matrix. This result considered 
together with the results of the migration assays indicate a possible role for the bacterial 
proteins in corneal erosion(Lin & Kurpakus-Wheater 2002; Yamaguchi et al. 2011; 
Markoulli et al. 2011). 
 
5.6 The effect of Bacillus protein on adhesion of hTCEpi cells 
 
 Cell adhesion assays were performed as described in section 2.31.5, using a 
variety of components of the ECM (Collagens I, IV, V, Lamanin, Fibronectin and 
Gelatin). These proteins were coated onto the lid of a 96 well plate. Cells were pre-
incubated with antigen preparation, trypsinised and applied at a concentration of 1 x 10
4
 
cells/ml onto the different ECMs. The cells that adhered were stained and counted. The 
hTCEpi cells adhered consistently at an increased density to collagen I (Figure 5.8) 
following exposure to 2 and 6 µg/ml of bacterial antigens, however student t-test 
revealed no statistical significance. There was a consistent decrease in adherence to 
lamanin of 1.7 fold (p=0.002) following exposure to 2 µg/ml of bacterial antigens, 
adherence was decreased only 1.26 fold following exposure to 6 µg/ml of the antigens. 
Adherence to collagen IV and gelatin was increased by 1.47 fold (p=0.01) and 1.5 fold 
(p=0.004), respectively following exposure to 6 µg/ml of antigens. Adherence of 
hTCEpi cells to fibronectin and collagen V both decreased significantly following 
exposure to 2 µg/ml and then increased slightly compared to control cells when exposed 
to 6 µg/ml of Bacillus antigens. 
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Control stained cells before migration assay  Untreated Control 
    
BSA treated control     2 µg/ml antigen 
    
4 µg/ml antigen     6 µ/ml antigen 
Figure 5.27 Images of porous membranes with hTCEpi cells that have migrated 
through 8 µm pores 
Corneal epithelial cells stained with crystal violet dye and some examples are labeled 
with white arrows, while the pores of the inserts can be seen marked by black arrows. 
Images were taken at 40 x magnification. 
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Figure 5.28 The effect of B. oleronius antigen on the migration of hTCEpi cells 
through 8 µm porous membranes 
These data are representative of 3 repeats of the assay where * denotes p<0.05 and ** is 
p<0.01. 
Membranes were viewed at 40 x magnification and 3 x fields of view were counted per 
treatment for each replicate in the assay. 
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Figure 5.29 The effect of B. oleronius antigen on the invasion of hTCEpi cells 
through a matrigel membrane 
These data are representative of two replicates of the assay where * denotes p<0.05 
while ** in p<0.01. 
Membranes were viewed at 40 x magnification and 3 x fields of view were counted per 
treatment for each replicate in the assay. 
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Figure 5.30 The effect of B. oleronius antigens on the adhesion of hTCEPi cells to 
extracellular matrix components 
These data are representative of a single assay where technical replicates were used to 
perform statistical analysis and * denotes p<0.05, while ** is p<0.01. 
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5.7 Summary 
 
Initial results revealed that the proteins extracted from Bacillus oleronius 
inhibited growth of hTCEpi cells and increased movement of the cells. Cell growth 
decreased as the concentration of protein extract in the media increased (Figure 5.1). 
The scratch wound assay (Figure 5.2-5.4) revealed that the cells were migrating at an 
increased rate at the leading edge of the wound following exposure to the antigens. Plate 
assays using porous inserts that examine migration (Figure 5.5-5.6) and invasion 
(Figure 5.7) also added to the evidence that hTCEpi cells become more motile in 
response to treatment with Bacillus proteins. Adhesion assays showed a consistent 
decrease of hTCEpi cell adherence to laminin of 1.7 fold (p=0.002) following exposure 
to 2 µg/ml of bacterial proteins. Altered migration, wound healing, invasion and 
adhesion to the basement membrane are factors that would potentially contribute to 
corneal cell erosion (Lin & Kurpakus-Wheater 2002; Yamaguchi et al. 2011; Markoulli 
et al. 2011). Corneal erosion is linked to the development of microbial keratitis in 
contact lens wearers (Markoulli et al., 2011). It is possible that the presence of bacterial 
antigens in the tear fluid of individuals with ocular rosacea could cause an inflammatory 
response in corneal epithelial cells that may lead to corneal erosion. 
 
5.8 The effect of Bacillus antigens on protein expression in the hTCEpi 
cell line 
 
 The effect of B. oleronius antigens on the expression of certain proteins in both 
hTCEpi cell line and primary limbal epithelial cells derived from limbal stem cell tissue 
was assessed using Western blotting and immunofluorescence microscopy. As 
described in section 2.32 and protein was extracted from the cells after incubating for 
five days with varying concentrations of the antigen. This protein extract was separated 
by one dimensional SDS-PAGE and transferred to nitrocellulose membrane in 
preparation for Western blotting. Several antibody markers were employed to 
investigate possible changes in protein expression. Glass slides were placed in 24 well 
culture dishes prior to the hTCEpi cells being seeded in order to investigate the proteins 
using immunofluorescence microscopy. As described in section 2.34 cells were 
incubated in the presence of the Bacillus proteins or in KGM media alone for the 
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controls for four days. After this time the medium was removed and ice cold methanol 
or acetone (depending on which antibody was to be used) was added to fix the cells for 
10 minutes. At this point the slides could be stored at -20°C until the staining procedure 
was carried out as described in section 2.34. Goat anti-serum was employed as a 
blocking agent and as a diluent for the primary and secondary antibodies. Primary 
antibodies were generally incubated overnight (Table 2.6 Antibody dilutions) at 4°C. 
For samples where two primary antibodies were applied, the second was added for 1 
hour at 37°C. Following wash steps using PBS-tween, the secondary antibodies 
(Alexafluor) were diluted 1:1000 and applied for 1 hour at room temperature in the 
dark. At this point slides were washed again and mounted to cover slips then images 
were obtained using a Leica microscope. 
 
5.8.1 The effect of Bacillus antigens on the production of Cytokeratin 3 and 12  
Cytokeratins 3 and 12 are type II keratins and are expressed together in the 
corneal epithelium. Expression of these proteins was examined following treatment of 
the hTCEpi cells with the bacterial antigens by Western blotting and 
immunofluorescence microscopy. Each row of images (A-C) represents one replicate of 
immunofluorescence protocol described in section 2.32. There appeared to be a 
decrease in the intensity of keratin 3 staining in cells that were treated with the bacterial 
antigen as seen in Figure 5.9 A & B. However on subsequent occasions the staining 
intensity seemed to be similar in control and treated cells (Figure 5.9 C). Western 
blotting analysis showed a slight decrease in expression of cytokeratin 3 following 
exposure, however student T-test revealed no significant change in expression of 
following exposure to the antigens (Figure 5.10).  
Immunofluoresence images of corneal cells stained for keratin 12 appeared to 
show little change in staining intensity and the antibody binding seemed non-specific 
(Figure 5.11). The staining could potentially have been improved by investigating 
further fixing agents for the slides or altering the antibody. Western blotting with this 
antibody also revealed a slight decrease in expression of this protein following exposure 
to the antigens, however no significant change in expression across the treatments 
(Figure 5.12) following student T-test analysis. 
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Control   2 µg/ml   6 µg/ml 
   A 
   B 
   C 
 
Figure 5.31 Cytokeratin 3 staining of hTCEpi cells exposed to bacterial protein 
nuclear material stained blue using DAPI 
 
The white arrows highlight some of the changes described in A-C below. 
(A) Expression of CK3 on the surface of untreated hTCEpi cells is bright and 
uniform throughout the culture. 
(B) Cells exposed to the bacterial protein appear to show decreased expression and 
irregular shape particularly in the 6 µg/ml treatment. 
(C) CK3 expression appears decreased even in treated cells that appear to have 
grown well when compared to controls. 
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Control   2 µg/ml   6 µg/ml 
   A 
   B 
 
Figure 5.32 Cytokeratin 12 staining of hTCEpi cells exposed to bacterial antigen 
nuclear material stained blue using DAPI 
The white arrows highlight some of the changes described in A-B below. 
(A) Staining intensity of CK12 appears to increase in the 2 µg/ml treatment 
compared to control cells. 
(B) In this case CK12 appears increase in the control cells compared to those 
exposed to the bacterial protein.  
Investigations with this antibody were not conclusive however the irregular shape 
and decreased growth of cells exposed to the bacterial protein is indicated here. 
 
Scale bar is 100 µm 
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Figure 5.33 Western blotting for Cytokeratin 3 expression of hTCEpi cells treated 
with bacterial protein 
The densitometric analysis indicates decreased expression of CK3 in hTCEpi cells 
exposed to 2 & 4 µg/ml of bacterial protein however the decrease was not significant. 
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Figure 5.34 Western blotting of hTCEpi cells treated with bacterial antigen stained 
for Keratin 12 expression 
Densitometric analysis suggests a decrease in CK12 expression however it was not 
significant. 
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5.8.2 The effect of Bacillus antigens on the expression of Cytokeratin 19 
Cytokeratin 19 is a type I keratin and the smallest unpaired acidic keratin and it 
is not uniformly expressed across all corneal epithelial cells in the hTCEpi. CK19 is 
said to be a marker for conjuctival epithelial cells in-vivo (Sacchetti et al. 2005). Figure 
5.13 A-C represents the expression of CK19 using immunofluorescence microscopy. 
Across all the treatments there are incidences were the nucleus is clearly stained with 
DAPI (blue) and no CK19 expression is present. Due to the sporadic expression of this 
protein even in controls it was difficult to judge if there was a change in the intensity in 
cells exposed to the bacterial proteins compared to controls. Keratin 19 appeared to be 
increased and decreased in various blots however proof of a significant change either 
way was not achieved by reproducible blots (Figure 5.14). Clinical cytological 
examination that reveals CK3 and CK19 expression on the ocular surface is indicative 
of limbal stem cell deficiency since this expression pattern is indicative of mixed 
corneal and conjuctival epithelia (Sacchetti et al. 2005). 
 
5.8.3 The effect of Bacillus antigens on proteins involved in cell motility (E-cadherin, β1-
integrin and Vinculin) 
Since increased migration was caused by treatment with the bacterial antigens it 
was decided that proteins involved in cell movement and interaction would be 
investigated. E-cadherin, β1-integrin and vinculin antibodies were employed. E-
cadherin is involved in cell-cell interactions and can be seen here staining brightly at the 
junctions between the cells. Figure 5.15 also depicts E-cadherin counter stained with 
p63 a nuclear protein that encodes transcription factor. There did not appear to be a 
difference in the staining intensity following treatment with the bacterial antigen this 
was also confirmed with Western blotting. β1-integrin is involved in cell binding to the 
extracellular matrix components such as fibronectin, lamanin and collagens it is 
therefore involved in cell motility, adhesion and signaling. This protein appeared to 
decrease by approximately 1.25 fold (p=0.01) in expression following exposure to the 
bacterial antigens as seen in Figure 5.17, using Western blotting and 
immunofluorescence investigations. Decreased expression of this protein induced 
migration of the cells since the cells become less adherent to the components of the 
ECM. 
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Cell movement and interaction with the extracellular matrix was likely affected 
by a range of transient cellular changes in response to these antigens. One protein that 
appeared to have a significant increase in expression was vinculin. The expression of 
this protein was examined by Western blotting only and it is clearly seen in Figure 5.18, 
that there is an increase in expression following treatment with the bacterial antigens. 
Reactivity to the vinculin antibody increased by approximately 2.05 fold (p=0.0026) 
and 2.7 fold (p=0.0009) in response to exposure to 4 µg/ml and 6 µg/ml of the purified 
antigen preparation respectively. Vinculin is a membrane cytoskeletal protein involved 
in linkage of integrins to the actin filaments of the cytoskeleton and is involved in 
anchoring F-actin to the membrane. 
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Control    2 µg/ml   6 µg/ml 
   A 
   B 
   C 
Figure 5.35 Cytokeratin 19 staining of hTCEpi cells treated with bacterial antigen 
 
The white arrows highlight some of the changes described in A-C below. 
(A) CK19 is expressed sporadically in control cells 
(B) Expression appeared to increase in cells exposed to 2 µg/ml of Bacillus protein 
(C) Expression appeared increased in the 2 µg/ml but not 6 µg/ml treated cells 
compared to controls 
Scale bar is 100 µm 
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Figure 5.36 Western blotting of hTCEpi cells treated with bacterial antigen stained 
for anti-Keratin 19 antibody expression 
There was no significant change in CK19 expression across all replicates. 
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Control   2 µg/ml   4 µg/ml 
   A 
   B 
 
Figure 5.37 E-cadherin/p63 staining of hTCEpi cells treated with bacterial antigen 
The white arrows highlight some of the changes described in A-B below. 
(A) There does not appear to be a difference in expression of Ecadherin (green 
staining) following exposure to the bacterial proteins 
(B) P63 staining is red and localized to the nucleus 
Scale bar is 100 µm 
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Figure 5.38 Western blotting of hTCEpi cells treated with bacterial antigen stained 
for E-cadherin expression 
E-cadherin is a protein involved in cell-cell interactions and its expression remained 
unchanged following exposure to bacterial proteins 
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Control   4 µg/ml Pure Antigen 
  A 
  B 
Figure 5.39 Immunofluorescence images and Western blotting of β1-integrin 
staining of hTCEpi cells treated with bacterial antigen 
Densitometric analysis revealed a fold change in expression of β1-integrin of 1.25 
(p=0.01) following exposure to 4 µg/ml of the bacterial proteins. p≤0.01 is denoted by 
**. Immunofluoresence did not indicate a change in expression of the β1-integrin in 
treated cells compared to controls. Scale bar is 100 µm 
** 
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Figure 5.40 Western blot of Vinculin expression in hTCEpi cells following antigen 
treatment 
Graph represents densitometric analysis of intensity of vinculin expression relative to 
the GAPDH loading control, with significant differences denoted by ** were p<0.01 
There was a 2 fold (p=0.026) increase in expression of vinculin in cells exposed to 4 
µg/ml and a 2.7 fold (p=0.0009) increase in expression following exposure to 6 µg/ml 
of B. oleronius protein. 
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5.8.4 The effect of Bacillus antigens on MMP-9 expression and activity 
Matrix metalloproteinases are a family of enzymes involved in degradation of 
extracellular matrix components such as collagens, fibronectin and lamanin. MMP-2 
and 9 in particular are implicated in ocular surface diseases. Western blotting (Figure 
5.19) revealed an increase in expression of this antibody when cells were exposed to 2 
µg/ml of Bacillus antigens of 1.34 fold (p=0.033). Zymography is an electrophoresis 
technique used to study the activity of MMPs, in this incidence gelatin was used as the 
substrate. The bright bands shown in Figure 5.20 represent the amount of gelatin 
substrate that has been digested therefore when the unstained area of the gel increases 
and this reflects an increase in the MMP activity. MMP-9 or gelatinase activity 
increased by an average of 1.96 fold (p=0.043) when cells were exposed to 4 µg/ml of 
the bacterial antigens compared to untreated control cells.  
 
5.9 Summary 
 
 The Western blotting and immunofluorescence work presented here has 
established that exposure to Bacillus antigens affects protein expression in cultured 
hTCEpi cells. While the expression of some of the markers for corneal epithelial cells 
such as the cytokeratins remained relatively unchanged, there were significant 
alterations to expression of proteins involved in cell migration and gelatin degradation. 
β 1-integrin expression was decreased (Figure 5.17) in cells exposed to the antigens 
compared to control cells and vinculin expression was increased (Figure 5.18). MMP-9 
expression and activity also increased (Figures 5.19 & 5.20) and previously it was 
shown that treated cells adhered less to lamanin coated plates compared to control cells 
(Figure 5.8), this may be due to the degradation of lamanin by MMPs. These results 
give an insight into the proteomic changes that are influencing cell migration, tissue 
remodeling and angiogenesis of telangeictastasis. In severe cases patients with ocular 
rosacea can develop keratitis which is an inflammatory condition of the cornea. This 
Chapter provides evidence that the effects caused by the Bacillus antigens have the 
potential to contribute to the development of the serious symptoms of rosacea. 
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Figure 5.41 Western blot of MMP-9 expression in hTCEpi cells following antigen 
treatment 
Graph Represents densitometric analysis of the blots with significant differences 
denoted by * were p<0.05 
MMP-9 protein expression was significantly increased by 1.34 fold (p=0.033) in corneal 
cells exposed to 2 µg/ml of B oleronius proteins 
  
Control 
4 µg 
BSA 
2 µg 4 µg 
159 
 
 
 
 
 MMP-9 
 
C
on
tr
ol
g 
Pu
re
2 
g 
Pu
re
4 
g 
B
SA
4 
0
50000
100000
150000
*
Treatment
D
en
s
it
o
m
et
r
ic
 U
n
it
s
 
Figure 5.42 Zymogram of MMP-9 activity in hTCEpi cells following antigen 
treatment 
Graph Represents densitometric analysis of the blots with significant differences 
denoted by * were p<0.05 
MMP-9 protein activity was significantly increased by 1.96 fold (p=0.043) in corneal 
cells exposed to 2 µg/ml of B. oleronius proteins 
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5.10 Isolation of limbal stem cells and generation of primary limbal 
epithelial cell cultures 
 
Limbal stem cells are located at the outer most ring of the cornea and are 
esential to the maitanence and regeneration of the corneal surface (Notara & Daniels, 
2008). When corneal epithelial cells are shed, limbal epithelial cells migrate from the 
periphery towards the centre of the cornea and from the basal layers of the corneal 
epithelium towards the surface thus replenishing the corneal epithelial surface. In severe 
cases of ocular rosacea limbal stem cell deficiency has been reported (Kheirkhah et al., 
2007). In this condition there is a recurrent loss of corneal epithelial cells and the limbal 
stem cells become gradually ineffective at regenerating the corneal surface (Kolli et al., 
2010). This leads to a situation where conjunctival cells begin to re-epithelialize the 
corneal surface, the consequences of this are the neo-vascularization and ulceration of 
the corneal epithelium. The corneal surface becomes opaque and visual aquity is 
challenged.  
Culture of limbal stem cells and transplantation of limbal epithelial cell sheets 
was first established as a technique for the treatment of limbal stem cell deficiency in 
1997 (Pellegrini et al., 1997). This technique has been extensively investigated and 
advanced in recent years (Baylis et al., 2011). In this section it was sought to use 
cultured limbal epithelial cells in assays to investigate the potential effect that Bacillus 
oleronius proteins might have on these cells. Donor limbal tissue was obtained and 
small pieces of the tissue were dissected and placed in gelatin coated culture dishes. 
Growth medium was added and the tissue explants were incubated overnight to allow 
them to adhere. Culture medium was supplemented with irradiated 3T3 cells, this is an 
established protocol which aids the growth of epithelial cells by providing key growth 
factors to the cells. In Figure 5.18A the dark area in the corner of the image is the 
explant of limbal tissue and epithelial cells can be seen growing out from the tissue. 
Once the epithelial cells began to grow successfully they could be maintained with 
media and expanded for use in the assays. 
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 A  B 
 C  D 
 E 
Figure 5.43 Primary human limbal epithelial cells growing out from explants of 
limbal stem cell tissue 
(A) Limbal epithelial cells are growing out from the tissue explant indicated by the 
arrow 
(B) Cells begin to proliferate faster until a confluent layer (C-E) is formed. At this 
point cells were trypsinised and used for investigations of wound healing and 
protein expression. 
Scale bar is 200 µm 
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5.10.1 The effect of Bacillus proteins on wound healing in primary corneal epithelial cells 
 When the limbal epithelial cultures grew to a confluent layer the cells were 
removed using trypsin and re-seeded into 6 well culture dishes (3 wells per treatment) in 
order to set up wound healing assays similar to those that were carried out with the 
immortalized cell line. Cells were nourished until they reached approximately 100 % 
confluence (Figure 5.20) then scratch wounds were made using 200 µl pipette tips as 
described in section 2.35.1. Figure 5.23 represents the wound healing response of the 
limbal cells following exposure to bacterial antigens compared to control cells that were 
incubated in untreated growth medium. The outcome of this assay was different to that 
of the cell line assay where cells exposed to the bacterial antigens migrated at an 
accelerated rate to close the wounds compared to the control cells (Figure 5.2). 
 In the case of the primary cultures there was closure of the scratch wounds at 
around the same rate in treated and control cells. In all 3 replicate wells (2 are shown) 
the wounds were almost completely closed at 24 hours. Since there was limited 
availability of the limbal tissue these assays could not be repeated however it was 
suggested that capturing the images at shorter time intervals may have revealed changes 
in the rate of wound closure. 
 
5.10.2 The effect of Bacillus proteins on protein expression in primary  
corneal epithelial cells 
 The aim of this section was to expose the primary limbal epithelial cells to the 
bacterial antigens then assess the effect using Western blotting. Primary corneal 
epithelial cells were treated with the antigen for four days as described in section 2.35.2. 
Samples were resolved on 1D 10% SDS-PAGE gels and transferred to nitrocellulose 
membranes in preparation for Western blotting with a variety of antibodies (Table 2.6). 
All desitometric graphs represent 3 technical replicates of the blots however since there 
was a limited amount of this tissue, the treated cells could only be obtained once. Of the 
markers tested (Keratin3, Keratin 19, E-cadherin and p63) only Keratin 19 exhibited a 
significant increase in expression. When exposed to 2 µg/ml of the antigen, expression 
of keratin 19 increased 1.24 fold on average (p=0.005), this increase was not consistent 
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as the higher concentration of antigen (6 µg/ml) caused only a 1.14 fold increase 
compared to control cells. 
Therefore, for the purpose of examining the potential effect of the Bacillus 
antigens on the ocular surface these markers did not give a significant insight into how 
cellular changes could contribute to the progression of rosacea. Elevated cytokeratin 19 
expression was found in the sera of patients with inflammatory and vascular lung 
disorders (Fujita et al., 1999). The results shown here implicate that there is more scope 
to continue the study of B. oleronius antigen effects on primary cells. 
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Time 0    24 Hours   48 Hours 
       Control A 
       Control B 
       2 µg/ml A 
       2 µg/ml B 
       4 µg/ml A 
       4 µg/ml B 
Figure 5.44 Limbal epithelial cell scratch wound assay 
Migration occurs at a similar rate in control cells and those exposed to the bacterial 
proteins 
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Figure 5.45 Western blotting analysis of Keratin 3 expression in primary limbal 
epithelial cells 
Expression of CK3 was decreased in cells exposed to B. oleronius protein compared to 
control cells however a student T test did not indicate a significant difference. 
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Control 2 µg/ml 4 µg/ml 
 Keratin 19 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.46 Western blotting analysis of Keratin 19 expression in primary limbal 
epithelial cells 
Limbal epithelial cells exposed to 2 µg/ml of B oleronius protein showed increased 
expression of CK19 (1.24 fold, p=0.005) 
Significance is indicated by ** where p≤0.01 
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 p63 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.47 Western blotting analysis of p63 expression in primary limbal 
epithelial cells 
Expression of p63 was decreased in cells exposed to B. oleronius protein compared to 
control cells however a student T test did not indicate a significant difference. 
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Figure 5.48 Western blotting analysis of E-cadherin expression in primary limbal 
epithelial cells 
Expression of E-cadherin was decreased in cells exposed to B. oleronius protein 
compared to control cells however a student T test did not indicate a significant 
difference. 
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5.11 Discussion 
 
 The focus of this Chapter was to study the effect of Demodex associated 
bacterial antigens on a corneal epithelial cell line (hTCEpi) and to a limited extent on 
primary limbal epithelial cells. It has been discussed at great length how dysregulation 
of the innate immune response is responsible for the progression of rosacea (Dahl et al., 
2002; Lacey et al., 2007; Li et al., 2010; Powell, 2005; Yamasaki & Gallo, 2009). 
Corneal epithelial cells make up an important part of the innate immune response as 
they provide a barrier that protects the eye from physical and environmental damage. 
Studies using epithelial cell lines and sebaceous cell lines (Lacey et al., 2007) have been 
carried out in relation to rosacea. Yamasaki et al., (2007) stated that treating human 
keratinocytes with LL-37 caused increased release of IL-8 by the cells. Bacillus 
oleronius antigens may be present at increased concentrations in the skin due to the 
presence of higher numbers of Demodex mites in people with rosacea (Diazperez, 
1994). Demodex mites reside in the pilosebaceous units of the pores and in the eyelash 
follicles. Upon death the mites may cause local inflammation by release of bacterial 
endosymbionts into the surrounding tissue and may be present in the tears and on the 
corneal surface. Therefore the hTCEpi cell line was chosen as a suitable model for the 
ocular surface and experiments were carried out to discover the effects that the bacterial 
proteins caused in these cells. 
In order to design appropriate experiments with these cells the toxicity of the 
antigen to the growth of the cells was assessed. As depicted in Figure 5.1, cell growth 
decreased in the presence of bacterial proteins. There was a statistically significant 
decrease of 26 % in cell growth following exposure to 2 µg/ml of the bacterial antigen 
and cell growth dropped by 75 % when the concentration of antigen was increased to 6 
µg/ml (Figure 5.1). The wound healing response of the cells was assessed since there 
are many factors that contribute to corneal wound healing, therefore the changes 
observed in this response could provided information as to which aspects of the corneal 
epithelial cells to investigate. As seen in the images (Figure 5.2) there was an increase 
in migration of cells at the leading edge of the wound following treatment with the 
antigen compared to control cells. Since the toxicity assay had shown a reduction in cell 
growth due to incubation with the antigens it was speculated that increased cell motility 
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caused by changes in protein synthesis rather than increased cell proliferation (Zieske et 
al., 1989) was responsible for this result.  
Epidermal growth factor (EGF) is an essential mediator of adhesion, migration 
and wound healing in corneal epithelial cells and reactive oxygen species (ROS) 
generation were shown in the study by Huo et al., (2009) to be mediators of EGF in 
relation to wound healing. The research reported that control cells were slow to close 
the scratch wound while cells treated with EGF completely closed the wound within 20 
hours. However by inhibition of ROS production using an antioxidant there was a return 
to the control phenotype. The experiment depicted in Figure 5.2 revealed a less dramatic 
phenotype to that seen in the study by Hou et al., (2009) however there is increased 
migration of the hTCEpi cells at the leading edge to close the wound in response to 
exposure to the Bacillus antigen preparation. In Chapter 4 it was shown that there was 
increased motility of neutrophils and increased IL-8 production which would lead to the 
infiltration of neutrophils to the surrounding tissue and this in turn could potentially lead 
to an increase in inflammatory mediators in localized areas of the dermal and ocular 
tissue. There is potential that corneal epithelial cells could be exposed to these antigens 
in vivo leading to an accelerated rate of migration and shedding of corneal epithelial 
cells. Chronic inflammation and loss of corneal epithelium induces conjunctival 
epithelial cells to migrate to the corneal surface and contributes to ulceration of the 
cornea (Kolli et al. 2010). It would therefore be interesting to investigate the response of 
conjunctival epithelial cells following exposure to these antigens. 
Following the changes observed with live cell imaging it was decided that the 
wound healing response would be investigated using immunofluorescence microscopy. 
Figures 5.3 and 5.4 show cells stained with E-cadherin and phalloidin, there does not 
appear to be any significant change in intensity of expression of these proteins. 
However the images do provide a clear view of the migration of the cells in responses to 
the bacterial antigens, with Figure 5.4 showing a zoomed in view of the shape of the 
cells and their actin filaments extending as they migrated. The effect of the bacterial 
antigens on migration was further investigated using another plate assay format, where 
cell movement through a porous insert was assessed (section 5.4). The results of this 
assay proved that incubating the cells in the presence of the bacterial antigen caused 
more cells to migrate through the membrane of the insert while untreated cells did not 
migrate at all in some replicates. Migration increased 3.6 fold (p=0.001) in response to 2 
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µg/ml of the antigen and by 14.5 fold in response to 6 µg/ml treatment (p=0.0001) when 
compared to control cells (Figure 5.6). Invasion of cells into gel inserts composed of 
extracellular matrix was also investigated, and again there was an increase in the 
number of antigen treated cells migrating through the insert compared to control cells. 
Results of these assays revealed an increase in hTCEpi cell invasiveness of 1.7 fold 
(p=0.003) in response to 2 µg/ml of the antigen and by 1.8 fold (p=0.01) in response to 
6 µg/ml when compared to control cells (Figure 5.7). Adhesion of cells is another 
consideration when investigating the wound healing responses. As seen in the graph 
depicting stained cells where one field of view per well was counted and there were 8 
replicate wells for each ECM (Figure 5.8). Student T-tests (GraphPadPrism) revealed 
adherence to collagen IV and gelatin was increased by 1.47 fold (p=0.01) and 1.5 fold 
(p=0.004), respectively following exposure to 6 µg/ml of antigens. Adherence of 
hTCEpi cells to fibronectin and collagen V both decreased significantly following 
exposure to 2 µg/ml and then increased slightly compared to control cells when cells 
were exposed to 6 µg/ml of antigens. There was a consistent decrease in adherence to 
lamanin of 1.7 fold (p=0.002) following exposure to 2 µg/ml of bacterial antigens, 
adherence was decreased only 1.26 fold following exposure to 6 µg/ml of the antigens. 
Both invasion and adhesion assays could benefit from further replications and perhaps 
variation of the parameters to further investigate these results. 
Preliminary investigations into the effect of Bacillus antigens on protein 
production in the hTCEpi cell line were carried out with antibodies targeting 
cytokeratins which are involved in differentiation and proliferation (section 5.6.1-5.6.2). 
Cytokeratins 3 and12 are structural proteins that are expressed in the corneal epithelium. 
Immonufluoresence images (Figures 5.9 & 5.10) and Western blots (Figures 5.11 & 
5.12) appeared to show a slight decrease in the expression of these proteins following 
exposure to the antigens however statistical analysis revealed no significant changes in 
expression. Keratin 19 which is expressed in several epithelial cell types and strongly 
expressed in the limbal region of the eye, remained unchanged in the control and 
antigen treated cells (Figure 5.13 & 5.14). E-cadherin is involved in cell-cell 
interactions (Suzuki et al., 2003) and its expression also remained relatively unchanged 
(Figure 5.15 & 5.16) following exposure to the bacterial antigens. 
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Since cell migration increased following exposure to these bacterial antigens it 
was decided to investigate some proteins involved in cell shape movement, such as β1-
integrin and vinculin. The expression of β1-integrin appeared to decrease an average of 
1.25 fold (p=0.01) in expression following exposure to the bacterial antigens as seen in 
the Western blot shown in Figure 5 17. Reactivity to the vinculin antibody increased an 
average of 2.05 fold (p=0.0026) and 2.7 fold (p=0.0009) in response to exposure to 4 
µg/ml and 6 µg/ml of the purified antigen preparation. β1-integrin interacts with 
components of the ECM (Suzuki et al., 2003) therefore reduced expression of this 
protein could cause cells to become more motile because they are less tightly bound to 
the ECM. Vinculin is a membrane cytoskeletal protein involved in anchoring of F-actin 
to the basement membrane. Studies have shown that vinculin expression is increased in 
migrating rat corneal epithelial cells in response to wound healing by up to 27 fold 
(Zieske et al., 1989). Western blotting for this marker was carried out after experiments 
on wound healing had been completed however it is likely that this marker may have 
been seen to be increased at the leading edge of the wound by fluorescent microscopy. 
Matrix metalloproteinases are a family of proteins that are involved in normal 
processes such as reproduction and remodeling of tissue, they are also involved in 
pathogenic processes such as angiogenesis and wound healing (Li et al., 2001). These 
enzymes have been linked to the pathogenesis of rosacea (Yamasaki & Gallo 2009). 
There is evidence that the production of MMPs is up regulated by a number of factors 
including exposure to UV radiation, presence of reactive oxygen species and 
inflammation (Lu & Wahl 2005; Jang et al. 2010; Manicone & McGuire 2008). In 
Chapter 4 (section 4.4.2) it was highlighted how exposure of neutrophils to Bacillus 
antigens can up-regulate the expression of MMP-9 during degranulation. In this Chapter 
(section 5.6.4) MMP-9 was seen to be produced at higher levels and also to be more 
active in corneal epithelial cells exposed to the bacterial antigens compared to control 
cells. Western blotting (Figure 5.19) revealed an increase in expression of the enzyme 
when exposed to 2 µg/ml of Bacillus antigens of 1.34 fold (p=0.033). MMP-9 or 
gelatinase activity increased by an average of 1.96 fold (p=0.043) when cells were 
exposed to 4 µg/ml of the bacterial antigens compared to untreated control cells. Studies 
have shown that MMP-8 and 9 are elevated in the tear fluid of ocular rosacea patients 
(Kari & Kari, 2006). This study also highlights the ability of tetracyclines such as those 
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used to treat ocular rosacea to inhibit the production of these enzymes (Kari & Kari, 
2006). 
In Figure 5.21 primary limbal epithelial cells were successfully cultured from 
donor limbal tissue on gelatin coated plates supplemented with irradiated 3T3 cells. 
Limbal epithelial stem cells represent a niche that is promising in terms of regenerative 
medicine. People who become deficient in these cells through injury or disease suffer 
painful damage to the cornea and can eventually lose their sight. Advanced 
transplantation techniques have been developed using cells grown on amniotic 
membranes to optimize the healing potential of the grafts (Baylis et al., 2011). The 
limbal region of the eye is located between the cornea and the conjunctiva and contains 
stem cells which replenish the corneal tissue as corneal epithelial cells are shed. The 
limbus also provides a barrier to the vascularisation of the cornea (Notara & Daniels, 
2008), when this barrier is disturbed scarring and ulceration of the corneal surface 
occurs. Due to the nature of how samples of this tissue are obtained, the amount of 
experiments that could be carried out was limited. Wound healing assays carried out 
with these cells were inconclusive and there was an increase in only one of the protein 
markers that were tested which was cytokeratin 19. The responses recorded in the 
hTCEpi cell line provide evidence that a more comprehensive study of limbal cells and 
possibly including conjuctival cells could provide further evidence that Bacillus 
antigens have a role in the pathogenesis of ocular rosacea. 
The work outlined here has shed light on some of the significant cellular 
changes that occur in response to Bacillus antigens on the cornea. Corneal epithelial 
cells became more motile and protein expression was affected. The antigen becomes 
toxic to the epithelial cells over time as the concentration increases and build up of this 
antigen in vivo could have a similar effect by damaging the surrounding cells. Corneal 
and limbal epithelial cells are components of the innate immune response and the 
changes induced in these cells by the B. oleronius antigens could potentially contribute 
to the chronic inflammation that leads to serious complications for ocular rosacea 
patients. This work adds to the growing evidence that Demodex mites and bacteria that 
are usually harmless can contribute to the pathogenesis of rosacea. 
 
 
 
 
Chapter 6 
 
 
 
A proteomic approach to investigating the 
effect of environmental conditions and 
exposure to hydrogen peroxide on protein 
production by Bacillus oleronius 
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6.0 Introduction 
 
Bacillus oleronius was first isolated from the hindgut of the termite 
Reticulitermes santonensis (Feytaud). According to Kuhnigk et al., (1995) the rod-
shaped bacterium stained Gram negative and was capable of forming endospores. 
Bacillus bacteria are ubiquitous in the environment and are commonly found in the soil 
(Machado et al., 1998). Bacillus oleronius was recently isolated as a contaminant from 
a selection of dairy farms in Europe (Heyndrickx et al., 2011). Bacillus species are not 
often the cause of serious disease with the exception of B. anthracis which can cause 
lethal infections and has been used as a biological weapon (Crawford et al., 2006) and 
B. cereus which can cause food poisoning (Carlin et al. 2010). Many species of bacteria 
have been identified as opportunistic pathogens therefore they colonise humans without 
causing disease until the host becomes immune compromised and bacteria can initiate 
factors that cause infection. 
Delaney (2004) isolated B. oleronius from a Demodex mite from the face of a 
papulopustular rosacea patient. It was postulated that the bacterium was located in the 
gut of the Demodex and that it may play a role in digestion within the mite. It has been 
discussed in Chapter 3 that the bacterium elicits an immune response from rosacea 
patient serum. The focus of this Chapter was to investigate if any B. oleronius proteins 
were up or down regulated in response to the culture conditions of the bacterium. To 
perform this study bacterial cultures were grown in minimal medium compared to rich 
medium, at 30 °C or to 37 °C, static or to aerated and at pH ranging from 5-8. Cultures 
were also exposed to hydrogen peroxide since it is a component of the Reactive Oxygen 
Species (ROS) response mounted by neutrophils during inflammation. Proteins were 
extracted from the cultures using lysis buffer (section 2.8) containing Triton-X 100. 
Lysates were solubilised and subjected to 1D SDS-PAGE, 2D SDS-PAGE and Western 
blotting. 2D gels were analysed using progenesis same spots technology and spots of 
interest were picked and digested for Liquid Chromatography Mass Spectrometry 
analysis. This work has potential to provide information on which environmental 
conditions in the skin may cause immunogenic proteins to be produced.  
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6.1 Growth response of Bacillus oleronius to alterations of environment 
 
 Previous work by Lacey (2007) characterised Bacillus oleronius as a slow 
growing bacterium. It was found that when the bacterium was subcultured from solid 
nutrient agar to liquid nutrient broth medium at 30 °C and 200 rpm, approximately 48 
hours were required to obtain a dense stationary phase culture. Here we sought to re-
establish the growth response to a number of culture conditions. Bacteria were sub-
cultured from nutrient agar to 100 mls of nutrient broth and cultured overnight. In order 
to examine various growth conditions, 1ml of this culture was transferred into 100 ml of 
the media to be examined (LB broth, Nutrient broth or 2XYT broth). The pH, culture 
temperature and agitation of the media were also altered. Aliquots of the cultures (1 ml) 
were taken at 2 hourly intervals and the optical density at 600 nm (O.D. 600) was 
recorded (Figures 6.1-6.3) 
 
6.1.1 Growth response of Bacillus oleronius to nutrient rich and nutrient poor media 
 The growth of B. oleronius was examined in Nutrient broth (NB), Luria broth 
(LB) and 2XYT broth at 30 °C and 37 °C. Nutrient broth is a minimal medium, Figure 
6.1 (B) demonstrates how the bacteria grows slowly in this medium however the growth 
rate is slightly higher at 30 °C than 37 °C. The growth rate increased when the 
bacterium was cultured in LB broth which is composed of a slightly higher nutrient 
content. The most nutrient rich medium was the 2XYT broth consisting of twice the 
amount of tryptone and yeast extract per litre as the nutrient broth. At around 10 hours 
into the culture period bacteria in this broth began to outgrow the others. Following 24 
hours of incubation at 30 °C the growth rate had doubled in the 2XYT (O.D. 600 = 
5.72) compared to the LB (O.D. 600 = 2.28) and NB (O.D. 600 = 1.56) broths (Figure 
6.1 A-C). 
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 (A) 
 (B) 
 (C) 
 
Figure 6.1 Growth curve for Bacillus oleronius at 30 °C and 37 °C in LB (A), NB (B) 
and 2XTY (C) broths 
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6.1.2 Growth response of Bacillus oleronius to temperature 
 Bacterial species can withstand a diverse range of temperatures, some have 
adapted to the most extreme climates on earth below 0 °C and above 100 °C (Tehei et 
al. 2004). Figure 6.1 (B) represents the comparison between 30 °C (O.D 600 = 2.25 at 
48 hrs) and 37 °C (O.D. 600 = 1.97 at 48 hrs) it is clear that bacterium grows 
preferentially at the lower temperature in the nutrient poor medium. A recent study 
described strains of B. oleronius that were isolated from dairy farms, the study mentions 
that the bacterium can grow over a broad temperature range of 30 °C – 50 °C and that 
the organism is capable of forming endospores that can withstand high temperatures 
(Heyndrickx et al. 2011). 
Human pathogens generally thrive at 37 °C however in this case B. oleronius 
cultured in both minimal and nutrient rich media grows consistently better at 30 °C 
(Figures 6.1 A-C and 6.3 A-C). The temperature of the skin surface may be slightly 
lower than normal body temperature and the availability of nutrients may be more 
variable since the skin (the habitat of Demodex mites and their associated bacteria) is 
exposed to the elements. This work shows that B. oleronius can thrive at a range of 
temperatures and nutrient levels. 
 
6.1.3 Growth response of Bacillus oleronius to pH 5-8 
 Most bacterial growth media are around pH7 and bacteria generally adapt to and 
grow in a wide pH range. In order to investigate the effect of pH on growth of B. 
oleronius, the pH range of the medium was adjusted by addition of 1 M NaOH or 1 M 
HCl. In this case nutrient broth at 30 °C was adjusted to pH 5, 6, 7 and 8. It can be seen 
in Figure 6.2 that this bacterium does not adjust well to the more acidic culture media at 
pH 5 – 6. The growth rate begins to increase at 10 hrs in the media at pH 7 and 8, the 
cells begin to divide exponentially. At the 24 hrs there is very little difference between 
the growth rates in the neutral (O.D. 600 = 1.24) and the more alkaline (O.D. 600 = 
1.34) media. The growth begins to lag at this point as the nutrients in the media are 
depleted, by 48 hrs the cell density in the pH 7 medium is slightly higher (O.D. 600 = 
1.54) while the density reading in the pH 8 medium has dropped (O.D. 600 = 1.23). 
This work indicates that the bacterium can survive a more alkaline pH. 
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6.1.4 Growth response of Bacillus oleronius to oxygen content of media 
 Bacillus oleronius is a gram negative aerobic bacterium. The organism is 
catalase positive (Heyndrickx et al. 2011) therefore it can respond to oxidative stress 
through the breakdown of hydrogen peroxide. The growth response of the bacterium to 
oxygen content in the medium was examined by placing the cultures in aerated 
‘shacking’ incubators or static incubators. The three media were tested at 30 °C and 37 
°C. As expected the bacteria grew more favourably in the aerated conditions over the 48 
hours the highest growth rate was recorded in the 2XYT culture (Figure 6.3 C) at 37 °C 
and 200 rpm. (O.D. 600 = 2.92). The highest growth rate in the static cultures at 48 hrs 
was recorded in the nutrient broth at 37 °C (Figure 6.3 (B), O.D. 600 = 0.83). There was 
a sharp increase in growth recorded in the static LB culture at 37 °C (O.D. 600 = 1.73) 
however this may have been due to some aeration of the culture and the growth rate 
eventually fell back in line with the other static cultures. Although the cells did not 
thrive over the 48 hour time frame there was some growth recorded in the static cultures 
and this proves that the bacterium can withstand low oxygen levels. Growth curves 
were not recorded past 48 hours however when cells were later cultured for extended 
periods of up to 5 days in static conditions cultures that provided cell density sufficient 
to perform protein extractions were achieved. These cultures tended to form clumps or 
films in the flasks which is more representative of how bacteria grow in our ecosystem. 
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Figure 6.2 Growth curve for Bacillus oleronius at 30 °C in Nutrient broth with altered 
pH 5-8 
This graph shows the comparison of growth rate in acidic and alkaline media. 
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 (A) LB 
(B) NB 
 (C) 2XYT 
 
Figure 6.3 Growth curve for Bacillus oleronius at 30 °C and 37 °C, in aerated or static 
medium in LB (A), NB (B) and 2XYT (C) broths 
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6.1.5 Summary 
 In this section it was established that Bacillus oleronius grew fastest at 30 °C, 
pH 7 in nutrient rich 2XYT broth under aerated conditions (Figure 6.1 & 6.3). It was 
also established that the bacterium could survive a broad range of growth conditions 
which is beneficial for the organism in a competitive environment which could be 
encountered in the gut of a termite or Demodex mite. Throughout the experiments 
(section 6.1 – 6.1.4) the organism grew in a range of temperatures, pH and in very low 
oxygen levels. This bacterium is also capable of forming spores (Heyndrickx et al. 
2011) when the environment becomes unfavourable and has the potential to re-establish 
itself when the nutrient levels increase and conditions become more favourable. This 
organism can certainly survive a broad range of environmental conditions in culture and 
therefore can likely withstand conditions in the gut of the mite and on the surface of the 
human skin. 
 
6.2 Factors affecting protein expression by Bacillus oleronius 
 
 In the previous section it was established that B. oleronius, like many bacterial 
species, can thrive in a broad range of environmental conditions. In this section it was 
sought to discover how protein production was affected by the different growth 
conditions. The bacterium was cultured under various conditions then prepared for 
protein extraction (section 2.12). Bacterial proteins were solubilised and separated by 1 
dimensional SDS-PAGE. Gels were duplicated so that Western blots could be 
performed with the 62 kDa anti-rabbit antibody and with pooled patient sera. Statistical 
analysis was carried out on blots probed with the 62 kDa antibody using student T-test. 
Statistical significance is denoted by * when p ≤ 0.05 and ** when p ≤ 0.01. Whole 
cells were also fixed and incubated in the anti-62 kDa antibody and viewed using 
confocal microscopy in order to establish the location of the immune reactive antigens. 
Another aim was to discover whether culture conditions could alter the amount of 
stimulatory antigens in particular the 62 kDa antigen being produced by the bacterium 
in order to use these conditions when fractionating the bacterial proteins (Chapter 3). 
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6.2.1 The effect of culture media and temperature on the 1-Dimensional proteomic 
profile of Bacillus oleronius 
 Cells were cultured in Nutrient broth and 2XYT broth at 30 °C or 37 °C in order 
to analyse their proteomic profiles in these conditions. It is clear (Figure 6.4 A & B) that 
the expression of proteins varies depending on the culture conditions. Cells cultured in 
nutrient broth at 30 °C with aeration show a 2.1 fold increase in expression of the 62 
kDa protein compared to the lowest expression seen in cells cultured in 2XYT broth at 
30 °C with aeration. Expression of the 83 kDa protein is also highest in cells cultured at 
30 °C in nutrient broth; there is a 2 fold increase compared to the lowest expression 
seen in cells cultured at 37 °C with aeration in 2XYT medium. Interestingly the 
bacterium shows the fastest growth rate when cultured in the 2XYT broth however this 
medium appears to produce the least serological reaction from rosacea positive patients. 
It is indicated that the bacterium when grown in nutrient poor broth or under low 
oxygen conditions produces higher levels of the proteins known to cause an immune 
reaction in rosacea patients (Lacey et al., 2007). The 2-dimensional proteomic analysis 
in section 3.6 indicates that cells grown under oxygen and nutrient poor conditions 
express proteins capable of interacting with the immune response.  
Expression of the 62 kDa protein was examined using a rabbit anti 62 kDa 
antibody (Figure 6.4). There was no significant difference between cells cultured in 
nutrient broth at both temperatures. Upon comparison of expression in cells grown in 
2XYT broth at 30 and 37 °C there was a 1.7 fold increase in expression of the 62 kDa 
protein at 30 °C (p=0.01). Cells cultured in 2XYT broth at 30 °C with aeration show a 
1.3 fold (p=0.029) increase in expression of the 62 kDa protein compared to cells 
cultured in low oxygen. A comparison between cells cultured in optimum growth 
conditions (2XYT broth, 30 °C, with aeration) expressed 1.3 fold (p=0.04) more of the 
protein than cells cultured in the slowest growth conditions (Nutrient broth, 30 °C, 
Static). 
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Figure 6.4 (A) SDS-PAGE and (B) Western blot probed with rabbit anti-62 kDa 
antibody coupled with Densitometric analysis 
B. oleronius was cultured in Nutrient broth and 2XYT at 30 °C and 37 °C. Cultures 
aerated by shaking are denoted by (O2+) and static cultures are denoted by (O2-). 
Statistically significant increased expression of the 62 kDa protein was found when 
comparing cells grown in 2XYT broth at 30°C with aeration to cells cultured at 37 °C 
with aeration (p=0.01 **) and 30 °C static (p=0.029 *) in the same medium and cells 
grown with low oxygen at 30 °C in nutrient broth (p=0.04 *). 
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6.2.2 Effect of minimal oxygen on the 1D proteomic profile of Bacillus oleronius 
 In section 6.1.4 it was discovered that the bacterium could grow in conditions 
when culture flasks were kept static therefore reducing the amount of oxygen available 
to the cells. In this section it was sought to discover how these culture conditions 
effected the expression of the 62 kDa protein using the rabbit antibody. Figures 6.4 (A) 
and 6.5 (A) represent B. oleronius cultures grown under low and high oxygen levels. In 
both cases the SDS-PAGE gels reveal that higher numbers of protein bands where seen 
in the aerobic compared to the anaerobic environment. Figure 6.5 (B) represents a 
Western blot of the reactivity of the 62 kDa antibody to the bacteria grown in nutrient 
rich and poor media at 30 °C and under low or high oxygen conditions. This 
investigation revealed that the bacterium produces the highest levels of the serum 
reactive 62 kDa protein when grown in aerobic conditions in rich medium at 30 °C 
therefor this condition was used to compare to the others. There was a 3.1 fold (p=0.02) 
increase in expression in cells grown in optimum conditions compared to cells grown in 
static culture, a 1.9 fold (p=0.04) increase compared to cells grown in nutrient broth 
under aerated conditions and a 3.3 fold (p=0.02) increase in cells grown in nutrient 
broth under static conditions.  
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 (A) 
 (B) 
 
Figure 6.5 (A) SDS-PAGE and (B) Western blot probed with rabbit anti-62 kDa 
antibody coupled with Densitometric analysis 
B. oleronius was cultured in Nutrient broth 30 °C in aerated and static conditions. Cells 
increased expression of the 62 kDa protein at a statistically significant level when 
cultured in 2XYT broth at 30 °C with aeration compared to 2XYT without aeration 
(p=0.02), nutrient broth with aeration (p=0.04) and nutrient broth without aeration 
(p=0.02). 
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6.2.3 Effect of medium pH on the 1D proteomic profile of Bacillus oleronius 
 In this section it was sought to discover if Bacillus cells cultured at different pH 
levels. Cells were cultured in nutrient broth adjusted to pH 6, 7, 8 and 9 at 30 °C. The 
normal pH of nutrient broth is pH 7 while the pH profile of human skin can range from 
pH 6-8 (Wagner et al., 2003). The growth rate of B. oleronius was optimal at pH 7-8 
(Figure 6.2). The bacterium was isolated from the hindgut of a Demodex mite which is 
thought to be a vector (Wolf et al., 1988) for the bacterium. It is hypothesized that the 
bacterium is deposited by the mite and proliferates in the skin of rosacea patients. 
Therefore it was investigated whether B. oleronius produced the stimulatory 62 kDa 
protein over a pH range 6-9 that it may encounter in the gut of the mite or the skin of 
rosacea patients. Bacterial cells cultured at pH 8 showed a statistically significant 
increase of expression (1.7 fold) of the 62 kDa protein (p = 0.038) when compared to 
cells cultured at pH 7. Cells cultured at pH 8 also showed an increase in expression of 
1.7 fold (p=0.013) compared to cells cultured at pH 9 (Figure 6.6). 
 
6.2.4 Examining the effect of culture conditions of protein expression using confocal 
microscopy 
Lacey, (2007) previously identified the location of the stimulatory 62 kDa 
protein on the surface of B. oleronius cells and concentrated in structures though to be 
the endospores. In this section it was sought to examine if the expression of the 62 kDa 
antigen on the surface of B. oleronius varied under different growth conditions. Bacteria 
were cultured in Nutrient broth under aerobic and anaerobic conditions at pH 6, 7 and 8. 
Cells were then prepared for viewing by confocal microscopy as described in section 
2.13. Cells were heat fixed to glass slides and fixed with formaldehyde (3.7%), 
following wash steps and blocking with 1% BSA in PBS, cells were incubated in the 
rabbit anti-62 kDa antibody at 4 °C overnight. A TRITC labelled anti-rabbit secondary 
antibody was employed. Cells cultured under anaerobic conditions appear to express 
elevated levels of the 62 kDa protein on their surface with pH 6, 7 and 8 showing 
similar levels of expression (Figure 6.7). 
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Figure 6.6 (A) SDS-PAGE and (B) Western blot probed with rabbit anti-62 kDa 
antibody coupled with Densitometric analysis 
B. oleronius was cultured in Nutrient broth adjusted to pH 6, 7, 8 and 9 at 30 °C. 
Nutrient broth when made according to instructions is pH 7; therefore all conditions 
were compared to pH 7. Cells cultured at pH 8 showed a statistically significant 
increase of expression of the 62 kDa protein (p = 0.038). 
  
0 
20000 
40000 
60000 
80000 
100000 
120000 
140000 
160000 
pH 6 pH 7 pH 8 pH 9 
D
en
si
to
m
et
ri
c 
U
n
it
s 
Medium pH 
62 kDa 
Marker pH 6 pH 7 pH 8 pH 9 
Nutrient Broth 
62 k Da 
62 k Da 
83 k Da 
* 
188 
 
Nutrient Broth Aerobic Cultures  Nutrient Broth Anaerobic Cultures 
    pH 6 
 
    pH 7 
 
    pH 8 
 
Figure 6.7 Confocal fluorescence images of B. oleronius (X 60). 
Cells were incubated in the antibody generated towards the 62 kDa antigen and probed 
with TRITC labeled secondary antibody. These images indicate that the bacterium 
expresses more of the 62 kDa protein on its surface when cultured in nutrient and 
oxygen poor conditions.  
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6.2.5 Summary 
 Investigation of the one dimensional proteomic profile of the bacterium grown 
in various environmental conditions has established that the stimulatory antigens (62 
kDa and 83 kDa) are present under all of the conditions. In this section it has been 
shown that B. oleronius can adapt to changes in environment and continue to produce 
antigens that cause immune reactivity in human rosacea serum samples. By culturing 
the bacterium in the nutrient rich 2XYT medium at pH 7, 30 °C with aeration of the 
culture and investigating the level of 62 kDa antibody produced with the rabbit antibody 
it appears that these conditions cause the bacteria to produce the highest level of the 62 
kDa antigen (Figure 6.4 B & 6.5 B). However when Western blots were performed 
using human sera; reactivity to the stimulatory antigens appeared higher in conditions 
that could be stressful to the bacterium (Figure 6.4 B). The reactive band in the 62 kDa 
region appeared more intense when the bacterium was cultured in conditions that caused 
slow growth (section 6.1-6.5) such as at 30 °C in the nutrient poor medium or at 37 °C 
in the rich medium with low oxygen. The expression of the 62 kDa protein in poor 
nutrient and oxygen conditions is also represented in the confocal images (Figure 6.7). 
The ability of this bacterium to proliferate and produce immunogenic proteins under 
varied environmental conditions could be a contributing factor to the difficulty in 
treating rosacea effectively. 
 
6.3 Examining the effect of environmental conditions on the 2 
Dimensional proteomic profile of Bacillus oleronius 
 
 It was previously established that this bacterium adapted to a broad range of 
environmental conditions (section 6.1-6.1.5) and that variation of the growth conditions 
can bring about changes in the proteomic profile (section 6.2-6.2.4). There are 
limitations to one dimensional analysis therefore it was decided that two dimensional 
proteomic techniques were required. The technique of 2-Dimensional Electrophoresis 
was first described using bacterial cells (O’Farrell, 1975), it involves the separation of 
proteins according to isoelectric point by isoelectric focusing in the first dimension, and 
according to molecular weight by sodium dodecyl sulfate electrophoresis in the second 
dimension. In this section bacterial proteins were extracted as previously described 
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(section 2.12), re-suspended in IEF buffer at a concentration of 500 µg/250 µl and 
applied to a pH gradient 4-7 IPG strip then subjected to isoelectric focusing (section 
2.21) and separated by 12.5% SDS-PAGE (section 2.17) followed by Colloidal 
Coomassie staining, (section 2.20) and Progenesis SameSpot™ analysis. 2D SDS-
PAGE gels were produced in triplicate for each condition being investigated. 
Experiments were designed to compare gels from 2 growth conditions to each other and 
the SameSpot™ software automatically generated statistically ordered list of spots from 
a one way ANOVA analysis. Progenesis SameSpot™ analysis allowed the 
identification of protein spots of interest which were excised and subjected to trypsin 
digestion prior to LC/MS analysis (Section 2.22).  
 
6.3.1 Comparison of the 2 Dimensional proteomic profiles of Bacillus oleronius grown at   
30 °C compared to 37 °C 
 In order to perform this analysis B. oleronius cultures were grown in nutrient 
broth at 30 °C or 37 °C and aerated by shacking at 200 rpm. Bacterial protein (500 µg) 
was prepared as described (section 2.12), gels were carried out in triplicate and 
subjected to Progenesis SameSpot™ analysis. The analysis identified 47 spots (Figure 
6.9 (C)) that were altered, 11 of these spots showed a statistically significant change in 
volume (p ≤ 0.05). Six spots in total were identified by LC/MS from this analysis 
(Figure 6.9) and 4 of those were statistically significant while 2 were borderline 
significant (p < 0.09). Identified proteins are presented in Table 6.1 with the spot ID 
assigned by the Progenesis analysis (Reference image). 
Spot 145 demonstrated homology to superoxide dismutase from Bacillus sp. m3-
13 and expression of this enzyme was 2.3 fold higher (p = 0.017) in cultures grown at 
30 °C. Superoxide dismutase (SOD) catalyzes the conversion of the superoxide radical 
(O
2−
) to H2O2 and O2 (Areekit et al., 2011). This provides a protective function in the 
cell against superoxide radicals which could be encountered by the bacterial cells when 
challenged by their host immune system. Spot 50 was homologous to ptsH, a 
phosphocarrier protein HPR from Staphylococcus carnosus which is a component of the 
phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS). Bacteria 
cultured at 37 °C demonstrated a 2.5 fold increase (p = 0.031) in expression of this 
protein compared to the 30 °C cultures. Spot 241 represented the other protein that 
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showed increased expression at 37 °C which was homologous to an ATP-dependent Clp 
protease proteolytic subunit from Bacillus sp. SG-1. This enzyme is vital for the cellular 
homeostasis through the regulation of metabolic enzymes and removal of damaged 
peptides (Porankiewicz et al., 1999).  
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4 7  4 7 
   
(A) Nutrient Broth 30 °C  (B) Nutrient Broth 37 °C 
 (C) 
 
Figure 6.8.  B. oleronius cultured at (A) 30 °C and (B) 37 °C in Nutrient broth 
(C) Reference image (from 30 °C culture) used for Progenesis ™ SameSpots analysis. 
Spots that were significantly changed were excised and are represented in Figure 6.9. 
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Spot IdentifiedProtein Treatment Average volume Fold expression 
   NB 30 °C NB 37 °C 30 °C 37 °C FC p value 
 
      
      
      
 
Figure 6.9 Individual analysis of protein spots which showed a change in 
expression when grown at 30 °C or 37 °C. 
Progenesis™ SameSpot analysis was used to calculate the average volume, fold change 
and statistical significance values. LC/MS followed by Mascot analysis were employed 
for protein identification and proteins are presented in Table 6.1. 
FC=Fold Change 
 
50. ptsH 
2.20 5.56 2.5 0.031 
145. Superoxide 
dismutase 
241. ATP-dependent 
Clp protease 
proteolytic subunit 
3.01 1.31 2.3 0.017 
1.61 3.10 1.9 0.048 
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Spot 
ID 
Protein Accession Mass PI Value Mascot 
Z-Score 
Coverage 
% 
Uniprot Function 
50 ptsH AAA26663 4767 4.09 76 26 Involved in the 
phosphorylation of 
incoming sugar 
substrates 
145 Superoxide 
dismutase 
ZP_07708887 22492 5.17 103 25 Enzyme that 
catalyzes superoxide 
into oxygen and 
hydrogen peroxide 
241 ATP- 
dependent Clp 
ptotease 
proteolytic 
ZP_01860338 22647 4.94 156 12 Proteolytic enzyme 
regulates metabolism 
and honeostasis 
 
Table 6.1 Summary of proteins identified by LC/MS analysis. 
Proteins presented in Figure 6.9 were identified using Mascot and functions were found through Uniprot. 
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6.3.2 Comparison of the 2 Dimensional proteomic profiles of Bacillus oleronius grown in 
Nutrient Broth compared to 2XYT Broth 
 B. oleronius cultures were grown at 30 °C and aerated by rotation at 200 rpm in 
either Nutrient broth (minimal medium) or 2XYT broth (rich medium). Bacterial 
protein (500 µg) was prepared as described (section 2.12), gels were carried out in 
triplicate and subjected to Progenesis SameSpot™ analysis. The analysis identified 45 
spots (Figure 6.10) that were altered in expression, 14 of these spots showed a 
statistically significant change in volume (p ≤ 0.05). Six spots were identified by 
LC/MS from this analysis (Figure 6.11) and five of those were statistically significantly 
altered in expression while one was borderline significant (p ≤ 0.1). Identified proteins 
are presented in Table 6.2 with the spot ID assigned by the Progenesis analyses. 
 Spot 54 was homologous to a dihydrolipoamide dehydrogenase from Bacillus 
sp. SG-1, this enzyme was increased 1.8 fold (p = 0.032) when the bacterium was 
cultured in nutrient poor compared to nutrient rich medium. This protein is a component 
of the pyruvate dehydrogenase system which provides the link between glycolysis and 
the citric acid cycle (Mande et al., 1996). Therefore this protein is crucial for the 
process of respiration within the cells and the increase noted could reflect the cells 
adapting to the minimal nutrient conditions. Spot 207 was also increased in the cells 
cultured in nutrient poor media by 3.6 fold (p = 0.035). Mascot analysis revealed 
homology to naphthoate synthase which was described previously as also having 
involvement in cellular respiration (Ramchandra & Sturm 2010) and oxidative stress 
response (section 6.3.1).  
 Expression of a cell division protein FtsZ from Bacillus sp. NRRL B-14911 
(Spot 167) was increased 3.2 fold (p = 0.011) in cells cultured in nutrient broth. This 
protein is essential for bacterial cell division (Erickson et al., 1996) and the upregulation 
seen in cells in the poor medium may indicate that the cells are growing slower due to 
the lack of nutrients. Cells in the nutrient rich medium initially grow rapidly and cell 
division may have slowed due to depletion of nutrients. Spot 173 also showed a 2.5 fold 
increase in expression (p = 0.046) in cells cultured in nutrient poor medium and was 
identified as being homologous to an Elongation Factor Tu from Bacillus coahuilensis 
m4-4. This elongation factor and in highly conserved across bacterial species and is 
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involved in protein synthesis. Immune reactivity to these proteins has been reported in 
several bacterial species (Kyungwoo, 2011; Nieves et al., 2010; Sharma, et al., 2011) 
such as the Gram negative Bacillus, Burkholderia pseudomallei. Spot 242 was 
homologous to a hypothetical protein HMPREF1013_01383 from Bacillus sp. 
2_A_57_CT2. Expression of this protein was increased 3.2 fold (p = 0.054) in cells 
cultured in nutrient poor medium. This protein is involved in the assembly of flagellar 
filaments which allow the cells increase their motility. 
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4 7  4 7 
   
(A) 2XYT Broth 30 °C   (B) Nutrient Broth 30 °C 
 (C) 
 
Figure 6.10. B. oleronius cultured at 30 °C in (A) 2XYT broth and (B) Nutrient 
broth 
(C) Reference image (from nutrient broth culture) used for Progenesis ™ SameSpots 
analysis. Spots that were significantly changed were excised and are represented in 
Figure 6.11 
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Spot IdentifiedProtein Treatment Average volume Fold expression 
   NB 30 °C 2XYT 30 °C NB 2XYT FC p value 
      
      
      
      
 
Figure 6.11 Individual analysis of protein spots which showed a change in 
expression when grown in 2XYT and Nutrient broth. 
Progenesis™ SameSpot analysis was used to calculate the average volume, fold change 
and statistical significance values. LC/MS followed by Mascot analysis were employed 
for protein identification and proteins are presented in Table 6.2. 
 
54. 
Dihydrolipoamide 
dehydrogenase 
207. Naphthoate 
synthase 
9.26 5.09 1.8 0.032 
4.71 1.32 3.6 0.035 
167. Cell division 
protein FtsZ 3.40 1.07 3.2 0.011 
173. Elongation 
Factor Tu 
2.59 1.03 2.5 0.046 
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Spot 
ID 
Protein Accession Mass PI Value Mascot 
Z-Score 
Coverage 
% 
Uniprot Function 
54 Dihydrolipoamide 
dehydrogenase 
ZP_01862040 49716 4.93 173 10 Component of the 
pyruvate 
dehydrogenase 
system involved in 
metabolism 
 
207 Naphthoate 
synthase 
ZP_01859915 30230 5.51 283 22 Enzyme involved in 
ubiquinone synthesis 
and respiration 
167 Cell division 
protein FtsZ 
ZP_01172493 40805 5.09 172 19 Essential for cell 
division and 
involved in GTP 
binding 
173 Elongation  
Factor Tu 
ZP_03224888 43488 4.76 131 7 GTP binding 
translation factor 
 
 
Table 6.2 Summary of proteins identified by LC/MS analysis. 
Proteins presented in Figure 6.11 were identified using Mascot and functions were found through Uniprot. 
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6.3.3 Comparison of the 2 Dimensional proteomic profiles of Bacillus oleronius grown in 
minimal conditions compared to its optimum growth conditions 
 In order to perform this analysis B. oleronius cultures were grown at 37 °C and 
aerated by shaking at 200 rpm in 2XYT broth (optimum growth conditions) or at 30 °C 
in static (oxygen poor) conditions in nutrient broth (minimal growth conditions). 
Bacterial protein (500 µg) was prepared as described (section 2.12), gels were carried 
out in triplicate and subjected to Progenesis SameSpot™ analysis. The analysis 
identified 26 spots (Figure 6.12 C) that were altered, 13 of these spots showed a 
statistically significant change in volume (p ≤ 0.05). Eight of these spots were identified 
by LC/MS from this analysis (Figure 6.13 A & B). Identified proteins are presented in 
Table 6.3 with the spot ID assigned by the Progenesis analyses. 
 Four of these proteins showed increased expression in cells that were cultured 
under optimum conditions in nutrient rich 2XYT broth at 37 °C with 200 rpm. The first, 
spot 22 was identified as a superoxide dismutase form Bacillus sp. m3-13 and was 
increased 1.6 fold (p = 0.002). This enzyme is expressed in response to oxidative stress. 
Spot 28 which was homologous to a transketolase from Bacillus sp. SG-1, increased 2.4 
fold (p = 0.025) is involved in carbohydrate transport and metabolism. Spot 101 showed 
homology to a putative secreted protein from Listeria ivanovii FSL F6-596 which was 
increased by 1.9 fold (p = 0.039) and spot 106, which was homologous to Flagellin was 
increased 2.8 fold (p = 0.003) in cells grown in nutrient rich medium. Both proteins 
have functions in the assembly of flagellar filaments involved in cell motility. 
The remaining four proteins showed increased expression in cells that were 
cultured under nutrient poor conditions in nutrient broth, in a static incubator at 30 °C. 
Spot 261 was identified as a hypothetical protein HMPREF1013-01383 from Bacillus 
sp. 2_A_57_CT2 which was increased 2.4 fold (p = 0.033).  
Spot 7 was identified as an aconitate hydratase from Bacillus sp. SG-1. This 
enzyme involve in the TCA cycle was increased 1.6 fold (p = 0.050). Spot 268 was 
identified as a Hag protein from Bacillus sp. NRRL B-14911 and its expression was 
increased 1.6 fold (p = 0.015). These proteins are involved in the assembly of flagellar 
filaments. Spot 260 was homologous to alkyl hydroperoxide reductase (small subunit) 
from Bacillus licheniformis ATCC 14580 and its expression increased 2.4 fold (p = 
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0.028) in cells cultured in minimal conditions. Its function is in protecting cells from 
oxygen radicals and maintaining homeostasis.  
 
6.3.4 Summary 
 Gel electrophoreisis combined with LC Mass Spectrometry were employed to 
investigate the potential proteomic changes that allow B. oleronius to adapt to a broad 
range of environmental conditions. Among the proteins identified several were found to 
be involved in respiration and metabolism, others were involved in cell motility and 
response to oxidative stress. This analysis has proven that the bacterium alters the 
expression of key proteins in response to its environment; several of these proteins have 
antigenic potential. Similar proteomic adaptations may occur as the bacteria adjust to 
varying habitats from the gut of the Demodex mite to the sebum rich environment of the 
pilosebaceous unit. 
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4 7  4 7 
   
(A) 2XYT 37 °C Aerobic   (B) Nutrient Broth 30 °C Anaerobic 
 (C) 
Figure 6.12 B. oleronius cultured in (A) optimum growth conditions and (B) 
minimal growth conditions. 
(C) Reference image (from optimum growth culture) used for Progenesis ™ SameSpots 
analysis. Spots that were significantly changed were excised and are represented in 
Figure 6.13 
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Spot IdentifiedProtein Treatment Average volume Fold expression 
  2XYT 37 °C Sh NB 30 °C St 2XYT NB FC p value 
 
      
      
      
      
 
Figure 6.13 (A) Individual analysis of protein spots which showed a change in 
expression when grown in optimum or minimal growth conditions. 
Progenesis™ SameSpot analysis was used to calculate the average volume, fold change 
and statistical significance values. LC/MS followed by Mascot analysis were employed 
for protein identification. 
 
  
7. Aconitate hydratase 3.16 4.91 1.6 0.050 
22. Superoxide 
dismutase 
9.8 4.01 2.4 0.025 
1.35 0.82 1.6 0.002 
28. Transketolase 
101. Putative 
secreted protein 
7.42 3.83 1.9 0.039 
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Spot IdentifiedProtein Treatment Average volume Fold expression 
  2XYT 37 °C Sh NB 30 °C St 2XYT NB FC p value 
 
      
      
      
      
 
Figure 6.13 (B) Individual analysis of protein spots which showed a change in 
expression when grown in optimum or minimal growth conditions. 
Progenesis™ SameSpot analysis was used to calculate the average volume, fold change 
and statistical significance values. LC/MS followed by Mascot analysis were employed 
for protein identification. 
106. Flagellin 4.20 1.165 2.8 0.003 
2.86 6.99 2.4 0.028 
5.67 13.5 2.4 0.033 
4.02 6.50 1.6 0.015 
260. Alkyl 
hydroperoxide 
reductase 
261. Hypothetical 
protein 
268. Hag protein 
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Spot 
ID 
Protein Accession Mass pI 
Value 
Mascot 
Z-Score 
Coverage  
% 
Uniprot Function 
7 Aconitate hydratase ZP_01858967 99213 4.94 675 15 TCA cycle enzyme 
 
22 Superoxide 
Dismutase 
ZP_07708887 22492 5.17 131 25 Catalyse the 
conversion of 
superoxide radicals 
to H2O2 and O2 
28 Transketolase  ZP_001861729 
 
72950 5.11 133 4 Carbohydrate 
transport and 
metabolism 
101 Putative secreted 
protein 
ZP_07873717 12671 9.12 67 17 Unknown 
106 Flagellin NP_228567 41662 5 260 6 Flagellar motility 
 
260 Alkyl hydroperoxide 
reductase 
YP_081364 20874 4.66 126 22 Antioxidant 
properties involved 
in cell redox 
homeostasis 
261 Hypothetical protein ZP_08004778 44170 4.95 185 17 Bacterial flagellin 
 
268 Hag protein ZP_01173483 80767 4.71 105 3 Flagellin N 
terminal helical 
region 
 
Table 6.3 Summary of proteins identified by LC/MS analysis. 
Proteins presented in Figure 6.13 (A & B) were identified using Mascot and functions were found through Uniprot. 
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6.4 Investigation of the proteomic profile of Bacillus oleronius in response 
to hydrogen peroxide 
 
In this section a proteomic approach was employed to investigate the response 
of B.oleronius cells to hydrogen peroxide. Hydrogen peroxide is one of a number of 
Reactive Oxygen Species (ROS) produced by neutrophils during the oxidative response 
to pathogens (Manara et al., 1991). A study by Timsa et al., (2009) has reported that 
serum peroxide levels are significantly higher in individuals with rosacea compared to 
control subjects and that rosacea patients had significantly lower antioxidant levels. 
Therefore the aim of adding hydrogen peroxide to the culture media was to identify 
protein changes that could potentially occur in vivo when the bacterium is challenged by 
the host immune response. ROS have been implicated in the pathogenesis of rosacea 
(Yamasaki & Gallo 2009). This analysis was performed by culturing B. oleronius cells 
over night before adding 10 mM of hydrogen peroxide to the cultures for varying 
lengths of time (1, 2, 4 and 24 hrs). 
 
6.4.1 2-Dimensional electrophoresis and LC/MS analysis of Bacillus oleronius whole cell 
lysate which was exposed to hydrogen peroxide 
 It was decided that to understand if any proteins were altered in response to 
hydrogen peroxide a 2 dimensional electrophoresis approach should be investigated. 
Bacteria were cultured over night before adding 10 mM of hydrogen peroxide to the 
cultures for varying lengths of time (1, 2, 4 and 24 hrs). Protein (150 µg) was extracted 
(section 2.12), applied to 7 cm IPG strips and separated by SDS-PAGE (section 2.17) 
on 10 cm 12.5% SDS gels. Figures 6.14 (A & B) represent the proteomic profiles of 
control cells and cells exposed to hydrogen peroxide. Gels were performed in triplicate 
and SameSpot™ software automatically generated statistically ordered list of spots from 
a one way ANOVA analysis. Progenesis SameSpot™ analysis allowed the 
identification of protein spots of interest which were excised and subjected to trypsin 
digestion prior to LC/MS analysis (Section 2.22).  
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4 7 4 7 
  
A Control    B 10 mM H2O2 1 hour 
 
4 7 4 7 
  
C 10 mM H2O2 2 hours   D 10 mM H2O2 4 hours 
 
Figure 6.14 Bacillus oleronius protein profile following exposure to hydrogen 
peroxide 
(A) Represents the untreated B. oleronius profile protein, (B-D) are the profiles 
following exposure to 10 mM H2O2 for 1, 2 and 4 hours  
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 Liquid Chromatography Mass Spectrometry analysis identified 24 spots (Figure 
6.15) that showed altered expression, 5 of these spots showed a statistically significant 
change in volume (p ≤ 0.05). These spots were identified by LC/MS from this analysis 
(Figure 6.15 & 6.16). Identified proteins are presented in Table 6.3 with the spot ID 
assigned by the Progenesis analyses. Only one spot identified as a hypothetical protein 
from Bacillus sp. 2_A_57_CT2 (spot 36) showed an increase in expression of 1.8 fold 
(p = 0.011) in cells exposed to hydrogen peroxide compared to untreated cells. This 
protein has been described previously as being involved in the assembly of flagellin 
fillaments.  
The protein corresponding to spot 18 all showed decreased expression in cells 
exposed to 10 mM hydrogen peroxide for 2 and 4 hours compared to untreated cells and 
these proteins are also involved in the assembly of flagellin fillaments and cell motility. 
Spot 18 showed homology to a flagellin from Bacillus sp. Kps3 and its expression 
decreased 1.9 fold (p = 0.004) following exposure to hydrogen peroxide. Spot 11 
showed homology to an enzyme involved in the glycolysis pathway of respiration, 
phosphopyruvate hydratase from Bacillus sp. SG-1 which decrease 1.9 fold (p = 0.007) 
following exposure to 10 mM hydrogen peroxide. Spot 23 was identified as a 
glyceraldehyde-3-phosphate dehydrogenase GAPDH from Geobacillus 
thermodenitrificans NG80-2 and its expression decreased 2.2 fold (p = 0.011) in cells 
exposed to hydrogen peroxide. GAPDH is another enzyme involved in glycolysis. Spot 
24 was identified as a hypothetical protein BB14905_07369 from Bacillus sp. B14905 
which decreased 2.9 fold (p = 0.003). This protein is involved in growth inhibition. 
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Figure 6.15 Spots indicated to have altered expression by Progenesis Same Spot™ 
analysis 
Spots which showed significant (p ≤ 0.05) alterations in expression were excised from a 
gel representing untreated bacterial cells. These spots are comparatively analysed in 
Figure 6.17 and represented on Table 6.4. 
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Spot IdentifiedProtein Treatment Average volume Fold expression 
 
     
     
     
     
     
 
Figure 6.16 Individual analysis of protein spots which showed a change in 
expression when grown in optimum or minimal growth conditions. 
Progenesis™ SameSpot analysis was used to calculate the average volume, fold change 
and statistical significance values. LC/MS followed by Mascot analysis were employed 
for protein identification. 
18. Flagellin  
36. 
Hypothetical 
Protein 
2.3 3.72 4.15 1.8 0.011 
3.07 1.59 2.50 1.9 0.004 
11. 
Phosphopyr
uvate 
hydratase 
6.44 5.72 1.07 1.9 0.007 
23. GAPDH  
24. 
Hypothetical 
protein 
3.15 1.44 2.76 2.2 0.011 
2.55 0.87 1.86 2.9 0.003 
Untreated 10 mM H2O2 10 mM H2O2      UT     2hrs     4hrs     FC     p value 
  2 hrs  4 hrs 
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Spot 
ID 
Protein Accession Mass pI 
Value 
Mascot 
Z-Score 
Coverage  
% 
Uniprot Function 
18 Flagellin BAH8035 40089 4.80 101 10 Bacterial flagellar 
motility 
36 Hypothetical 
 protein 
ZP_08004778 44170 4.95 201 13 Bacterial flagellin N 
terminal helical 
region 
11 Phosphopyru 
Vate 
Hydratase 
ZP_01862097 46717 4.68 859 40 Enzyme component 
of Glycolysis 
pathway 
23 Glyceraldehy  
De-3- 
Phosphate  
Dehydrogena 
YP_001126741 37612 6.64 159 8 Enzyme catalyzes 
the sixth step of 
glycolysis and thus 
release energy and 
carbon molescules 
24 Hypothetical protein ZP_01723688 12811 6.73 69 13 PemK like protein 
which is a growth 
inhibitor 
 
 
Table 6.4 Summary of proteins identified by LC/MS analysis. 
Proteins presented in Figure 6.16 were identified using Mascot and functions were found through Uniprot. 
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6.5 Discussion 
 
 It has been hypothesised that the Demodex mite and its associated bacteria 
contribute to the chronic inflammation seen in rosacea patients due to the fact that 
several studies have reported higher Demodex levels in rosacea skin compared to 
control skin (Diazperez, 1994; Gao et al., 2005; Kheirkhah et al., 2007; Li et al., 2010). 
Demodex mites feed on sebum produced by the host and also ingest bacteria (Elston 
2010; Wolf et al. 1988), the mites have no anus and therefore when their life span of 
several weeks ends they harbour large amounts of bacteria. In people that are sensitive 
to the triggers associated with rosacea this deposition of bacteria may cause localised 
inflammation (Hsu et al., 2009). The classic treatment for rosacea involves the use of 
systemic and topical antibiotics (Federici 2011) however the effectiveness of the 
treatment was largely thought to be due to the anti-inflammatory properties of the drugs 
rather than their ability to act on bacteria (Federici 2011; Monk et al., 2011). Treatments 
that reduce the number of Demodex mites in the skin such as tea tree oil clear symptoms 
successfully (Kheirkhah et al., 2007), however the condition cannot be completely 
cured and often occurs in patterns of flare ups and remissions. Upon consideration of 
the literature our hypothesis is that antibiotics can reduce Demodex numbers by killing 
symbiotic bacteria and decreasing the bacteria on which they feed. However some mites 
may remain or the host could become re-populated with mites, which potentially re-
establish the pattern of localised inflammation in the hair follicles that becomes chronic 
over time causing vascular and tissue damage. 
The role of Bacillus oleronius, a bacterium isolated from a Demodex mite in the 
induction of rosacea has been under investigation for 10 years (Delaney, 2004; Lacey, 
2007). Researchers have also begun investigating the role of other bacteria (S. 
epidermidis and H. Pylori) in the condition (Whitfeld et al., 2011; Dahl et al., 2004; 
Utaş et al., 1999; Lazaridou et al., 2011). The aim of this section of work was to 
investigate B. oleronius growth and protein production in response to various 
environmental conditions. It has been established that Bacillus oleronius can produce 
proteins which cause serum reactivity in rosacea patients (Delaney, 2004; Lacey et al., 
2007). This section of work has shown that the bacterium can grow and produce these 
proteins across a range of culture conditions (section 6.1-6.1.4 & section 6.2-6.2.5). It 
has not been proven whether the bacterium encounters these conditions in vivo on the 
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surface of the skin, however these results provide an insight into the capability of the 
bacterium to adapt to conditions that may be present in vivo. 
B. oleronius is thought to be associated with the hindgut of the Demodex mite 
and after the death of the mite the bacterium could be deposited in the pilosebaceous 
unit, the temperature, pH and oxygen availability in these environments may differ 
slightly. B. oleronius could potentially evade the host immune response since it is 
initially located in the gut of the Demodex mites (Finlay & McFadden, 2006). Following 
the death of mites in the hair follicle there could be a localized proliferation in B. 
oleronius and other bacteria within the pilosebaceous unit. The fastest growth rate was 
seen in cells cultured at 30 °C in 2XYT broth with aeration. This condition also induced 
a 3.3 fold (p=0.02) increase in expression of the 62 kDa stimulatory protein (probed 
with the rabbit anti-62 kDa antibody) compared to cells cultured at 30 ° in minimal 
nutrient and oxygen conditions. 
One dimensional gels and Western blots (Figures 6.4-6.7) provided evidence 
that the stimulatory 62 and 83 kDa antigens are produced under stressful environmental 
conditions such as low oxygen or nutrients. There was a 2.1 fold increase in production 
of the 62 kDa protein in the blot probed with rosacea sera when cells were cultured in 
nutrient broth at 30 °C compared to 2XYT broth at 30 °C. The immunoblot represented 
in Figure 6.4 indicated that cells in low nutrient and oxygen conditions at 37 °C 
expressed 1.8 fold more of the 62 kDa protein that cells in optimum growth conditions. 
Culture of cells at 30 °C in low nutrient medium also produced a 2 fold increase in 
expression of the 83 kDa protein than those cultured at 37 °C in nutrient rich medium. 
The effect of culture temperature on protein expression in B. oleronius cells indicated 
that the bacterium produced increased amounts of protein at 37 °C. However Western 
blotting revealed that the stimulatory antigens are produced at both temperatures, 
therefore the bacterium could cause an immune response in a wide range of 
environmental conditions. Research carried out by Dahl et al., (2004) investigating the 
role of Staphylococcus epidermidis in rosacea discovered that that bacterium secreted 
more proteins when cultured at 37 °C compared to 30 °C. The paper also suggests that 
the temperature of the skin of rosacea patients is generally higher than controls (Dahl et 
al., 2004) due to flushing and inflammation. The group did not look for a specific 
stimulatory protein however the findings add to the evidence that bacterial components 
are contributing to rosacea. The response of B. oleronius to culture in a pH range of 6-9 
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indicated that cells can tolerate these conditions although slow growth was recorded in 
culture media at pH 6 (Figure 6.2). The immunoblot presented in Figure 6.6 indicated 
that cells cultured at pH 8 produced 1.7 fold more of the 62 kDa protein than those 
cultured at pH 7 (p=0.038) and pH 9 (p=0.013). The pH of human skin is said to range 
from pH 6-8 (Wagner et al., 2003) Further investigation into the pH of rosacea skin 
during exacerbation of the condition may give insight into the significance of the 
finding that this bacterium can proliferate at an alkaline pH. 
The environmental conditions which bacteria are exposed to have a great impact 
on the proteins they produce, which can mean they become more virulent or better able 
to evade the host immune response (Finlay & McFadden 2006). Studies have shown 
that bacteria can produce a wide and varied range of proteins with non-specific 
functions in response to stress (Carlin et al., 2010; Hecker et al., 1996). In order to 
examine the proteomic changes further 2D electrophoresis and LC/MS were employed. 
When the significantly increased protein spots from the comparison of culturing at 30 
°C and 37 °C were compared, four of them were increased at 30 °C and two at 37 °C. 
Growth curves have suggested that B. oleronius grows preferentially at 30 °C in 
minimal medium however it is a slow growing bacterium. Naphthoate synthase and 
superoxide dismutase (SOD) were both increased at 30 °C and have been described as 
stress response proteins (Ramchandra & Sturm 2010; Areekit et al., 2011). Naphthoate 
synthase is a key enzyme in the production of menaquinone in and has a role in the 
anaerobic biosynthesis of pyrimidines (Ramchandra & Sturm 2010). Lactate 
dehydrogenase, an enzyme involved in glycolysis and a TetR family transcriptional 
regulator were also up-regulated at 30 °C. Components of the glycolysis pathway are 
increased in glucose rich conditions (Hecker et al., 2008) therefore the increased 
expression of lactate dehydrogensase by 3.9 fold (p=0.052) in cells cultured at 30 °C in 
minimal medium compared to cells at 37 °C may represent the cells utilising their 
nutrient source preferentially at this temperature. 
Two metabolic enzymes, PtsH a component of the phosphoenolpyruvate-
dependent sugar phosphotransferase system and ATP-dependent Clp protease involved 
in cellular homeostasis were increased in cells cultured at 37 °C. PtsH expression was 
increased 2.5 (p=0.031) fold in cells cultured at 37 °C in nutrient broth compared to 
cells cultured at 30 °C; Lacey (2004) previously identified a stimulatory protein from 
the 62 kDa region as having homology to ptsH. This protein has a known ability to 
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stimulate serological reactivity in rosacea patients (Lacey et al, 2007) and individuals 
with rosacea are said to have increased skin temperature compared to control skin due to 
inflammation and vasodilation (Dahl et al., 2004). 
When the minimal medium was compared to the nutrient rich medium five of 
the significantly altered spots showed increased expression in the nutrient broth 
compared to one being up-regulated in the 2XYT. Proteins increased in the nutrient 
poor medium were also identified as being involved in metabolism and growth such as 
naphthoate synthase, dihydrolipoamide dehydrogenase, cell division protein FtsZ and 
elongation factor Tu. Proteins such as those essential to bacterial cell growth and 
metabolism often have antigenic properties (Kyungwoo 2011; Nieves et al., 2010; 
Sharma et al., 2011). A hypothetical protein identified as being involved in the 
assembly of flagellar filaments was also increased (3.2 fold, p=0.05) in the nutrient poor 
conditions compared to the nutrient rich. Flagellins aid the motility of bacterial cells and 
are often recognised by the host immune response as virulence factors or triggers (Gao 
et al., 2010; Hozono et al., 2006; Kumar et al., 2007).  
Comparison between optimum and minimal growth conditions as observed in 
the growth curve resulted in four significantly increased proteins being identified from 
each growth condition. Optimum growth was achieved in the 2XYT broth at 37 °C and 
200 rpm, proteins that were increased under these conditions were, transketolase, 
involved in carbohydrate metabolism, a putative secreted protein (function unknown) 
and two proteins involved in assembly of flagellar filaments. Culture in the minimal 
growth conditions lead to increased expression of aconitate hydratase, superoxide 
dismutase (SOD), alkyl hydroperoxide reductase (AHP) and a Hag protein. SOD and 
AHP are involved in cellular stress responses by protecting the bacterium from harmful 
oxygen radicals (Kim et al., 2010). Cells cultured at 30 °C expressed 2.3 fold (p=0.017) 
more SOD than cells cultured at 37 °C. Expression of SOD was also increased 1.6 fold 
(p=0.002) in cells cultured in low nutrient and oxygen conditions than cells cultured in 
optimum conditions. Increased expression of SOD and other stress proteins reflects the 
bacterial cells response to the environment. The deposition of B. oleronius in the 
pilosebaceous unit by the Demodex mite could also be perceived as a stress inducer for 
the bacterium. Purified bacterial SOD has been proven to induce an immune response in 
mice involving the increased production of cytokines TNF-α and IL-6 (Mullerad et al., 
2002). 
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 Many bacterial products can stimulate the human immune response (Philpott et 
al., 2001; Tapping, 2009). Exposure of microorganisms to hydrogen peroxide is one of 
the ways in which the human immune system retaliates against invading pathogens 
(Manara et al., 1991). Neutrophils are a major component of the first line of defence 
that is the innate immune response (Segal 2005). Bacteria have adapted to this response 
by producing enzymes such as superoxide dismutase which catalyses harmful oxygen 
radicals into hydrogen peroxide and water. Five proteins that showed significantly 
decreased expression in H2O2 treated cells compared to untreated bacteria were 
presented in Table 6.4.  
 One hypothetical protein was revealed to have a function linked to flagellin 
assembly, flagellins are well known to trigger the human innate immune response via 
TLR signalling (Tapping 2009). In an investigation by Honzo et al., (2006) it was found 
that flagellins of pathogenic and non-pathogenic bacteria induced a differential response 
from human corneal epithelial cells (HCEC). Expression of TLR5 was increased in 
HCEC in response to flagellin derived from P. aeruginosa which has been implicated in 
the pathogenesis of bacterial keratitis among contact lens users (Hozono et al., 2006; 
Cheng et al., 1996). Signalling through TLR5 induces the production of TNF-α and IL-
8. In chapter 4 evidence that Bacillus proteins induced the production of IL-8 at an 
increased rate in exposed neutrophils compared to control cells. 
The protein corresponding to spot 18 is also involved in flagellin assembly and 
cell motility and this spot showed decreased expression following 2 hrs of exposure to 
10 mM hydrogen peroxide (fold change 1.9, p=0.004) however production was 
deceased by a fold change of only 1.2 after 4 hrs of exposure. Flagellins are proteins 
that are recognized as antigens by host cells in order to trigger a reaction from the 
immune system (Honzono et al., 2006). Therefore the decrease in these proteins may 
represent the bacterial cells attempts to evade the host immune defence in response to 
the hydrogen peroxide exposure. Further down-regulated proteins identified were 
phosphopyruvate hydratase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
both involved in metabolic pathways that provide energy to the cells. The decrease of 
respiratory proteins following the challenge of of H2O2 may be also be due to the cells 
slowing down production of proteins that could potentially be seen as antigens. A 
hypothetical protein involved in growth inhibition was identified along with a DNA 
polymerase. These proteins along with several of the others showed decreased 
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expression at 2 hours but expression began to increase again by 4 hours of treatment 
indicating that the cells have mounted a response to the challenge of the oxygen radicals 
and begun to grow and respire again. 
The work presented in this section has highlighted the ability of B. oleronius 
cells to adapt to a broad range of environmental conditions. The bacterium may increase 
certain proteins in response to environmental stresses such as starvation, nutrient 
depletion, low oxygen or exposure to hydrogen peroxide. Western blots carried out with 
rosacea patient serum showed many reactive bands as seen in the individual blots in 
Chapter 3. Proteins spots that are increased in the various environmental conditions may 
correspond to these reactive bands. There is a clear need for a better understanding of 
the immune response in rosacea patients. The ability of this bacterium to produce 
antigenic proteins under varied environmental conditions has potential implications for 
the treatment of the condition. 
 
 
 
Chapter 7 
 
 
 
General Discussion
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7.0 Discussion 
 
 The onset of a chronic skin disorder in such a highly visible area as the face can 
have a dramatic impact on the self esteem of an individual. Rosacea involves chronic 
inflammatory and vascular symptoms that can become progressively worse (Yamasaki 
& Gallo, 2009). The phenotypic characteristics of rosacea have previously been 
associated with excessive alcohol consumption leading to the term ‘whiskey nose’ being 
used to describe the thickening of the skin on the nose seen in rhinophyma. Some forms 
of rosacea can cause sudden erythema or prolonged blushing that has many triggers that 
the patient must try to avoid (Gupta & Chaudhry, 2005). Psoriasis is also a chronic 
inflammatory skin disorder that has a prevalence of around 2% in Ireland and similarly 
prevention of flare ups can be achieved by avoidance of triggers (Tonel & Conrad 
2009). Like rosacea (Bamford 2001) it has been suggested that genetic predisposition is 
linked to the onset of psoriasis (Valdimarsson et al., 1995) however the cause of the 
condition remains unknown. Despite the growing number of patients presenting with 
the four subtypes of rosacea (over 16 million in the USA and up to 2% of the Irish 
population) and the vast amount of research in the area there is no definitive evidence or 
clinical diagnostic marker for a specific causative factor. There is no cure for rosacea, 
the condition is managed by avoidance of triggers and treatment of flare-ups with anti-
inflammatory therapies (Elewski et al., 2010; Gupta & Chaudhry, 2005; van Zuuren et 
al., 2007). Both rosacea and psoriasis represent inflammatory skin disorders with ocular 
manifestations (Oltz & Check, 2011; Rehal et al., 2011) and both are notoriously 
difficult to clear and often require multiple forms of treatment depending on the stage of 
the condition. Early diagnosis and efficient treatment are extremely important in the 
management of chronic disease and the lack of diagnostic markers combined with the 
elusiveness of the causative factors in relation to rosacea represent problems that affect 
prompt treatment and patient care (Dahl et al., 2002; Powell, 2005; Wilkin et al., 2004). 
 Demodex mites (Lacey et al., 2011) and many species of bacteria 
(Krutmann, 2009) are part of the normal skin flora however it is hypothesized by 
several research groups that both may play a role in the pathogenesis of rosacea 
(Yamasaki & Gallo, 2009). The Demodex mite has been suspected as playing a role in 
dermatological conditions since its discovery in 1842 (Bonnar et al.,1993; Desch & 
Nutting, 1972; Fell, 1886; Lacey et al., 2011). D. folliculorum has been described as a 
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bacterial vector (Wolf et al., 1988) and increased mite density has been reported in the 
pilosebaceous units (Aylesworth & Vance, 1982; Bonnar et al., 1993; Norn, 1970) and 
eyelashes (Gao et al., 2005; Kheirkhah et al., 2007) of rosacea patients. Therefore as the 
density of mites increases in the skin of individuals with rosacea, the density of bacteria 
would also increase. Bonnar et al., (1993) reported that there was no significant 
reduction in Demodex mites in the skin of rosacea patients following one month of 
treatment with tetracycline although symptoms were cleared. This may suggest that the 
drug attacked the bacteria associated with the mite rather than having a direct effect on 
the mite. Treatments such as acaricides and Tea Tree oil which reduce mite numbers 
can also alleviate symptoms of rosacea (Bonnar et al., 1993; Gao et al., 2005).  
Although antibiotics have been the main treatment for rosacea for many years 
(van Zuuren et al., 2007) bacterial involvement has never been proven and the efficacy 
of this treatment procedure has largely been attributed to the anti-inflammatory effect of 
the drugs (Monk et al., 2011). Since the discovery of Bacillus oleronius in the Demodex 
mite of a rosacea patient (Delaney, 2004) the possible role of this bacterium in the 
induction of rosacea has been under investigation (Lacey et al, 2007; Lacey et al., 2009; 
Li et al., 2010). Bacteria such as Staphylococcus epidermidis (Dahl et al.,2004; 
Whitfeld et al., 2011) and Helicobacter pylori (Lazaridou et al., 2011; Utaş et al., 1999) 
have also been investigated as contributing factors in the development of rosacea. 
Whitfeld et al., (2011) isolated S. epidermidis from the pustules of 9 of 15 patients with 
papulopustular rosacea while no swabs taken from non-affected areas of the skin 
contained the bacterium (p = 0.0003). S. epidermidis was also isolated from the eyelid 
margins of 4 of 15 patients with papulopustular rosacea while no pure growth was 
isolated from the eyelids of age- and sex-matched control subjects (p = 0.05). The study 
also found that this bacterium was susceptible to antibiotics commonly used to treat 
rosacea such as tetracycline (Whitfeld et al., 2011). Dahl et al., (2004) investigated the 
effect of temperature on S. epidermidis and found that the bacterium secreted more 
proteins when cultured at 37 °C than at 30 °C. It was suggested that the skin of rosacea 
patients is thought to be increased compared to control skin and this increase in 
temperature would increase the amount of secreted bacterial protein present in the skin 
(Dahl et al., 2004). It was also found that S. epidermidis isolated from rosacea patients 
was consistently β-hemolytic, whereas bacteria from control subjects were non-
hemolytic which is a characteristic virulence factor (Wilkin et al., 2004).  
220 
 
B.oleronius is the only bacteria isolated to date that potentially contributes to the 
development of rosacea for which serological markers have been identified (Lacey 
2007; Li et al. 2010). In Chapter 3 of this study it was shown that two B. oleronius 
proteins (62 and 83 kDa) previously identified by Lacey et al., (2007) cause serological 
reactivity in individuals with ocular and erythematotelangeictatic (type one) rosacea. 
Following blind testing of 59 sera samples from patients with ocular rosacea and 
controls (Li et al., 2010), there was 66% correlation between serum immunoreactivity 
and occurrence of rosacea. In sera that showed no reactivity to the stimulatory proteins 
78% were found to be from controls. Following a study of sera from type one rosacea 
and controls, 92% of those who showed serum reactivity were positive for rosacea and 
there was one rosacea patient that did not show serum reactivity to either antigen. None 
of the controls (5/5) showed serum reactivity. The type one rosacea study has the 
potential to be strengthened with the addition of more samples. The results of both 
patient sera studies along with the previous results from a papulopustular study (Lacey, 
2007) strengthen the case that B. oleronius has a potential role in the induction of 
rosacea. 
The potential to detect reactivity to B. oleronius antigens in tear fluid was also 
investigated. This proved quite difficult with the Western blotting technique employed 
and only 6 samples showed weak binding with the anti-62 kDa antibody. Tear fluid 
from case number 45 showed reactivity in the 83 kDa region while cases 16, 18, 22 and 
23 were reactive to the 62 kDa protein. In the 6 cases where tear fluid reacted to the B. 
oleronius rabbit-62 kDa antibody; all showed serum immunoreactivity to both the 62 
and 83 kDa proteins. Detecting the presence of B.oleronius antibodies in tear fluid could 
prove a useful diagnostic assay perhaps by changing to an ELISA format such as that 
used to detect the presence of Pseudomonas aeruginosa in the tear fluid of contact lens 
users (Cheng et al., 1996). There is also potential to detect specific proteins in tear fluid 
using LC/MS (An et al., 2005).  
The stimulatory antigens were previously identified by MALDI-ToF mass 
spectrometry by Lacey, (2007). The 62 kDa antigen showed the strongest homology to a 
Phosphoenolpyruvate phosphotransferase sensory system (PTS) involved in the 
metabolism of carbohydrates. The 83 kDa protein showed homology to a Heat shock 
chaperon protein involved in stress responses. In this study the identification of these 
proteins was repeated by LC/MS on tryptic digests of bands corresponding to the 62 and 
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83 kDa regions. The immune stimulatory protein at the 62 kDa region showed 
homology to a groEL chaperonin protein from Bacillus subtilis. This protein is known 
to elicit serological reactivity in patients affected by several conditions involving 
bacteria (Shinnick et al., 1988; Qoronfleh et al., 1998; Woo et al., 2001; Mayr et al., 
1999). GroEL is conserved across many species of bacteria and has been implicated as 
an antigenic marker in the serum of individuals infected with Burkholderia 
pseudomallei which causes melioidosis a serious human disease that is endemic in 
Southeast Asia (Woo et al., 2001). The condition has acute and chronic phases and the 
GroEL protein identified was suggested as a diagnostic marker for the infection. 
Chlamydia trachomatis can cause the chronic inflammatory disease trachoma which can 
lead to blindness and an antigenic protein homologous to GroEL has been identified as 
causing serum reactivity in patients with the condition (Morrison et al., 1989). A 
recombinant protein clone of this antigen elicited an ocular inflammatory response in 
guinea pigs (Morrison et al., 1989). The 83 kDa band was identified as aconitate 
hydratase from Bacillus sp. SG-1. Aconitate hydratase is a TCA cycle enzyme involved 
in metabolism of carbohydrates, this pathway is particularly active when cells are in low 
nutrient conditions (Michael et al., 2008; Rosenkrands et al., 2002) which could reflect 
the response of the bacteria to the change in nutrient levels from the hindgut of the 
Demodex mite to the pilosebaceous unit. 
Anion exchange with Q-sepharose charge separation combined with 
fractionation using ÄKTA-Fast Protein Liquid Chromatography was employed to 
separate B. oleronius protein. This method allowed the isolation of fractions that 
contained a ‘semi-pure’ preparation of the 62 kDa stimulatory protein. In Chapters 4 
and 5, neutrophils and corneal epithelial cells were exposed to this protein preparation 
in order to determine what effect it had on cells of the innate immune system thought to 
be affected by the progression of rosacea (Yamasaki & Gallo 2009; Kheirkhah et al., 
2007). The protein preparation was resolved by 1D SDS-PAGE and all bands present 
were excised and subjected to LC/MS in order to assign functionality to the proteins 
being exposed to the human cells. Flagellin which is known to be a ligand for TLR-5 
was present in the protein preparation. Signalling through the toll like receptor (TLR) 
pathways leads to production of cytokines such as IL-8 (Vance et al., 2009, Hozono et 
al., 2006), which was shown to be increased in neutrophils treated with the bacterial 
proteins. A peptidoglycan synthesis protein (Hypothetical protein Noc_2222) was 
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identified and peptidoglycan recognition is a trigger for the innate immune response 
(Dziarski 2004). Elongation factor G was also among the identified proteins and several 
studies have reported proteins with elongation and translational functions in the 
ribosome as antigenic (Shin, et al., 2007, Shin et al., 2009). A protein involved in 
metabolism (oligopeptide ABC transporter periplasmic protein) was identified as having 
a function in the movement of substances in and out of the cell. A study by Travis 
(2000), has highlighted the use of drugs to disrupt metabolic pathways as a new target 
for treatment of pathogenic bacteria. A study by Jeavons et al., (1998) describes the 
isolation of proteins from Penicillium marneffei which caused immunoreactivity in 
human sera one of which had homology to catalase. Catalase was among a number of 
proteins released in response to oxidative stress such as Kat E1, vegetative catalase, 
superoxide dismutase and alkyl hydroperoxide reductase (Mostertz & Hecker, 2003). 
Recognition of pathogen-associated molecules (PAMPs) leads to stimulation of the 
innate and eventually the adaptive immune responses. Bacillus oleronius is thought to 
be a commensal or opportunistic pathogen (Lacey et al., 2011). Several of the proteins 
described may have the ability to stimulate the immune response since PAMPs are not 
exclusively associated with pathogenic microbes (Cookson et al., 2001; Gallo & Nizet, 
2008). Some of the proteins mentioned here were identified in Chapter 6 when protein 
expression in B. oleronius cultured under varied environmental conditions was 
investigated.  
In Chapter 3 the potential to develop a serological diagnostic assay was also 
investigated. As previously discussed examination of serum with crude B. oleronius 
protein preparations by Western blotting revealed a 66% correlation between serum 
reactivity and the occurrence of ocular rosacea. Therefore it was decided that the ‘semi-
pure’ B. oleronius protein would be used in an ELISA diagnostic assay. However the 
assay design proved unsuccessful when 20 positive rosacea patients were compared 
with 19 control samples. All sera (diluted 1/100) bound to the proteins present on the 
plate and 14/20 rosacea patient samples recoded absorbance over 0.5 (O.D.=450) while 
15/19 samples proven to be controls using the Western blotting method recorded the 
same level of absorbance. More of the sera samples from patients (n=7) recorded 
absorbance over 1 compared to controls (n=6) and when the cut off was raised to 1.5 
(O.D=450) only 2 control patients showed this level of reactivity compared to 4 of the 
patient sera samples. ELISA assays represent an easy, reproducible and fast technique 
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for the detection of antigens or antibodies (Diniz et al., 1999). The development of a 
diagnostic assay for rosacea has not yet been achieved and with some alterations this 
technique could prove a useful diagnostic tool. 
Lacey et al., (2007) demonstrated that B.oleronius produced antigens capable of 
stimulating peripheral blood mononuclear cells (PBMC) proliferation in 16 of 22 (73%) 
patients with rosacea but only five of 17 (29%) control subjects (P =0.0105). In Chapter 
4 the effect of the ‘semi pure’ Bacillus protein preparation of human neutrophils was 
examined. As an integral part of the innate immune response (Segal 2005), neutrophils 
are essential for the detection and destruction of potential pathogens. Neutrophils are 
involved in the induction of inflammation and degranulation (Manara et al., 1991; Pham 
2008). Inflammation is a protective mechanism of the immune response involving 
epithelial cells and circulating white blood cells (Hozono et al., 2006; Philpott et al., 
2001; Ueta & Kinoshita, 2010) which leads to induction of signalling pathways through 
Toll like receptors (TLRs) (Bellocchio et al., 2004). However when this response is not 
regulated it becomes chronic and factors that usually contribute to the killing of 
invading microbes can begin to damage host cells (Bevins & Liu, 2007). 
In Chapter 4 it was discovered that B.oleronius antigens have the ability to 
stimulate the production of IL-8 and TNF-α in isolated human neutrophils. TNF-α is 
essential to the induction of inflammatory responses (Teranishi et al., 1995) and IL-8 is 
a chemotatic cytokine (Ramos 2003) that encourages the movement of white blood cells 
to the site of inflammation, therefore induction of these cytokine could contribute to the 
chronic nature of the condition (Yamasaki & Gallo, 2009). The induction of these 
cytokines was likely caused by the recognition of the bacterial protein components 
being potentially pathogenic (Vance et al., 2009). Many of the B. oleronius proteins 
identified were shown to have antigenic properties when their functions were 
investigated (section 3.4.2, Table 3.4) and therefore have the potential to induce 
cytokine production in neutrophils. The highest increase in IL-8 production of 2.7 fold 
(p=0.0027) was observed following 16 hrs of exposure to 2 µg/ml of the crude Bacillus 
protein extract. The crude extract (2 µg/ml) also elicited the highest concentration of 
TNF-α production in human neutrophils, at 3 hrs a 2.9 fold (p=0.0008) fold increase 
was noted and at 16 hrs a 2.8 fold (p=0.0002) increase was seen. The potential for these 
antigens to induce significantly increased concentrations of IL-8 and TNF-α compared 
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to control neutrophils could contribute to the overall dysregulation of the immune 
system that induces rosacea symptoms(Yamasaki & Gallo, 2009). 
Increased migration of neutrophils in response to Bacillus protein exposure was 
also detected with an assay using a porous insert. When a 3 µm porous insert was 
employed and neutrophils were exposed to 2 µg/ml of the ‘semi-pure protein 
preparation’ a 4.3 fold (p=0.02) increase in migrated cells was seen compared to control 
samples. This increase rose to 7 fold (p=0.027) when 2 µg/ml of the crude extract was 
used compared to control cells. Increased IL-8 production by the treated neutrophils in-
vitro and the migration assay adds to the theory that in-vitro migration is being induced 
in response to the Bacillus proteins which suggests that migration of neutrophils could 
potentially occur in-vivo. Infiltration of neutrophils is part of the inflammatory response 
(Gambero et al., 2004) and has been previously linked to the pathogenesis of rosacea 
(Crawford et al., 2004).  
If the infiltration of neutrophils is not regulated by the immune response there is 
potential for inflammation to become chronic (Hartl et al., 2008; Mizgerd et al., 1999). 
The main function of neutrophils is phagocytosis of pathogens which is followed by 
degranulation (Lacy 2006), this process sometimes involves the release of granule 
contents into the surrounding tissue (Levy 2000). In Chapter 4, Western blotting was 
employed to detect degranulation proteins secreted by neutrophils in response to 
exposure to the bacterial antigens. Myeloperoxidase (MPO), matrix metalloprotease 9 
(MMP-9) and cathelicidin (hCAP-18) are antimicrobial components of neutrophil 
granules which are released into lysosome vacuoles which contain pathogens engulfed 
by the neutrophil (Curnutte et al., 1987; Manara et al., 1991). Increased secretion of all 
three proteins was detected in neutrophil cells exposed to the Bacillus antigens 
compared to controls. The highest fold change in MPO (3.9, p=0.0003) was observed 
when neutrophils were exposed to 2 µg/ml of the crude protein extract for 6 minutes in 
a stirred chamber. MMP-9 secretion was detected to be 2.9 fold (p=0.0001) following 3 
minutes of exposure to 2 µg/ml of the ‘semi-pure protein’ compared to control cells. 
MMPs are involved in processes such as tissue remodelling and neo-vascularisation 
(Manicone & McGuire 2008; Pflugfelder et al., 2005). These enzymes are involved in 
the degradation of ECM components and have been linked to inflammation in 
granulomatous rosacea (Jang et al., 2010). Cathelicidin peptides have vasoactivating 
and pro-inflammatory functions and are implicated in the induction of rosacea 
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(Yamasaki & Gallo, 2009). Detection of this protein was increased 2.4 fold (p=0.037) 
when neutrophils were exposed to 2 µg/ml of the ‘semi-pure’ protein for 6 minutes 
compared to control cells. 
In Chapter 5 the effect of Bacillus proteins on the corneal epithelial cell line 
(hTCEpi) and on primary limbal epithelial cells was investigated. Corneal epithelial 
cells function as a protective barrier of the ocular surface and form part of the innate 
immune response (Ueta & Kinoshita 2010). Rosacea patients manifest ocular symptoms 
in up to 50% of cases (Oltz & Check 2011). In the most severe cases of ocular rosacea, 
sight diminishing ulcers can form on the corneal surface resulting in the need for 
surgical correction in some cases (Oltz & Check, 2011; Kheirkhah et al., 2007). In 
Chapter 3 the detection of B. oleronius proteins in the tear fluid of 6 people with ocular 
rosacea was observed therefore it is possible that the presence of Demodex mites and 
this associated bacterium in the eyelash follicles and meibomian glands could induce 
inflammation of the corneal surface observed in severe cases of ocular rosacea.  
The growth of hTCEpi cells in response to the potentially antigenic proteins was 
assessed first. There was a significant inhibition of 26% (p = 0.018) in corneal cell 
growth following 5 days of antigen exposure (2 µg/ml). Growth was inhibited by 75% 
following exposure to 6 µg/ml of the ‘semi pure’ protein. The slowing of epithelial cell 
growth indicates that the protein had a toxic affect on the corneal cells over time (Huo et 
al., 2009). The next aim in this Chapter was to investigate the wound healing response 
of hTCEpi cells to the bacterial proteins (2 & 6 µg/ml). Images presented in section 5.3 
revealed that the cells were closing the wound more rapidly following exposure to the 
proteins. Therefore it was thought that cells were migrating at an increased rate at the 
leading edge of the wound following exposure to the antigens (Zieske et al., 1989). A 
number of experiments were then designed to examine the effect of the bacterial 
proteins on cell movement. 
Migration was examined in a similar assay to that used to test neutrophil 
responses. Corneal cells were placed inside porous inserts (8 µm) and incubated in 
KGM-2 medium containing bacterial protein (2, 4 & 6 µg/ml), an increase in migration 
was noted following exposure to the proteins. Migration increased 3.6 fold (p=0.001) in 
response to 2 µg/ml of the antigen and by 14.5 fold in response to 6 µg/ml treatment 
(p=0.0001) when compared to control cells. hTCEpi cell invasion was examined using a 
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similar technique and was shown to increase by 1.7 fold (p=0.003) in response to 2 
µg/ml of the antigen and by 1.8 fold (p=0.01) in response to 6 µg/ml when compared to 
control cells. These assays along with the wound healing assay indicate increased 
motility of corneal epithelial cell following exposure to the bacterial proteins. Adhesion 
assays showed a consistent decrease in adherence to laminin of 1.7 fold (p=0.002) 
following exposure to 2 µg/ml of bacterial proteins. Altered migration, wound healing, 
invasion and adhesion to the basement membrane are factors that would potentially 
contribute to corneal cell erosion (Lin & Kurpakus-Wheater 2002; Yamaguchi et al. 
2011; Markoulli et al., 2011). Corneal erosion is linked to the development of microbial 
keratitis in contact lens wearers (Markoulli et al., 2011). It is possible that the presence 
of bacterial antigens in the tear fluid and on the ocular surface cause an inflammatory 
response in corneal epithelial cells that can lead to corneal erosion  
In Chapter 5 the expression of a number of proteins in corneal epithelial cells in 
response to the Bacillus antigens were also investigated. Several of the proteins 
investigated by immunofluorescence imaging and Western blotting revealed no change 
in response to these antigens. Cytokeratins 3, 12 and 19 expressions were not altered in 
treated compared to control cells, neither was the cell-cell interaction protein E-
cadherin. In line with the increase in migration there was an increase in vinculin 
expression recorded along with a decrease in expression of β1-integrin. Vinculin is a 
membrane cytoskeletal protein that interacts with the basement membrane (Wu et al., 
1995) and it was increased 2.7 fold (p=0.0009) in response to exposure to 6 µg/ml of the 
protein preparation. Increased vinculin expression has been demonstrated in migrating 
cells at the leading edge of a corneal wound in rat cells (Zieske et al., 1989). Matrix 
metalloproteinases have been implicated in degradation of the stromal basement 
membrane over which the cell migrates (Fini et al., 1996). The presence and activity of 
MMP-9 in corneal epithelial cell exposed to Bacillus antigens was investigated. An 
increase of 1.34 fold (p=0.03) in MMP-9 expression was recorded following exposure 
to 2 µg/ml of bacterial protein. MMP-9 activity increased by 1.96 fold (p=0.046) 
following exposure to 4 µg/ml of the proteins. Exposure of hTCEpi cells to the 
Demodex-associated bacterial proteins caused increased cell movement which could 
potentially cause an increased loss of corneal cells through re-epithelialization. 
Recurrent movement of the cells coupled with increased production of MMP-9 which 
degrades components of the basement membrane can contribute to the formation of 
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corneal ulcers (Fini et al., 1998; Fini et al., 1996; Suzuki et al., 2003). The presence of 
MMPs has previously been detected at increased concentrations in the tear fluid of 
ocular rosacea patients (Kari & Kari, 2006). 
In Chapter 5 the limbal epithelial cells (LECs) were cultured using limbal stem 
cell tissue explants. The limbal region of the eye harbours stem cells which service the 
corneal epithelial surface (Ahmad et al., 2010). A limited amount of limbal tissue was 
available therefore results from this section are inconclusive and the need for further 
investigation in this area is indicated. LECs were investigated in a wound healing assay 
and cells indicated a growth response similar to that seen in the hTCEpi cell line in that 
the cells exposed to the bacterial proteins tended to close the wound faster than control 
cells. Immunoblots were performed by exposing LECs to Bacillus proteins (2 & 4 
µg/ml) for four days then obtaining the protein extract from the limbal cells. Most of the 
markers tested showed no significant change in response to the antigens. Cytokeratin 19 
expression was increased 1.24 fold (p=0.005) following exposure to 2 µg/ml of bacterial 
protein, however these results are represented from technical replicates. Further 
investigation is necessary to indicate if any significant changes are induced in these 
cells by B. oleronius proteins.  
In Chapter 6 it was sought to examine the effect of culture conditions on protein 
production in the bacterium B. oleronius. It has been established throughout this body of 
work that this bacterium produces proteins capable of inducing an inflammatory 
immune response (Lacey et al., 2007; Li et al., 2010). The growth response of the 
bacterium to various culture conditions was assessed first and it was found that this 
bacterium could adapt to many environments. Two-Dimensional proteomic analysis 
was coupled with LC/MS to allow a more detailed comparison of the proteins with 
altered expression in the different growth environments (Michael et al., 2008). 
Following comparison of protein production at 30 °C and 37 °C in minimal nutrient 
broth, four proteins were found to be increased at 30 °C and two at 37 °C. Growth 
curves have suggested that B. oleronius grows preferentially at 30 °C in minimal 
medium. Naphthoate synthase and superoxide dismutase (SOD) were both increased at 
30 °C and have been described as stress response proteins (Ramchandra & Sturm 2010; 
Areekit et al., 2011). SOD was also identified in the protein preparation used to treat the 
neutrophil and corneal cells. SOD is produced by bacterial cells in response to reactive 
oxygen species (ROS) in the host tissue. ROS are elevated in rosacea patient skin and 
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the anti-inflammatory drugs used to treat the condition are known to target these 
molecules (Yamasaki & Gallo, 2009). Lactate dehydrogenase, an enzyme involved in 
glycolysis and a TetR family transcriptional regulator were also up-regulated at 30 °C.  
PtsH a component of the phosphoenolpyruvate-dependent sugar 
phosphotransferase system showed increased expression in cells cultured at 37 °C, this 
enzyme was previously identified as a stimulatory protein spot from the 62 kDa region 
(Lacey et al., 2007). Growth curves have shown that B. oleronius cultured in nutrient 
broth at 37 °C grow slower that those at 30 °C. One dimensional electrophoresis has 
shown that this bacterium tends to produce more proteins at 37 °C. A study performed 
by Dahl et al., (2004) investigated protein secretion by S. epidermidis at 30 °C and 37 
°C and found that protein production was increased at 37 °C. They also postulate that 
skin temperature might regulate the protein secretion of these proteins and the skin of 
rosacea patients in thought to be elevated compared to control subjects. Western 
blotting analysis using both the rabbit anti62 kDa antibody and human serum indicated 
that aerated cultures at 30 and 37 °C produce similar levels of the stimulatory protein. 
Both 1D and 2D techniques were employed to make a comparison between 
nutrient rich (2XYT broth) and nutrient poor (nutrient broth) media. Upon identification 
of the significantly up-regulated proteins most were found in cells cultured in nutrient 
poor medium. Proteins involved in metabolism and growth such as naphthoate synthase, 
dihydrolipoamide dehydrogenase, cell division protein FtsZ and elongation factor Tu 
were all upregulated in cells grown at 30 °C in nutrient poor medium compared to those 
cultured at 30 °C in 2XYT broth. Proteins such as those essential to bacterial cell 
growth and metabolism often have antigenic properties (Kyungwoo 2011; Nieves et al., 
2010; Sharma et al., 2011). Growth curves revealed that B. oleronius grew more rapidly 
in the rich medium and production of the 62 kDa stimulatory antigen is similar in both 
media under aerated conditions when probing with the rabbit antibody. However by 
immunoblotting with rosacea patient sera it can be seen that the bacterium produced 
more stimulatory proteins in nutrient poor conditions than in nutrient rich conditions at 
30 °C. Production of flagellin was also increased in nutrient poor conditions at 30 °C, 
this was another protein identified in the protein preparation used to in cell culture 
assays. Flagellins aid the motility of bacterial cells and are often recognised by the host 
immune response as virulence factors or triggers (Gao et al., 2010; Hozono et al., 2006; 
Kumar et al., 2007).  
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Following consideration of the growth curves it was noted that culture of B. 
oleronius at 30 °C nutrient broth in a static incubator gave the slowest growth and 
culture at 37 °C in 2XYT medium with aeration gave the fastest growth. Upon 
examination of the expression of the stimulatory 62 kDa antigen under these conditions 
it was seen (with the use of the rabbit anti-62 kDa antibody) that optimum growth 
conditions produced higher amounts of this protein. Similar results were noted upon 
blotting with rosacea patient sera however cells grown in static culture did produce a 
visible reactive band at the 62 and 83 kDa regions. Proteins identified to have increased 
expression when cells were cultured in optimum conditions were, transketolase, 
involved in carbohydrate metabolism, a putative secreted protein (function unknown) 
and two proteins involved in assembly of flagellar filaments. Culture in the minimal 
growth conditions lead to increased expression of aconitate hydratase, superoxide 
dismutase (SOD), alkyl hydroperoxide reductase (AHP) and a Hag protein. SOD and 
AHP are involved in cellular stress responses by protecting the bacterium from harmful 
oxygen radicals (Kim et al., 2010) and these proteins were also identified in the protein 
preparation used to treat cells of the innate immune system.  
It has been postulated that the proliferation of Demodex mites in the 
pilosebaceous unit and the eyelash follicles known to occur in rosacea patients (Bonnar 
et al., 1993) leads to increased density of the bacteria for which these mites act as 
vectors (Wolf et al., 1988; Lazaridou et al., 2011). The Demodex-associated bacterium 
Bacillus oleronius and its associated stimulatory proteins could potentially induce and 
immune response (Delaney, 2004;Lacey et al., 2007; Lacey, 2007; Li et al., 2010) in the 
tissue surrounding the pilosebaceous unit meibomian glands. The work outlined here 
has shed light on the potential cellular responses of cells of the innate immune response 
to these bacterial proteins. Many questions remain to be answered about the etiology 
and pathogenesis of rosacea, this is an active area of research with many groups 
worldwide focused on elucidating the molecular and cellular mechanisms involved in 
the progression of the condition.  
The work discussed here indicates the potential for further investigation of the 
role of Demodex and the bacterium Bacillus oleronius in the pathogenensis of rosacea. 
Further investigation into producing a diagnostic assay perhaps with the use of 
recombinant anti 62 kDa antigen could be beneficial. ROS production through the 
NADPH oxidase pathway in response to Bacillus antigens could provide further insight 
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into the pathogenesis of the bacterium. The effect of B. oleronius on corneal epithelial 
cells could be further investigated with the addition of an air-lifted cell model. The use 
of other ocular surface cell lines such as conjuctival epithelial cells and more extensive 
investigations using limbal epithelial cells could also provide useful information. 
Further investigations employing sebaceous gland cells or other skin cells in air-lifted 
models could provide more insight into the cutaneous effects caused by the bacterial 
antigens. 
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Appendix 
 Immunoblot analysis of sera from ocular rosacea patients, 
erythematotelangeictatic rosacea patients and controls. These blots correspond to the 
datain Chapter 3, section 3.2.1 & 3.2.2. The data is summarised in Table 3.1. 
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Figure 8.1 A Western blot analysis of sera from rosacea patients to the B. oleronius 
protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with ocular rosacea. 
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Figure 8.1 B Western blot analysis of sera from rosacea patients to the B. oleronius 
protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with ocular rosacea. 
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Figure 8.2 A Western blot analyses of control sera to the B. oleronius protein 
extract 
The blots represented here are control samples that showed no or very weak reactivity to 
the stimulatory antigens. (Ocular Rosacea study) 
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Figure 8.2 B Western blot analysis of control sera to the B. oleronius protein 
extract 
The blots represented here are control samples that showed no or very weak reactivity to 
the stimulatory antigens. (Ocular Rosacea study) 
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Figure 8.2 C Western blot analysis of control sera to the B. oleronius protein 
extract 
The blots represented here are control samples that showed no or very weak reactivity to 
the stimulatory antigens. (Ocular Rosacea study) 
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Figure 8.3 Western blot analysis of sera from rosacea patients to the B. oleronius 
protein extract 
The blots represented here showed reactivity to one or both of the stimulatory antigens 
but where later revealed to be controls. (Ocular Rosacea study) 
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Figure 8.4 Western blot analysis of sera from rosacea patients to the B. oleronius 
protein extract 
 
The blots represented here showed weak reactivity to one or both of the stimulatory 
antigens, they were labelled as controls and where later revealed to be positive for 
ocular rosacea. (Ocular Rosacea study) 
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Figure 8.5 A Western blot analysis of sera from type one rosacea patients to the B. 
oleronius protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with type one rosacea. 
(Erythematotelangiectatic Rosacea study) 
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Figure 8.5 B Western blot analysis of sera from type one rosacea patients to the B. 
oleronius protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with type one rosacea. 
(Erythematotelangiectatic Rosacea study) 
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Figure 8.5 C Western blot analysis of sera from type one rosacea patients to the B. 
oleronius protein extract 
These blots represent cases where the sera showed positive reaction to one or both of 
the stimulatory antigens and the person had been diagnosed with type one rosacea. 
(Erythematotelangiectatic Rosacea study) 
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Figure 8.6 A Western blot analysis of control sera to the B. oleronius protein 
extract 
The blots represented here are control samples that showed no or very weak reactivity to 
the stimulatory antigens. (Erythematotelangiectatic Rosacea study) 
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Figure 8.6 B Western blot analysis of control sera to the B. oleronius protein 
extract 
The blots represented here are control samples that showed no or very weak reactivity to 
the stimulatory antigens. (Erythematotelangiectatic Rosacea study) 
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